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1 © European Food Safety Authority, 2011 
SCIENTIFIC OPINION  
Scientific Opinion on Flavouring Group Evaluation 8, Revision 3 
(FGE.08Rev3): 
Aliphatic and alicyclic mono-, di-, tri-, and polysulphides with or without 
additional oxygenated functional groups from chemical groups 20 and 301 
EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
(CEF)2, 3  
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT  
The Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids of the European 
Food Safety Authority was requested to evaluate 70 flavouring substances in the Flavouring Group 
Evaluation 08, Revision 3, using the Procedure in Commission Regulation (EC) No 1565/2000. For 
the substances 2-methylpropane-2-thiol [FL-no: 12.174], methyl methanethiosulphonate [FL-no: 
12.159], 2-methylbutane-2-thiol [FL-no: 12.172] and 2,4,4-trimethyl-1,3-oxathiane [FL-no: 16.057] 
there is an indication of a genotoxic potential in vitro. Therefore, in the absence of further genotoxicity 
data, the Panel concluded that the Procedure could not be applied to these four substances. For four 
substances, 3-mercaptooctanal [FL-no: 12.268], 3-mercaptodecanal [FL-no: 12.269], methanedithiol 
diacetate [FL-no: 12.271] and 3,5-dimethyl-1,2-dithiolane-4-one [FL-no: 12.295] no data on use as 
flavouring substances in Europe are available. Therefore, no intakes in Europe can be estimated and 
accordingly the Panel concluded that the Procedure could not be applied to these four substances 
either. The remaining 62 substances were evaluated through a stepwise approach that integrates 
information on structure-activity relationships, intake from current uses, toxicological threshold of 
concern, and available data on metabolism and toxicity. The Panel concluded that 48 substances do 
not give rise to safety concerns at their levels of dietary intake, estimated on the basis of the MSDI 
approach. For the remaining fourteen substances [FL-no: 12.120, 12.093, 12.094, 12.097, 12.100, 
12.112, 12.116, 12.164, 12.167, 12.199, 15.007, 15.102 and 15.125 and 15.134] evaluated through the 
Procedure, no appropriate NOAEL was available and additional data are required. Besides the safety 
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preparatory work on this scientific Opinion. 
Flavouring Group Evaluation 08, Revision 3
 
 
2 EFSA Journal 2011; 9(5):1988 
assessment of these flavouring substances, the specifications for the materials of commerce have also 
been considered and for eightteen substances information on specifications is lacking.  
 
© European Food Safety Authority, 2011 
SUMMARY  
The European Food Safety Authority (EFSA) asked the Panel on Food Contact Materials, Enzymes, 
Flavourings and Processing Aids (the Panel) to provide scientific advice to the Commission on the 
implications for human health of chemically defined flavouring substances used in or on foodstuffs in 
the Member States. In particular, the Panel was requested to evaluate 70 flavouring substances in the 
Flavouring Group Evaluation 8, Revision 3 (FGE.08Rev3), using the Procedure as referred to in the 
Commission Regulation (EC) No 1565/2000. These 70 flavouring substances belong to chemical 
groups 20 and 30, Annex I of the Commission Regulation (EC) No 1565/2000. 
The present Flavouring Group Evaluation (FGE) deals with 70 straight or branched chain or 
heterogeneous ring aliphatic hydrocarbons containing one or more sulphur atoms. The sulphur-
containing functional groups are present as thiols, sulphides or sulphones. Based on their structures, 
the candidate substances can be subdivided into 11 subgroups.  
Twenty-two of the 70 flavouring substances possess one or more chiral centres [FL-no: 12.104, 
12.106, 12.120, 12.135, 12.177, 12.178, 12.180, 12.182, 12.214, 12.250, 12.266, 12.268, 12.269, 
12.278, 12.295, 15.007, 15.047, 15.048, 15.083, 15.134, 16.057 and 16.114]. The stereoisomeric 
composition has not been specified sufficiently for nine of these 22 substances [FL-no: 12.120, 
12.250, 12.266, 12.268, 12.269, 12.278, 15.007, 15.134 and 16.114]. Six of the 70 substances can 
exist as geometrical isomers [FL-no: 12.098, 12.163, 12.164, 12.298, 15.056 and 15.110]. Industry has 
informed that these substances occurs as mixtures of geometrical isomers, however, the composition 
of the mixtures have not been  specified sufficiently, as the actual ratio has to be given.  
Composition of mixtures should be clarified for [FL-no: 12.298 and 15.007]. 
Forty-four of the candidate substances belong to structural class I, 19 belong to structural class II and 
six belong to structural class III. 
Forty-five of the flavouring substances in the present group have been reported to occur naturally in a 
wide range of food items. 
According to the default MSDI approach, the 66 of the 70 flavouring substances for which Flavour 
Industry have submitted data, have intakes in Europe ranging from 0.0012 to 6.1 
microgram/capita/day, which are below the threshold of concern value for structural class I (1800 
microgram/person/day), structural class II (540 microgram/person/day) and structural class III (90 
microgram/person/day) substances. 
On the basis of the reported annual production volumes in Europe (MSDI approach), the combined 
intake of the 39 of 44 candidate substances belonging to class I for which data were submitted and the 
substance evaluated through the Procedure, the 17 of the 19 candidate substances belonging to class II 
for which data were submitted and the substance evaluated through the Procedure, and the six of seven 
candidate substances belonging to class III and evaluated through the Procedure, would result in total 
intakes of approximately 11, 6 and 16, respectively, which do not exceed the thresholds of concern. 
Based on reported production volumes, European per capita intakes (MSDI) could be estimated for 68 
of the 127 supporting substances. The total combined intakes of the candidate and supporting 
substances (for which there are European intake data) are approximately 648, 115 and 16 
Flavouring Group Evaluation 08, Revision 3
 
 
3 EFSA Journal 2011; 9(5):1988 
microgram/capita/day for structural class I, II and III, respectively, which do not exceed the thresholds 
of concern for structural class I, II or III of 1800, 540 or 90 microgram/person/day, respectively.  
Data on genotoxicity of the candidate substances are limited and the genotoxicity could not be 
adequately assessed. The data available, however, give rise to some concern of a genotoxic potential 
of two of the candidate substances 2-methylpropane-2-thiol [FL-no: 12.174] and methyl 
methanethiosulphonate [FL-no: 12.159]. The Panel, therefore, concluded that the Procedure could not 
be applied to these two substances, nor to the two to [FL-no: 12.174] structurally related candidate 
substances, 2-methylbutane-2-thiol [FL-no: 12.172] and 2,4,4-trimethyl-1,3-oxathiane [FL-no: 16.057] 
until adequate in vivo genotoxicity data become available. The Panel noted that in FGE.08 five of the 
supporting substances were tertiary thiols [FL-no: 12.038, 12.085, 12.137, 12.138 and 12.145] for 
which a concern for genotoxicity has been raised in FGE.08Rev1. These supporting substances have 
been evaluated by the JECFA at the 53rd meeting and are not scheduled for evaluation by EFSA. 
However, these substances should be considered by Panel based on the outcome of the evaluation of 
the two candidate substances being tertiary thiols [FL-no: 12.172 and 12.174]. 
The genotoxicity data available for the remaining candidate substances do not preclude their 
evaluation through the Procedure.  
For three substances in structural class I, 3-mercaptooctanal, 3-mercaptodecanal, methanedithiol 
diacetate [FL-no: 12.268, 12.269 and 12.271] and for one substance, 3,5-dimethyl-1,2-dithiolane-4-
one in structural class II [FL-no: 12.295] no data on use as flavouring substances in Europe are 
available, therefore no intakes can be estimated and accordingly these substances can not be evaluated 
through the procedure. 
The candidate substances and supporting substances are expected to share common routes of 
absorption, distribution and metabolism, and exhibit similar toxicological properties. These metabolic 
pathways are unlikely to be saturated, given the low levels of exposure from their use as flavouring 
substances. However, due to the reactivity of the metabolites, the candidate substances cannot be 
predicted to be metabolised to innocuous products. 
Except for subgroups II [FL-no: 12.120, 15.102 and 15.125], VI [FL-no: 12.093, 12.094, 12.097, 
12.100, 12.112, 12.116, 12.164 and 12.167], IX [FL-no: 12.199] and XI [FL-no: 15.007] and one 
candidate substance in subgroup VII [FL-no: 15.134], adequate repeated-dose toxicity studies are 
available for supporting substances from the different subgroups, allowing derivation of adequate 
margins of safety by comparing the NOAEL values with the MSDI.  
It is considered that on the basis of the default MSDI approach the 48 of the 62 candidate substances 
evaluated through the Procedure would not give rise to safety concerns at the estimated levels of 
intake arising from their use as flavouring substances. Additional toxicity data are required for the 
three candidate substances in subgroup II [FL-no: 12.120, 15.102 and 15.125], for the eight candidate 
substances in subgroup VI [FL-no: 12.093, 12.094, 12.097, 12.100, 12.112, 12.116, 12.164 and 
12.167], for one candidate substance in subgroup VII [FL-no: 15.134], for the candidate substance in 
subgroup IX [FL-no: 12.199]  and for the candidate substance in subgroup XI [FL-no: 15.007].  
Additional in vivo data on genotoxicity are required for candidate substances 2-methylpropane-2-thiol 
[FL-no: 12.174], methyl methanethiosulphonate [FL-no: 12.159], 2-methylbutane-2-thiol [FL-no: 
12.172] and 2,4,4-trimethyl-1,3-oxathiane [FL-no: 16.057].  
When the estimated intakes were based on the mTAMDI they ranged from 28 to 8000 
microgram/person/day for the 39 of the 44 candidate substances from structural class I for which 
intake data have been submitted and the substances have been evaluated through the Procedure. These 
intakes were below the threshold of concern for structural I of 1800 microgram/person/day, except for 
two candidate substances [FL-no: 12.250 and 12.282]. The estimated intakes for the 16 of the 19 
candidate substances assigned to structural class II for which intake data have been submitted and the 
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substances evaluated through the Procedure, based on the mTAMDI, ranged from 46 to 78 
microgram/person/day, which are below the threshold of concern for structural class II of 540 
microgram/person/day. The estimated intakes for the five candidate substances assigned to structural 
class III and evaluated through the Procedure, based on the mTAMDI, are in the range of 78 to 500 
microgram/person/day. For one of the substances [FL-no: 15.081] the mTAMDI is below the 
threshold of concern of 90 microgram/person/day. The 54 candidate substances which have mTAMDI 
intake estimates below the threshold of concern for structural class I, II and III, are also expected to be 
metabolised to innocuous products. 
For the six flavouring substances [FL-no: 12.120, 12.136, 12.250, 12.282, 15.134 and 16.114] 
evaluated through the Procedure, for which the intakes, estimated on the basis of the mTAMDI, 
exceed the relevant threshold for their structural class more reliable exposure data are required, as well 
as for the substances for which use levels have not been provided. On the basis of such additional data, 
these flavouring substances should be re-evaluated using the Procedure. Subsequently, additional 
toxicological data might become necessary. 
In order to determine whether the conclusion for the 62 candidate substances evaluated through the 
Procedure can be applied to the material of commerce, it is necessary to consider the available 
specifications. Specifications including complete purity criteria and identity for the materials of 
commerce have been provided for 68 of the 70 candidate substances. For two substances [FL-no: 
12.266 and 15.125] have specifications not been provided. Information on chirality has not been 
specified sufficiently for nine of the substances [FL-no: 12.120, 12.250, 12.266, 12.268, 12.269, 
12.278, 15.007, 15.134  and 16.114] and composition of the mixture of the geometrical isomers is 
lacking for six of the substances [FL-no: 12.098, 12.163, 12.164, 12.298, 15.056 and 15.110], and 
composition of mixture should be clarified for [FL-no: 12.298 and 15.007]. For four substances is an 
identity test missing [FL-no: 12.268, 12.269, 12.271 and 12.282]. Additional toxicity data are required 
for the three candidate substances in subgroup II [FL-no: 12.120, 15.102 and 15.125], for the eight 
candidate substances in subgroup VI [FL-no: 12.093, 12.094, 12.097, 12.100, 12.112, 12.116, 12.164 
and 12.167], for one candidate substance in subgroup VII [FL-no: 15.134], for the candidate substance 
in subgroup IX [FL-no: 12.199] and the candidate substance in subgroup XI [FL-no: 15.007].. 
Additional in vivo data on genotoxicity are required for candidate substances 2-methylpropane-2-thiol 
[FL-no: 12.174], methyl methanethiosulphonate [FL-no: 12.159], 2-methylbutane-2-thiol [FL-no: 
12.172] and 2,4,4-trimethyl-1,3-oxathiane [FL-no: 16.057]. For four substances, 3-mercaptooctanal 
[FL-no: 12.268], 3-mercaptodecanal [FL-no: 12.269], methanedithiol diacetate [FL-no: 12.271] and 
3,5-dimethyl-1,2-dithiolane-4-one [FL-no: 12.295] data on use as flavouring substances in Europe are 
required. 
Thus, the final evaluation of the materials of commerce cannot be performed for 32 of the 70 
substances [FL-no: 12.093, 12.094, 12.097, 12.098, 12.100, 12.112, 12.116, 12.120, 12.159, 12.163, 
12.164, 12.167, 12.172, 12.174,  12.199, 12.250, 12.266, 12.268, 12.269, 12.271, 12.278, 12.282, 
12.295, 12.298, 15.007, 15.056, 15.102, 15.110, 15.125, 15.134, 16.057 and 16.114], pending further 
information.  
The remaining 38 flavouring substances evaluated through the Procedure [FL-no: 12.096, 12.099, 
12.103, 12.104, 12.106, 12.111, 12.117, 12.124, 12.125, 12.127, 12.129, 12.135, 12.136, 12.151, 
12.152, 12.158, 12.165, 12.166, 12.177, 12.178, 12.180, 12.181, 12.182, 12.183, 12.189, 12.191, 
12.196, 12.200, 12.205, 12.214, 12.221, 12.277, 15.047, 15.048, 15.081, 15.083, 15.103 and 15.111] 
would present no safety concern at the levels of intake estimated on the basis of the MSDI approach. 
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BACKGROUND 
Regulation (EC) No 2232/96 of the European Parliament and the Council (EC, 1996a) lays down a 
Procedure for the establishment of a list of flavouring substances the use of which will be authorised 
to the exclusion of all other substances in the EU. In application of that Regulation, a Register of 
flavouring substances used in or on foodstuffs in the Member States was adopted by Commission 
Decision 1999/217/EC (EC, 1999a), as last amended by Commission Decision 2008/163/EC (EC, 
2009a). Each flavouring substance is attributed a FLAVIS-number (FL-number) and all substances are 
divided into 34 chemical groups. Substances within a group should have some metabolic and 
biological behaviour in common. 
Substances which are listed in the Register are to be evaluated according to the evaluation programme 
laid down in Commission Regulation (EC) No 1565/2000 (EC, 2000a), which is broadly based on the 
Opinion of the Scientific Committee on Food (SCF, 1999a). For the submission of data by the 
manufacturer, deadlines have been established by Commission Regulation (EC) No 622/2002 (EC, 
2002b).  
The FGE is revised to include substances for which data were submitted after the deadline as laid 
down in Commission Regulation (EC) No 622/2002 and to take into account additional information 
that has been made available since the previous Opinion on this FGE.  
The Revision also includes newly notified substances belonging to the same chemical groups 
evaluated in this FGE. 
After the completion of the evaluation programme the Community List of flavouring substances for 
use in or on foods in the EU shall be adopted (Article 5 (1) of Regulation (EC) No 2232/96) (EC, 
1996a). 
HISTORY OF THE EVALUATION 
FGE Opinion 
adopted by 
EFSA 
Link No. of 
candidate 
substances 
FGE.08 February 2007 http://www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1211902372956.htm 
52 
FGE.08Rev1 March 2009 http://www.efsa.europa.eu/en/scdocs/scdoc/1021.htm 66 
FGE.08Rev2 November 2009 http://www.efsa.europa.eu/en/scdocs/scdoc/1408.htm 67 
FGE.08Rev3 February 2011  70 
 
The present Revision of FGE.08, FGE.08Rev3, includes the assessment of three additional candidate 
substances [FL-no: 15.007, 15.134 and 16.114]. No metabolism data were provided for these 
substances. A 90-day toxicity study has been provided for the candidate substance [FL-no: 15.007], no 
toxicity studies have been provided for the other two candidate substances (Flavour Industry, 2009o) 
(Flavour Industry, 2009s). A search in open literature for these substances did not provide any further 
data on toxicity or metabolism. The JECFA evaluated [FL-no: 15.134] in 1999 (JECFA no 550) as of 
no safety concern based on US MSDI intake data (none were available for EU at that time). The 
JECFA evaluated spiro[2,4-Dithia-1-methyl-8-oxabicyclo(3.3.0)octane-3,3'-(1'-oxa-2'-methyl)-
cyclopentane] (JECFA no 1296, not in the database and not in use in Europe), which is one of the two 
isomers of spiro(2,4-Dithia-1-methyl-8-oxa-bicyclo[3.3.0]octane-3,3’-(1’- oxa-2’-methyl)-
cyclopentane) and spiro(Dithia-6-methyl-7-oxa-bicyclo[3.3.0]octane-3,3’-spiro(2,4-(1’-oxa-2-
methyl)cyclopentane) [FL-no: 15.007]. Relevant information on the JECFA evaluated substance has 
been included in relevant sections of this revision of FGE.08.  
Furthermore, in the FGE.08, it was found that within subgroup II, no adequate toxicity study from 
which a NOAEL could be established was available, neither on the candidate substances nor on 
supporting substances. Therefore, the Panel concluded that additional data are required for the three 
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cyclic sulphides in subgroup II [FL-no: 12.120, 15.102 and 15.125]. Additional toxicity data have now 
become available for [FL-no: 12.120] and the present Revision of FGE.08, FGE.08Rev3 includes the 
evaluation of these toxicity data submitted by the Industry (Flavour Industry, 2009o). 
Since the publication of FGE.08Rev2, information on stereoisomeric composition has been provided 
by EFFA on the following 13 substances: [FL-no: 12.104, 12.106, 12.135, 12.177, 12.178, 12.180, 
12.182, 12.214, 12.295, 15.047, 15.048, 15.083 and 16.057] (EFFA, 2010a). 
TERMS OF REFERENCE 
The European Food Safety Authority (EFSA) is requested to carry out a risk assessment on flavouring 
substances in the Register prior to their authorisation and inclusion in a Union List according to 
Commission Regulation (EC) No 1565/2000 (EC, 2000a). In addition, the Commission requested 
EFSA to evaluate newly notified flavouring substances, where possible, before finalising the 
evaluation programme. 
In addition, in letter of 11 May 2009  the Commission requested EFSA to carry out a risk assessment 
on 2,5-dihydroxy-1,4-dithiane [FL-no: 15.134] and  2-pentyl-4-propyl-1,3-oxathiane [FL-no: 16.114] 
in accordance with Commission Regulation (EC) No 1565/2000 (EC, 2000a): 
“The European Commission requests the European Food Safety Authority to carry out a risk 
assessment on eighteen new flavouring substances in accordance with Commission Regulation (EC) 
No 1565/2000, if possible by the end of the evaluation programme, if not within nine month from the 
finalisation of that programme”. 
The deadline of the Terms of Reference was negotiated to 31 May 2011.  
The remaining 16 substances of this request were evaluated in other FGEs. 
ASSESSMENT 
1. Presentation of the Substances in Flavouring Group Evaluation 8, Revision 3 
1.1. Description 
The present revision of Flavouring Group Evaluation 8, (FGE.08Rev3), using the Procedure as 
referred to in the Commission Regulation (EC) No 1565/2000 (the Procedure – shown in schematic 
form in Annex I of this FGE), deals with 70 flavouring substances (candidate substances) from 
chemical groups 20 and 30 of Annex I of Commission Regulation (EC) No 1565/2000 (EC, 2000a).  
The 70 candidate substances under consideration in the present evaluation, with their chemical 
Register name, FLAVIS- (FL-), Chemical Abstract Service- (CAS-), Council of Europe- (CoE-) and 
Flavor and Extract Manufacturers Association- (FEMA-) numbers, and structures are listed in Table 1. 
The outcome of the Safety Evaluation is summarised in Table 2a. 
The 70 candidate substances are straight or branched chain or heterogeneous ring aliphatic 
hydrocarbons containing one or more sulphur atoms. The sulphur-containing functional groups are 
present as thiols, sulphides or sulphones. Based on their structures, the candidate substances can be 
subdivided into 11 subgroups (see Table 4.1 in Section 4): 
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Subgroup I) Acyclic sulphides: [FL-no: 12.096, 12.099, 12.117, 12.124, 12.127, 12.129, 
12.152, 12.158, 12.163, 12.166, 12.177, 12.178, 12.181, 12.182, 12.183, 
12.214, 12.277 and 12.298] 
Subgroup II) Cyclic sulphides: [FL-no: 12.120, 15.102 and 15.125] 
Subgroup III) Monothiols: [FL-no: 12.104, 12.135, 12.136, 12.172, 12.174, 12.180,  12.191, 
12.205, 12.250, 12.266, 12.268 and 12.269] 
Subgroup IV) Dithiols: [FL-no: 12.103] 
Subgroup V) Acyclic and cyclic disulphides: [12.098, 12.111, 12.151 and 12.295] 
Subgroup VI) Acyclic polysulphides: [FL-no: 12.093, 12.094, 12.097, 12.100, 12.112, 
12.116, 12.164 and 12.167] 
Subgroup VII) Mono-, di-, tri- and polysulphides with thioacetal structure: [FL-no: 12.200, 
15.047, 15.048, 15.056, 15.081, 15.083, 15.103, 15.110, 15.111, 15.134, 
16.057 and 16.114] 
Subgroup VIII) Thioesters: [FL-no: 12.106, 12.125, 12.165, 12.189, 12.196, 12.221, 12.271, 
12.278 and 12.282] 
Subgroup IX) Thioic acids: [FL-no: 12.199] 
Subgroup X) Sulphoxides/sulphones and sulphonates: [FL-no: 12.159] 
Subgroup XI) Cyclic thioketal with fused oxolane ring: [FL-no: 15.007]. 
 
 
The hydrolysis products of the candidate esters and thioesters are listed in Table 2b. In addition, the 
following hydrolysis products may theoretically be formed from the candidate thioacetals in an acid 
environment: Acetaldehyde, formaldehyde, hexanal, 2-methylpropanal, 3-methylbutanal, 3-
mercaptohexan-1-ol,  3-methyl-3-mercaptobutan-1-ol,  mercaptoacetaldehyde, ethanthiol and 
hydrogen sulphide. 
The 70 candidate substances are closely structurally related to 127 flavouring substances (supporting 
substances) evaluated at the 53rd meeting of the Joint FAO/WHO Expert Committee on Food 
Additives (JECFA) in the groups “Simple aliphatic and aromatic sulphides and thiols” (JECFA, 
2000b; JECFA, 2000c). The names and structures of the 127 supporting substances are listed in Table 
3, together with their evaluation status. In table III.1 in Annex III the structures of candidate 
substances and supporting substances are shown, including their division into subgroups. 
1.2. Stereoisomers 
It is recognised that geometrical and optical isomers of substances may have different properties. Their 
flavour may be different, they may have different chemical properties resulting in possible variability 
in their absorption, distribution, metabolism, elimination and toxicity. Thus information must be 
provided on the configuration of the flavouring substance, i.e. whether it is one of the 
geometrical/optical isomers, or a defined mixture of stereoisomers. The available specifications of 
purity will be considered in order to determine whether the safety evaluation carried out for candidate 
substances for which stereoisomers may exist can be applied to the material of commerce. Flavouring 
substances with different configurations should have individual chemical names and codes (CAS 
number, FLAVIS number etc.). 
Twenty-two of the 70 flavouring substances possess one or more chiral centres [FL-no: 12.104, 
12.106, 12.120, 12.135, 12.177, 12.178, 12.180, 12.182, 12.214, 12.250, 12.266, 12.268, 12.269, 
12.278, 12.295, 15.007, 15.047, 15.048, 15.083, 15.134, 16.057 and 16.114]. The stereoisomeric 
composition has not been specified sufficiently for nine these 22 substances [FL-no: 12.120, 12.250, 
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12.266, 12.268, 12.269, 12.278, 15.007, 15.134 and 16.114] (see Table 1). For [FL-no: 12.120] 
Industry has informed that the substance occurs as a mixture of isomers, however, the actual ratio has 
to be given (see Table 1).  
Due to the presence and the position of double bonds, four of the 70 substances [FL-no: 12.098, 
12.163, 12.164 and 12.298] can exist as geometrical isomers and due to the ring structure additional 
two substances [FL-no: 15.056 and 15.110] can exist as geometrical isomers. Industry has informed 
that these substances occurs as mixtures of geometrical isomers, however, the composition of the 
mixtures have not been  specified sufficiently, as the actual ratio has to be given. 
Composition of mixture should be clarified for [FL-no: 12.298 and 15.007] (see Table 1). 
1.3. Natural Occurrence in Food 
Forty-five of the 70 flavouring substances have been reported to occur in boiled or cooked meat (beef, 
pork, chicken, mutton), liver (pork), vegetables (onion, garlic, shallot, caucas, scallion, nira, leek, 
kohlrabi, radish, asparagus, potatoes, tomato), fruits and fruit juices (durian, grapefruit juice), cheese, 
egg, clam, mushroom (shiitake and Agaricus), tea (black), beer, wine (red, white), rum, spices, peanuts 
and sesame seed. Quantitative data on the natural occurrence in food have been reported for 12 of 
these substances (TNO, 2000). 
These reports are: 
• Allyl methyl sulfide [FL-no: 12.096]: up to 12 mg/kg in garlic 
• Butane-2-thiol [FL-no: 12.104]: up to 0.0002 mg/kg in beer 
• Dimethyl tetrasulfide [FL-no: 12.116]: up to 0.001 mg/kg in beer, 2.8 mg/kg in nira 
• 3-(Ethylthio)propan-1-ol [FL-no: 12.129]: up to 0.06 mg/kg in white wine 
• 3-Mercapto-2-methylpropionic acid [FL-no: 12.135]: 0.2 mg/kg in asparagus 
• Methyl butyl sulfide [FL-no: 12.152]: 0.001 mg/kg in beer 
• Methyl propyl sulfide [FL-no: 12.166]: 0.08 mg/kg in kohlrabi, 0.001 mg/kg in Guinea hen 
• Methyl propyl tetrasulfide [FL-no: 12.167]: up to 6.7 mg/kg in onion 
• 1-(Methylthio)pentan-3-one [FL-no: 12.181]: 0.1 mg/kg in kohlrabi 
• 3-(Methylthio)propionic acid [FL-no: 12.183]: up to 0.05 mg/kg in asparagus, up to 0.03 
mg/kg in beer 
• Pentane-1-thiol [FL-no: 12.191]: up to 0.008 mg/kg in beer 
• 1,2,4-Trithiolane [FL-no: 15.111]: 1.6 mg/kg in shiitake mushroom. 
According to TNO the remaining 25 candidate substances have not been reported in any food items 
(TNO, 2000; TNO, 2010): diallyl hexasulfide [FL-no: 12.093], diallyl heptasulfide [FL-no: 12.094], 
allyl methyl tetrasulfide [FL-no: 12.097], S-2-butyl 3-methylbutanethioate [FL-no: 12.106], 3-
mercapto-2-oxopropionic acid [FL-no: 12.136], 3-(methylthio)butyric acid [FL-no: 12.178], 2-
(methylthio)propionic acid [FL-no: 12.182], S-prenyl thioisobutyrate [FL-no: 12.196], ethanethionic 
acid [FL-no: 12.199], 1,1-bis(ethylthio)-ethane [FL-no: 12.200], mercaptoacetaldehyde [FL-no: 
12.205], isobutyl-3-(methylthio)butyrate [FL-no: 12.214], S-prenyl thioisopentanoate [FL-no: 12.221], 
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3-mercaptohexanal [FL-no: 12.250], methyl-2-mercaptopropionate [FL-no: 12.266], 3-
mercaptooctanal [FL-no: 12.268], 3-mercaptodecanal [FL-no: 12.269], methanedithiol diacetate [FL-
no: 12.271], 3-(methylthio)propyl butyrate [FL-no: 12.277], 3-acetyl-mercaptohexyl acetate [FL-no: 
12.278], spiro(2,4-Dithia-1-methyl-8-oxa-bicyclo[3.3.0]octane-3,3’-(1’-oxa-2’-methyl)-cyclopentane) 
and spiro(Dithia-6-methyl-7-oxa-bicyclo[3.3.0]octane-3,3’-spiro(2,4-(1’-oxa-2-methyl)cyclopentane) 
[FL-no: 15.007], 3-methyl-1,2,4-trithiolane [FL-no: 15.083], 4-tetrahydrothiopyranone [ FL-no: 
15.125], 2,5-dihydroxy-1,4-dithiane [FL-no: 15.134] and 2,4,4-trimethyl-1,3-oxathiane [FL-no: 
16.057]. 
2. Specifications 
Purity criteria for the 70 substances have been provided by the Flavour Industry (EFFA, 2002g; 
EFFA, 2004ak; Flavour Industry, 2006q; Flavour Industry, 2006r; Flavour Industry, 2009e; Flavour 
Industry, 2009o; Flavour Industry, 2009s). 
Judged against the requirements in Annex II of Commission Regulation (EC) No 1565/2000 (EC, 
2000a), the information is not adequate for all 70 substances. For two substances [FL-no: 12.266 and 
15.125] specifications have not been provided. Additionally, composition of mixture should be 
clarified for [FL-no: 12.298 and 15.007],  an identification test is missing for four substances [FL-no: 
12.268, 12.269, 12.271 and 12.282] and information on geometrical stereoisomerism and chirality is 
lacking for six and nine substances, respectively (see Section 1.2 and Table 1). Finally, a boiling point 
is missing for [FL-no: 12.250, 12.298], for [FL-no: 12.250] is information on specific gravity missing 
and for [FL-no: 15.134] is information on solubility in ethanol lacking  (see Table 1).  
3. Intake Data 
Annual production volumes of the flavouring substances as surveyed by the Industry can be used to 
calculate the “Maximised Survey-derived Daily Intake” (MSDI) by assuming that the production 
figure only represents 60 % of the use in food due to underreporting and that 10 % of the total EU 
population are consumers (SCF, 1999a). 
However, the Panel noted that due to year-to-year variability in production volumes, to uncertainties 
in the underreporting correction factor and to uncertainties in the percentage of consumers, the 
reliability of intake estimates on the basis of the MSDI approach is difficult to assess. 
The Panel also noted that in contrast to the generally low per capita intake figures estimated on the 
basis of this MSDI approach, in some cases the regular consumption of products flavoured at use 
levels reported by the Flavour Industry in the submissions would result in much higher intakes. In 
such cases, the human exposure thresholds below which exposures are not considered to present a 
safety concern might be exceeded. 
Considering that the MSDI model may underestimate the intake of flavouring substances by certain 
groups of consumers, the SCF recommended also taking into account the results of other intake 
assessments (SCF, 1999a). 
One of the alternatives is the “Theoretical Added Maximum Daily Intake” (TAMDI) approach, which 
is calculated on the basis of standard portions and upper use levels (SCF, 1995) for flavourable 
beverages and foods in general, with exceptional levels for particular foods. This method is regarded 
as a conservative estimate of the actual intake by most consumers because it is based on the 
assumption that the consumer regularly eats and drinks several food products containing the same 
flavouring substance at the upper use level. 
One option to modify the TAMDI approach is to base the calculation on normal rather than upper use 
levels of the flavouring substances. This modified approach is less conservative (e.g., it may 
underestimate the intake of consumers being loyal to products flavoured at the maximum use levels 
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reported) (EC, 2000a). However, it is considered as a suitable tool to screen and prioritise the 
flavouring substances according to the need for refined intake data (EFSA, 2004a). 
3.1. Estimated Daily per Capita Intake (MSDI Approach) 
The intake estimation is based on the Maximised Survey-derived Daily Intake (MSDI) approach, 
which involves the acquisition of data on the amounts used in food as flavourings (SCF, 1999a). These 
data are derived from surveys on annual production volumes in Europe. These surveys were conducted 
in 1995 by the International Organization of the Flavour Industry, in which flavour manufacturers 
reported the total amount of each flavouring substance incorporated into food sold in the EU during 
the previous year (IOFI, 1995). The intake approach does not consider the possible natural occurrence 
in food. 
Average per capita intake (MSDI) is estimated on the assumption that the amount added to food is 
consumed by 10 % of the population4 (Eurostat, 1998). This is derived for candidate substances from 
estimates of annual volume of production provided by Industry and incorporates a correction factor of 
0.6 to allow for incomplete reporting (60 %) in the Industry surveys (SCF, 1999a). 
In the present revision of Flavouring Group Evaluation 8 (FGE.08Rev3) the total annual volume of 
production of the 66 of the 70 candidate substances for use as flavouring substances in Europe, for 
which Industry has submitted production figures, has been reported to be approximately 270 kg 
(EFFA, 2002g; EFFA, 2002h; EFFA, 2002i; EFFA, 2004ak; Flavour Industry, 2006q; Flavour 
Industry, 2006r; Flavour Industry, 2009e; Flavour Industry, 2009o; Flavour Industry, 2009s). For the 
remaining four candidate substances [FL-no: 12.268, 12.269, 12.271 and 12.295] data are not 
available. For 68 of the 127 supporting substances the annual volume of production is 740 kg (JECFA, 
2000b). The annual volumes of production in Europe for 59 of the supporting substances were not 
reported. 
On the basis of the annual volumes of production reported for the 66 of the 70 candidate substances 
for which data are available, the MSDI values for each of these flavourings have been estimated (see 
Table 2a).  
Eighty-eight percent of the total annual volumes of production for the candidate substances is 
accounted for by nine of these flavourings: allyl methyl sulfide [FL-no: 12.096], allyl propyl sulfide 
[FL-no: 12.099], S-2-butyl 3-methylbutanethioate [FL-no: 12.106], 2,8-epithio-p-menthane [FL-no: 
12.120],  3-(methylthio)propyl butyrate [FL-no: 12.277], 3-acetyl-mercaptohexyl acetate [FL-no: 
12.278], spiro(2,4-Dithia-1-methyl-8-oxa-bicyclo[3.3.0]octane-3,3’-(1’-oxa-2’-methyl)-cyclopentane) 
and spiro(Dithia-6-methyl-7-oxa-bicyclo[3.3.0]octane-3,3’-spiro(2,4-(1’-oxa-2-methyl)cyclopentane) 
[FL-no: 15.007],  1,2,4-trithiolane [FL-no: 15.111] and 2,5-dihydroxy-1,4-dithiane [FL-no: 15.134].  
The total estimated daily per capita intake of those nine candidate substances from use as flavouring 
substance is 28 microgram. The daily per capita intakes for the remaining substances are for each less 
than 0.37 microgram, and in total less than 4.5 microgram (see Table 2a). 
3.2. Intake Estimated on the Basis of the Modified TAMDI (mTAMDI) 
The method for calculation of modified Theoretical Added Maximum Daily Intake (mTAMDI) values 
is based on the approach used by SCF up to 1995 (SCF, 1995). 
                                                     
 
4 EU figure 375 millions. This figure relates to EU population at the time for which production data are 
available, and is consistent (comparable) with evaluations conducted prior to the enlargement of the EU. No 
production data are available for the enlarged EU. 
Flavouring Group Evaluation 08, Revision 3
 
 
13 EFSA Journal 2011; 9(5):1988 
The assumption is that a person may consume a certain amount of flavourable foods and beverages per 
day. 
For the present evaluation of the 70 candidate substances, information on food categories and normal 
and maximum use levels5,6,4  were submitted by the Flavour Industry on 62 candidate substances 
(EFFA, 2002g; EFFA, 2002h; EFFA, 2002i; EFFA, 2004ak; EFFA, 2007a; Flavour Industry, 2006q; 
Flavour Industry, 2006r; Flavour Industry, 2009e; Flavour Industry, 2009o).  
The 62 candidate substances are used in flavoured food products divided into the food categories, 
outlined in Annex III of the Commission Regulation (EC) No 1565/2000 (EC, 2000a), as shown in 
Table 3.1. For the present calculation of mTAMDI, the reported normal use levels were used. In the 
case where different use levels were reported for different food categories the highest reported normal 
use level was used. 
                                                     
 
5 ”Normal use” is defined as the average of reported usages and ”maximum use” is defined as the 95th percentile 
of reported usages (EFFA, 2002i). 
6 The normal and maximum use levels in different food categories (EC, 2000) have been extrapolated from 
figures derived from 12 model flavouring substances (EFFA, 2004e). 
4 The use levels from food category 5 “Confectionery” have been inserted as default values for food category 
14.2 “Alcoholic beverages” for substances for which no data have been given for food category 14.2 (EFFA, 
2007a). 
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Table 3.1 Use of Candidate Substances for which data on use in food were submitted 
Food 
category 
Description Flavourings used 
01.0 Dairy products, excluding products of category 2 All 62 except [FL-no: 
15.134, 16.114]  
02.0 Fats and oils, and fat emulsions (type water-in-oil) All 62 except [FL-no: 
15.134, 16.114] 
03.0 Edible ices, including sherbet and sorbet All 60 except [FL-no: 
12.298, 15.134] 
04.1 Processed fruits All 62 except [FL-no: 
15.134, 16.114]   
04.2 Processed vegetables (incl. mushrooms & fungi, roots & tubers, pulses and 
legumes), and nuts & seeds 
[FL-no: 12.250, 12.282 
& 12.298]  
05.0 Confectionery All 62 except [FL-no: 
12.298, 15.134] 
06.0 Cereals and cereal products, incl. flours & starches from roots & tubers, pulses 
& legumes, excluding bakery 
All 62 except [FL-no: 
12.221, 12.250, 12.298, 
15.134, 16.114] 
07.0 Bakery wares All 62  except [FL-no: 
12.127, 16.114] 
08.0 Meat and meat products, including poultry and game All 62 except [FL-no: 
16.114] 
09.0 Fish and fish products, including molluscs, crustaceans and echinoderms  All 62 except [FL-no: 
12.298, 15.134, 16.114] 
10.0 Eggs and egg products None 
11.0 Sweeteners, including honey None 
12.0 Salts, spices, soups, sauces, salads, protein products etc. All 62except [FL-no: 
16.114]  
13.0 Foodstuffs intended for particular nutritional uses All 62 except [FL-no: 
12.250, 12.277, 12.282, 
12.298, 15.081, 15.134, 
16.114] 
14.1 Non-alcoholic ("soft") beverages, excl. dairy products All 62 except [FL-no: 
12.116, 12.200, 12.298, 
15.047, 15.048, 15.134] 
14.2 Alcoholic beverages, incl. alcohol-free and low-alcoholic counterparts All 62 except [FL-no: 
12.298, 15.134] 
15.0 Ready-to-eat savouries All 62 except [FL-no: 
12.165, 12.181, 12.277, 
12.298] 
16.0 Composite foods (e.g. casseroles, meat pies, mincemeat) - foods that could not 
be placed in categories 1 – 15 
All 62 except [FL-no: 
12.298, 15.111, 15.134] 
According to the Flavour Industry the normal use levels for the 62 candidate substances for which data 
have been provided, are in the range of 0.02 – 25 mg/kg food, and maximum use levels are in the 
range of 0.2 – 250 mg/kg (EFFA, 2002h; EFFA, 2002g; EFFA, 2004ak; EFFA, 2002i; EFFA, 2004ak; 
Flavour Industry, 2006q; Flavour Industry, 2006r; Flavour Industry, 2009e; Flavour Industry, 2009o). 
(see Table II.1.2, Annex II). 
The mTAMDI values for the 39 of the 44 candidate substances from structural class I for which data 
have been provided (see Section 6) range from 28 to 8000 microgram/person/day. For the 17 of the 19 
candidate substances from structural class II for which data have been provided the mTAMDI range 
from 46 to 78 microgram/person/day. For the six of the seven candidate substances from structural 
class III the mTAMDI range from 78 to 500 microgram/person/day. 
For detailed information on use levels and intake estimations based on the mTAMDI approach, see 
Section 6 and Annex II. 
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4. Absorption, Distribution, Metabolism and Elimination 
There are lacks of data to demonstrate to what degree the candidate substances may be absorbed from 
the gastro-intestinal tract. According to available data on lipophilicity and solubility it is presumed that 
relevant supporting substances may be absorbed to the same degree as the candidate substances.  
Depending on the type of sulphur-containing functional groups, the candidate substances can be 
subdivided into 11 subgroups, which are illustrated by representative structures shown in Table 4.1 
 
Table 4.1 Subgroups. The supporting substances are listed in brackets. 
 FL-no EU Register name  
I: ACYCLIC SULPHIDES 
 
S                      and   
 
S OH
O
 
12.096  Allyl methyl sulphide 
12.099 Allyl propyl sulphide 
12.117 Dipentyl sulphide 
12.124  Ethyl butyl sulphide 
12.127 Ethyl propyl sulphide 
12.129 3-(Ethylthio)propan-1-ol 
12.152  Methyl butyl sulphide 
12.158  Methyl isoprenyl sulphide 
12.163  Methyl prop-1-enyl sulfide  1) 
12.166 Methyl propyl sulphide 
12.177 8-(Methylthio)-p-menthan-3-one   1) 
12.178  3-(Methylthio)butyric acid   1) 
12.181  1-(Methylthio)pentan-3-one 
12.182 2-(Methylthio)propionic acid   1) 
12.183  3-(Methylthio)propionic acid 
12.214 Isobutyl-3-(methylthio)butyrate   1) 
12.277 3-(Methylthio)propyl butyrate 
12.298 Di-(1-propenyl)-sulfid (mixture) 
(12.001) 3-(Methylthio)propionaldehyde 
(12.002) Methyl 3-(methylthio)propionate 
(12.006) Dimethyl sulphide 
(12.007) Dibutyl sulphide 
(12.040) 2-Methylthioacetaldehyde 
(12.041) 1-(Methylthio)butan-2-one 
(12.042) 2-(Methylthio)phenol 
(12.052) Di-(3-oxobutyl) sulphide 
(12.053) Ethyl 3-(methylthio)propionate 
(12.056) 3-(Methylthio)butanal 
(12.057) 4-(Methylthio)butan-2-one 
(12.058) 4-(Methylthio)-4-methylpentan-2-one 
(12.060) Methyl 4-(methylthio)butyrate 
(12.061) 4-(Methylthio)butanal 
(12.062) 3-(Methylthio)propan-1-ol 
(12.063) 3-(Methylthio)hexan-1-ol 
(12.065) 2,8-Dithianon-4-en-4-carboxaldehyde 
(12.077) Benzyl methyl sulphide 
(12.078) 4-(Methylthio)butan-1-ol 
(12.084) Ethyl 4-(methylthio)butyrate 
(12.086) Methyl 2-(methylthio)butyrate 
(12.088) Diallyl sulphide 
(12.089) Ethyl 3-(methylthio)butyrate 
(12.113) Diethyl sulphide 
(12.118) 2,4-Dithiapentane 
(12.122) Ethyl 2-(methylthio)acetate 
(12.154) Methyl ethyl sulphide 
(12.162) Methyl phenyl sulphide 
(12.176) 4-(Methylthio)-2-oxobutyric acid 
(12.187) Methylthiomethyl butyrate 
(12.188) Methylthiomethyl hexanoate 
(12.211) But-1-enyl methyl sulphide 
(12.236) 3-(Methylthio)hexyl acetate 
(12.237) 3-(Methylthio)propyl acetate 
II: CYCLIC SULPHIDES  
S
 
12.120 2,8-Epithio-p-menthane   1) 
15.102 Tetrahydrothiophene 
15.125 4-Tetrahydrothiopyranone 
(15.012) 4,5-Dihydrothiophen-3(2H)-one 
(15.023) 4,5-Dihydro-2-methylthiophene-3(2H)-one 
(15.066) 1,4-Dithiane 
III:  MONOTHIOLS 
 
 
12.104  Butane-2-thiol   1) 
12.135 3-Mercapto-2-methylpropionic acid   1) 
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Table 4.1 Subgroups. The supporting substances are listed in brackets. 
 FL-no EU Register name  
SH
     and  
 
 
SH OH
O
 
 
 
12.136 3-Mercapto-2-oxopropionic acid 
12.172  2-Methylbutane-2-thiol 
12.174  2-Methylpropane-2-thiol 
12.180  1-(Methylthio)ethane-1-thiol   1) 
12.191 Pentane-1-thiol 
12.205 Mercaptoacetaldehyde 
12.250 3-Mercaptohexanal   1) 
12.266 Methyl-2-mercaptopropionate   1) 
12.268 3-Mercaptooctanal   1) 
12.269 3-Mercaptodecanal   1) 
(12.003) Methanethiol 
(12.004) Allylthiol 
(12.005) Phenylmethanethiol 
(12.010) Butane-1-thiol 
(12.024) 3-Mercaptobutan-2-ol 
(12.027) 2-Methylbenzene-1-thiol 
(12.029) Cyclopentanethiol 
(12.031) 3-Mercaptopentan-2-one 
(12.035) 2-,3- and 10-Mercaptopinane 
(12.036) 3-[(2-Mercapto-1-methylpropyl)thio]butan-2-ol 
(12.038) 8-Mercapto-p-menthan-3-one 
(12.039) 2-Mercaptopropionic acid 
(12.046) Ethyl 2-mercaptopropionate  
(12.047) 3-Mercaptobutan-2-one 
(12.048) 2-Methylbutane-1-thiol 
(12.049) 3-Methylbutane-2-thiol 
(12.054) 2-(Ethylthio)phenol 
(12.055) 4-Mercaptobutan-2-one 
(12.064) Thiogeraniol 
(12.071) 1-Propane-1-thiol 
(12.080) Thiophenol 
(12.082) 2,6-(Dimethyl)thiophenol 
(12.083) Ethyl 3-mercaptopropionate 
(12.085) p-Menth-1-ene-8-thiol 
(12.128) 2-Ethylhexane-1-thiol 
(12.132) Hexane-1-thiol 
(12.137) 3-Mercapto-3-methylbutan-1-ol 
(12.138) 3-Mercapto-3-methylbutyl formate 
(12.143) 1-Mercaptopropan-2-one 
(12.145) 4-Methoxy-2-methylbutane-2-thiol 
(12.170) 3-Methylbut-2-ene-1-thiol 
(12.171) 3-Methylbutane-1-thiol 
(12.173) 2-Methylpropane-1-thiol 
(12.192) Pentane-2-thiol 
(12.194) 2-Phenylethane-1-thiol 
(12.197) Propane-2-thiol 
(12.217) 3-Mercaptohexan-1-ol 
(12.234) 3-Mercaptohexyl acetate 
(12.235) 3-Mercaptohexyl butyrate 
IV: DITHIOLS  
 
HS
SH
 
12.103 Butane-1,4-dithiol 
(12.022) Butane-2,3-dithiol 
(12.034) Octane-1,8-dithiol 
(12.066) Ethane-1,2-dithiol 
(12.067) Hexane-1,6-dithiol 
(12.069) Nonane-1,9-dithiol 
(12.070) Propane-1,2-dithiol 
(12.072) Butane-1,2-dithiol 
(12.073) Butane-1,3-dithiol 
(12.076) Propane-1,3-dithiol 
V: ACYCLIC AND CYCLIC DISULPHIDES 
 
S
S
        and 
 
 
S S
O  
 
 
12.098 Allyl prop-1-enyl disulfide   1) 
  
12.111 Dibutyl disulfide 
12.151 Methyl butyl disulfide 
12.295 3,5-dimethyl-1.2-dithiolane-4-one    1) 
(12.008) Diallyl disulfide 
(12.014) Dipropyl disulfide 
(12.019) Methyl propyl disulfide 
(12.026) Dimethyl disulfide 
(12.028) Dicyclohexyl disulfide 
(12.037) Allyl methyl disulfide 
(12.043) Diphenyl disulfide 
(12.044) Prop-1-enyl propyl disulfide 
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Table 4.1 Subgroups. The supporting substances are listed in brackets. 
 FL-no EU Register name  
(12.068) Benzyl methyl disulfide 
(12.075) Methyl prop-1-enyl disulfide 
(12.081) Dibenzyl disulfide 
(12.109) Di-isopropyl disulfide 
(12.121) Ethyl 2-(methyldithio)propionate 
(12.161) Methyl phenyl disulfide 
(12.168) 2-Methyl-2-(methyldithio)propanal 
(12.218) Methyl-3-methyl-1-butenyl disulphide 
VI: ACYCLIC POLYSULPHIDES 
 
S
S
S
 
12.093 Diallyl hexasulfide 
12.094 Diallyl heptasulfide 
12.097 Allyl methyl tetrasulfide 
12.100 Allyl propyl trisulfide 
12.112  Dibutyl trisulfide 
12.116  Dimethyl tetrasulfide 
12.164  Methyl prop-1-enyl trisulfide   1) 
12.167 Methyl propyl tetrasulfide 
(12.009) Diallyl trisulfide 
(12.013) Dimethyl trisulfide 
(12.020) Methyl propyl trisulfide 
(12.023) Dipropyl trisulfide 
(12.045) Methyl allyl trisulfide 
(12.074) Diallyl polysulfides 
(12.155) Methyl ethyl trisulfide 
VII : MONO-, DI-, TRI- AND POLYSULPHIDES WITH THIOACETAL STRUCTURE 
 
SS
S
 
12.200 1,1-bis(Ethylthio)-ethane 
15.047  3,5-Di-isobutyl-1,2,4-trithiolane   1) 
15.048  3,5-Di-isopropyl-1,2,4-trithiolane   1) 
15.056  3,6-Dimethyl-1,2,4,5-tetrathiane   1) 
15.081 Lenthionine 
15.083  3-Methyl-1,2,4-trithiolane   1) 
15.103  1,2,4,5-Tetrathiane 
15.110 2,4,6-Trimethyl-1,3,5-trithiane   1) 
15.111 1,2,4-Trithiolane 
15.134 2,5-Dihydroxy-1,4-dithiane   1) 
16.057 2,4,4-Trimethyl-1,3-oxathiane   1) 
16.114 2-Pentyl-4-propyl-1,3-oxathiane   1) 
(15.006) 2,5-Dihydroxy-2,5-dimethyl-1,4-dithiane 
(15.009) Trithioacetone 
(15.025) 3,5-Dimethyl-1,2,4-trithiolane 
(15.034) 2-Methyl-1,3-dithiolane 
(15.036) 3-Methyl-1,2,4-trithiane 
(16.030) 2-Methyl-4-propyl-1,3-oxathiane 
VIII: THIOESTERS  
S
O
 
12.106  S-2-Butyl 3-methylbutanethioate   1) 
12.125  Ethyl propanethioate 
12.165  S-Methyl propanethioate 
12.189 S-(Methylthiomethyl) 2-methylpropanethioate 
12.196 S-Prenyl thioisobutyrate 
12.221  S-Prenyl thioisopentanoate 
12.271 Methanedithiol diacetate 
12.278 3-Acetyl-mercaptohexyl acetate   1) 
12.282 (S)-Methyl octanethioate 
(12.018) S-Ethyl acetothioate 
(12.032) S-Methyl butanethioate 
(12.059) Propyl thioacetate 
(12.101) Allyl thiopropionate 
(12.148) S-Methyl 4-methylpentanethioate 
(12.149) S-Methyl acetothioate 
(12.150) S-Methyl benzothioate 
(12.156) S-Methyl hexanethioate 
(12.157) S-Methyl isopentanethioate 
(12.195) S-Prenyl thioacetate 
(12.203) Methylthio 2-(acetyloxy)propionate 
(12.227) Methylthio-2-(propionyloxy)propionate 
IX: THIOIC ACIDS 
HS
O
 
12.199 Ethanethioic acid 
X: SULPHOXIDES/SULPHONES AND SULPHONATES 
O 12.159 Methyl methanethiosulfonate 
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Table 4.1 Subgroups. The supporting substances are listed in brackets. 
 FL-no EU Register name  
(12.175) Methylsulfinylmethane 
XI: CYCLIC THIOKETAL WITH FUSED OXOLANE 
RING 
  
 
O
S
S
O
 
15.007 Dithia-1-methyl-8-oxa-bicyclo[3.3.0]octane-3,3’-(1’- oxa-
2’-methyl)-cyclopentane) and spiro(Dithia-6-methyl-7-oxa-
bicyclo[3.3.0]octane-3,3’-spiro(2,4-(1’-oxa-2-
methyl)cyclopentane)    1) 
1) Stereoisomeric composition not specified 
 
Subgroups I (Acyclic sulphides), II (Cyclic sulphides), IX (thiocic acids) and X (Sulphoxides/sulphones 
and sulphonates) 
Acyclic and cyclic monosulphides (thioethers) primarily undergo S-oxidation, catalyzed by 
cytochrome P450 and flavin-containing monoxygenases, leading to the formation of sulphoxides, 
which can be further oxidised, at least partially, to sulphones. Sulphoxides and sulphones are 
hydrophilic and usually chemically stable. Sulphoxides are the major urinary excretion products in 
mammals exposed to thioethers, whereas the amount of sulphones is generally low. The S-oxidation of 
sulphoxides to sulphones is an irreversible reaction, whereas reduction of the sulphoxides back to 
sulphides is a common route of metabolism (See Figure III.1 Annex III).  
The oxygenated derivatives of sulphides, in addition to the above-described pathways, may be 
detoxified via the well-recognised biotransformations of alcohol, aldehyde, acid and ketone functional 
groups. Even, if also oxygen-containing functional groups are present in the organosulphur 
compounds, the S-oxidation is generally reported as the major metabolic pathway. 
Two of the candidate substances from subgroup I are esters, isobutyl-3-(methylthio)butyrate [FL-no: 
12.214] and 3-(methylthio)propyl butyrate [FL-no: 12.277], which are anticipated to be hydrolysed to 
2-methylpropanol [FL-no: 02.001] and 3-(methylthio)butyric acid [FL-no: 12.178] and respectively to 
be hydrolysed to 3-(methylthio)propan-1-ol [FL-no: 12.062] and butyric acid [FL-no: 08.005]. The 
substance from subgroup IX, ethanethioic acid [FL-no: 12.199] converts to acetic acid [FL-no: 
08.002]. The candidate substance methyl methanethiosulphonate [FL-no: 12.159] from subgroup X is 
anticipated to be hydrolysed to methanol and methanethiosulphonic acid. See Table 2b. 
Subgroups III (Monothiols) and IV (Dithiols)  
Thiols may follow a combination of pathways including S-oxidation, oxidative desulphuration and 
dealkylation, alkylation and conjugation with glutathione (GSH) and/or glucuronic acid. The majority 
of thiols are readily ionised at physiological pH to the nucleophilic thiolate anion giving rise to their 
reactivity. Thiols may form mixed disulphides, reacting with endogenous thiols present either in small 
hydrophilic molecules (i.e. GSH or cysteine, leading to products easily excreted in the urine) or in 
cellular macromolecules, as for instance in the catalytic site of many enzymes, resulting in adverse 
effect induction. Among conjugating reactions, thiol S-methylation catalysed by thiol-S-methyl-
transferases, is a quite common pathway of biotransformation for simple aliphatic and aromatic thiols, 
followed by S-oxygenation to water-soluble methyl-sulphoxides and/or sulphones. Alternatively, 
thiols are enzymatically oxidised to reactive unstable sulphenic (R-S-OH) acid, which can be further 
oxidised to sulphinic (R-SO2H) acid or react with excess thiol (preferentially GSH), yielding the 
corresponding disulphide. These latter can be either reduced back to thiols (enzymatically by thiol-
transferase or chemically by exchange with GSH or endogenous thiols), or be oxidised to thio-
sulphenic, sulphinic and sulphonic (R-SO3H) acid. This oxidation cycle followed by reduction could 
eventually deplete glycogen, due to NADPH production, deplete GSH and alter the cellular redox 
status. This condition has been associated, at least partially, with toxic effects induced by some 
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sulphur-containing compounds. The metabolism of dithiols usually involves the same pathways 
described for thiols. 
The oxygenated derivatives of thiols, in addition to the above-described pathways, may be detoxified 
via the well-recognized biotransformations of alcohol, aldehyde, acid and ketone functional groups. 
However, even in the presence of oxygenated functional groups in the organosulphur compounds, the 
S-oxidation is generally reported as the major metabolic pathway. 
One of the substances in subgroup III, 1-(methylthio)ethane-1-thiol [FL-no: 12.180] is a thioacetal, 
which can be hydrolysed to acetaldehyde [FL-no: 05.001], methanethiol [FL-no: 12.003] and 
hydrogensulfide [not a Register substance]. The hydrolysis products are shown in Table 2b. 
Subgroup V (Acyclic and cyclic disulphides) 
Disulphides may be reduced to the respective thiols. Consequently, metabolic options available for 
thiols may also be available for disulphides. Disulphides may also be oxidised to thiosulphinates or 
thiosulphonates and hydrolysed to sulphinates or sulphonates. Thiosulphonates are readily hydrolysed 
to the corresponding sulphonic acid. 
Cyclic disulphides may be metabolised through ringopening and disulfide reduction with consecutive 
formation of a dithiol, and then further metabolism following the scheme suggested for thiols. 
Subgroup VI (Acyclic polysuphides) 
The acyclic polysulphides may react with endogenous thiols such as reduced glutathione (GSH) or 
cysteine forming a thiol and a hydropersulphide or perthiol (RSH + R’SSH or R’SSSH or R’SxH, 
respectively). Compared to thiols, perthiols may be strong reducing agents, reacting rapidly with 
oxidants to form reactive products.  
Subgroup VII (Mono-, di-, tri- and polysulphides with thioacetal structure)  
The thioacetals and oxy-thioacetals may be subject to acid-hydrolysis in the stomach, similar to 
oxygen-containing acetals. However, thioacetals are more resistant to hydrolysis than oxygen-acetals 
(Satchell & Satchell, 1990; Smith & March, 2001). It is thus to be anticipated that these substances 
primarily may reach the intestinal lumen primarily intact and may be absorbed as such. Otherwise, the 
flavouring substances in subgroup VII are anticipated to be metabolised like the cyclic sulphides in 
subgroup II. 
Subgroup VIII (Thioesters) 
Thioesters are hydrolysed by lipase and esterases to the corresponding thiocarboxylic acids and 
alcohols, or to the thiols and carboxylic acids. The rate of the enzymatic reaction increases with the 
length of the carboxylic acid carbon chain, whereas it is negatively affected by the level of 
oxygenation of the thiol moiety. When the hydrolysis products are carboxylic acids or alcohols, they 
follow the usual metabolic pathways for this kind of molecules (mainly conjugation and excretion), 
whereas the thiols undergo the above-mentioned metabolic reactions. 
S-Thioesters are rapidly hydrolysed by lipases and esterases forming primarily the corresponding 
carboxylic acids and thiols. The rate of hydrolysis of thioesters increases as the C-chain length of the 
carboxylic acid fragment increases and decreases as oxygenation of the carbon chain in the thiol 
moiety increases. The hydrolysis products of the candidate thioesters are shown in Table 2b. 
Subgroup XI (Cyclic thioketal with fused oxolane ring) 
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No data have been submitted for the candidate substance [FL-no: 15.007] allocated to subgroup XI. A 
search in open literature did not reveal any further information on the candidate substance, however 
some data on structurally related substances was available. 
The candidate substance in subgroup XI, a cyclic thioketal with fused oxolane rings, is expected to be 
resistant to hydrolysis, and to be mainly absorbed as such. The sulphur atoms of the molecule are 
expected to be the main target for metabolic activity. The proposed preferred pathway of metabolism 
is sulphoxidation to yield the corresponding sulphoxide.  
 
In conclusion, due to the reactivity of certain of the anticipated sulphur-containing metabolites, none 
of the candidate substances can be predicted to be metabolised to innocuous products.  
More detailed information on the metabolism of candidate substances is given in Annex III. 
5. Application of the Procedure for the Safety Evaluation of Flavouring Substances 
The application of the Procedure is based on intakes estimated on the basis of the MSDI approach. 
Where the mTAMDI approach indicates that the intake of a flavouring substance might exceed its 
corresponding threshold of concern, a formal safety assessment is not carried out using the Procedure. 
In these cases the Panel requires more precise data on use and use levels. For comparison of the intake 
estimations based on the MSDI approach and the mTAMDI approach, see Section 6. 
For two of the candidate substances, 2-methylpropane-2-thiol [FL-no: 12.174] (subgroup III) and 
methyl methanethiosulphonate [FL-no: 12.159] (the only substance in subgroup X), there is an 
indication of a genotoxic potential in vitro. Therefore, in the absence of further genotoxicity data, the 
Panel concluded that the Procedure could not be applied to these two substances, and not to the two 
structurally related candidate substances, 2-methylbutane-2-thiol [FL-no: 12.172] (subgroup III) and 
2,4,4-trimethyl-1,3-oxathiane [FL-no: 16.057] (subgroup VII). 
For four candidate substances, 3-mercaptooctanal [FL-no: 12.268] (subgroup III), 3-mercaptodecanal 
[FL-no: 12.269] (subgroup III), methanedithiol diacetate [FL-no: 12.271] (subgroup VIII) and 3,5-
dimethyl-1,2-dithiolane-4-one [FL-no: 12.295] (subgroup V) no data on use as flavouring substances 
in Europe are available. Therefore, no intakes in Europe can be estimated and accordingly the Panel 
concluded that the Procedure could not be applied to these four substances.  
For the safety evaluation of the remaining 62 candidate substances from chemical groups 20 and 30 
the Procedure as outlined in Annex I was applied, based on the MSDI approach. The stepwise 
evaluations of the 62 substances evaluated through the Procedure are summarised in Table 2a. 
Step 1 
The candidate substances were classified following the procedure established by Cramer et al. (Cramer 
et al., 1978). For the 62 candidate substances evaluated through the Procedure, 39 substances were 
classified into structural class I. Further 17 substances were classified into structural class II. The final 
six substances were classified into structural class III. 
Step 2 
Step 2 requires consideration of whether metabolic pathways exist to metabolise the candidate 
substances to innocuous products at the expected levels of intake. The candidate substances may be 
biotransformed to reactive metabolites, such as thiols, sulphoxides and sulphones and, in consequence, 
they are not predicted to be metabolised to innocuous products. Therefore, the evaluation of all 62 
candidate substances proceeds via the B-side of the Procedure scheme (Annex I). 
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Step B3 
The 39 substances in structural class I have estimated European daily per capita intakes ranging from 
0.0012 to 6.1 microgram, which is below the threshold of concern of 1800 microgram/person/day. The 
17 substances evaluated through the Procedure in structural class II have estimated European daily per 
capita intakes ranging from 0.0024 to 2.4 microgram, which is below the threshold of concern for 
class II of 540 microgram/person/day. The six substances in structural class III have estimated 
European daily per capita intakes ranging from 0.012 to 6.1 microgram, which is below the threshold 
of concern for class III of 90 microgram/person/day. Accordingly, all 62 candidate substances proceed 
to step B4 of the Procedure. 
Step B4 
No adequate studies on candidate substances are available. Repeated-dose toxicity studies are 
available on some supporting substances, which, with very few exceptions, have been carried out 
testing only one dose, giving rise to no observed adverse effects. The results of adequate studies on 
supporting substances show a relatively high degree of variability in the reported No Observed 
Adverse Effect Levels (NOAELs), ranging from 0.06 to 250 mg/kg bw/day.  
The 18 candidate substances in subgroup I can be represented by the supporting substance dimethyl 
sulfide [FL-no:12.006], for which an adequate 90-day subchronic study is available, indicating that no 
adverse effects were produced by the highest oral dose tested (250 mg/kg body weight (bw)/day), 
which can be considered a NOAEL. The combined estimated daily per capita intake of 10 microgram 
for the 18 candidate substances in subgroup I corresponds to 0.17 microgram/kg bw/day at a body 
weight of 60 kg. Thus, a margin of safety of 1.5 x 106 can be calculated. The 18 candidate substances 
in subgroup I are accordingly not expected to be of safety concern at the estimated levels of intake. 
Within subgroup II, no adequate toxicity study from which a NOAEL could be established was 
available, neither on the candidate substances nor on supporting substances. Therefore, the Panel 
concluded that additional data are required for the three cyclic sulphides in subgroup II [FL-no: 
12.120, 15.102 and 15.125]. 
Within subgroup III, adequate 90-day subchronic studies are available for four supporting substances, 
2-mercapto-3-butanol [FL-no: 12.024], cyclopentanethiol [FL-no: 12.029], 2,3- and 10-
mercaptopinane [FL-no: 12.035] and 2,6-(dimethyl)thiophenol [FL-no: 12.082], which can be 
considered representative of the eight candidate substances evaluated through the Procedure in this 
subgroup. In the four studies, no adverse effects were produced by the highest oral dose tested ranging 
from 0.06 up to 0.7 mg/kg bw/day. By adopting a conservative approach the lowest value (0.06 mg/kg 
bw/day) can be considered a NOAEL. The combined estimated daily per capita intake of 0.9 
microgram for the eight candidate substances evaluated through the Procedure in subgroup III 
corresponds to 0.015 microgram/kg bw/day at a body weight of 60 kg. Thus, a margin of safety of 4 x 
103 can be calculated. The eight candidate substances in subgroup III, evaluated through the Procedure 
are accordingly not expected to be of safety concern at the estimated levels of intake. 
The candidate substance in subgroup IV can be represented by two supporting substances, butane-2,3-
dithiol [FL-no: 12.022] and octane-1,2-dithiol [FL-no: 12.034], for which adequate 90-day subchronic 
studies are available. In the two studies, no adverse effects were produced by the almost identical 
highest oral doses tested, that is 0.7 mg/kg bw/day, which can be considered a NOAEL. The estimated 
daily per capita intake of 0.3 microgram for the one candidate substance in subgroup IV corresponds 
to 0.005 microgram/kg bw/day at a body weight of 60 kg. Thus, a margin of safety of 1.4 x 105 can be 
calculated. The candidate substance in subgroup IV is accordingly not expected to be of safety 
concern at the estimated level of intake. 
Within subgroup V, adequate 90-day subchronic studies are available for two supporting substances 
dicyclohexyl disulfide [FL-no: 12.028] and benzyl methyl disulfide [FL-no: 12.068], which can be 
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considered representative of the three candidate substances in this subgroup evaluated through the 
Procedure. In the two studies, no adverse effects were produced by the highest oral dose tested: 0.23 
and 1.15 mg/kg bw/day. By adopting a conservative approach, the lowest value (0.23 mg/kg bw/day) 
can be considered a NOAEL. The combined estimated daily per capita intake of 0.54 microgram for 
the three candidate substances evaluated through the Procedure in subgroup V corresponds to 0.009 
microgram/kg bw/day at a body weight of 60 kg. Thus, a margin of safety of 2.6 x 104 can be 
calculated. The three candidate substances in subgroup V are accordingly not expected to be of safety 
concern at the estimated levels of intake. 
Within subgroup VI, no adequate toxicity study from which a NOAEL could be established was 
available, neither on the candidate substances nor on supporting substances. Therefore, the Panel 
concluded that additional data are required for the eight tri-, tetra- and polysulphides in subgroup VI 
[FL-no: 12.093, 12.094, 12.097, 12.100, 12.112, 12.116, 12.164 and 12.167]. 
Within subgroup VII, adequate 90-day subchronic studies are available for two supporting substances, 
3,5-dimethyl-1,2,4-trithiolane [FL-no: 15.025] and 2-methyl-4-propyl-1,3-oxathiane [FL-no: 16.030], 
which can be considered representative for 10 of the remaining 11 candidate substances in this 
subgroup to be evaluated through the Procedure. For the candidate substance [FL-no: 15.134] the 
structural similarity to the two supporting substances for which there is a NOAEL was not considered 
to be sufficient. In the two 90-day studies, no adverse effects were produced by the highest oral dose 
tested: 0.44 and 1.88 mg/kg bw/day. By adopting a conservative approach, the lowest value (0.44 
mg/kg bw/day) can be considered a NOAEL. The combined estimated daily per capita intake of 2,6 
microgram for these 10 candidate substances in subgroup VII corresponds to 0.043 microgram/kg 
bw/day at a body weight of 60 kg. Thus, a margin of safety of 105 can be calculated. The Panel is 
aware of a study that has been performed with a substance [FL-no: 15.006] which is structurally 
related to 2,5-Dihydroxy-1,4-dithiane [FL-no: 15.134]. However, this 90-day study from 1973 by Cox 
et al. was not available to the Panel and the validity of the derived NOAEL from this study could not 
be assessed. Consequently the evaluation of [FL-no: 15.134] cannot be finalised. The remaining 10 
candidate substances in subgroup VII, evaluated through the Procedure, are not expected to be of 
safety concern at the estimated levels of intake. 
. 
Within subgroup VIII, an adequate 90-day subchronic study is available for one supporting substance, 
ethyl thioacetate [FL-no: 12.018], which can be considered representative of the eight candidate 
substances evaluated through the Procedure in this subgroup. In the study, no adverse effects were 
produced by the highest oral dose tested: 6.63 mg/kg bw/day. Therefore, the NOAEL is concluded to 
be 6.63 mg/kg bw per day for ethyl thioacetate. The combined estimated daily per capita intake of 2.4 
microgram for the eight candidate substances in subgroup VIII corresponds to 0.04 microgram/kg 
bw/day at a body weight of 60 kg. Thus, a margin of safety of 1.7 x 105 can be calculated. The eight 
candidate substances in subgroup VIII are accordingly not expected to be of safety concern at the 
estimated levels of intake. 
Within subgroup IX, no data are available for the candidate substance ethanethioic acid [FL-no: 
12.199]. Therefore, the Panel concluded that additional data are required for the candidate substance in 
subgroup IX. 
Within subgroup XI, no adequate toxicity study from which a NOAEL could be established was 
available on the candidate substance. No supporting substances are available. Therefore the Panel 
concluded that additional data are required for the candidate substance in subgroup XI [FL-no: 
15.007]. 
The conclusion from step B4 is that for the 48 candidate substances belonging to subgroups I, III, IV, 
V, VII and VIII, and evaluated through the Procedure, adequate NOAELs exist for structurally related 
substances providing adequate margins of safety at the estimated levels of intake. Therefore, these 
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candidate substances are not expected to be of safety concern at the levels of exposure estimated by 
the MSDI approach. For the three candidate substances belonging to subgroup II [FL-no: 12.120, 
15.102 and 15.125], the eight candidate substances belonging to subgroup VI [FL-no: FL-no: 12.093, 
12.094, 12.097, 12.100, 12.112, 12.116, 12.164 and 12.167] and for one candidate substance 
belonging to subgroup VII [FL-no: 15.134] and the candidate substance of subgroup IX [FL-no: 
12.199] and the candidate substance belonging to subgroup XI [FL-no: 15.007] additional toxicity data 
are required. The substance in subgroup X is not evaluated through the Procedure due to concern for 
genotoxicity, see Section 8.4. 
6. Comparison of the Intake Estimations Based on the MSDI Approach and the mTAMDI 
Approach 
For 66 of the 70 candidate substances in this FGE, the intake estimates based on MSDI approach have 
been presented in Table 6.1. For 62 of the 70 candidate substances, the intake estimates based on 
mTAMDI approach also have been presented in Table 6.1. The candidate substances not evaluated 
through the Procedure [FL-no: 12.174, 12.159, 12.172 and 16.057] are not included in the following 
calculations. 
The estimated intakes for the 39 of 44 candidate substances in structural class I for which intake data 
have been submitted and which have been evaluated through the Procedure, based on the mTAMDI 
approach, range from 28 to 8000 microgram/person/day. For 37 of these substances, the mTAMDI 
values are below the threshold of concern for structural class I substances of 1800 
microgram/person/day. These substances are also expected to be metabolised to innocuous products. 
For the remaining two substances [FL-no: 12.250 and 12.282] the mTAMDI values are above the 
threshold of concern for structural class I substances of 1800 microgram/person/day. 
The estimated intakes for the 16 of the 19 candidate substances assigned to structural class II, for 
which intake data have been submitted and which have been evaluated through the Procedure, based 
on the mTAMDI approach, range from 46 to 78 microgram/person/day, which is below the threshold 
of concern for structural class II substances of 540 microgram/person/day. These substances are also 
expected to be metabolised to innocuous products. 
The estimated intakes for the five of the seven candidate substances assigned to structural class III for 
which intake data have been submitted and which have been evaluated through the Procedure,, based 
on the mTAMDI approach, range from 78 to 500 microgram/person/day. For one of the substances 
[FL-no: 15.081] the mTAMDI is below the threshold of concern for structural class III substances of 
90 microgram/person/day. This substance is also expected to be metabolised to innocuous products. 
For the remaining four substances [FL-no: 12.120, 12.136, 15.134 and 16.114] the mTAMDI values 
are above the threshold of concern for structural class III substances of 90 microgram/person/day. For 
comparison of the intake estimates based on the MSDI approach and the mTAMDI approach, see 
Table 6.1.  
For six candidate substances [FL-no: 12.120, 12.136, 12.250, 12.282, 15.134 and 16.114], as well as 
for the substances for which use levels have not been provided.  further information is required. This 
would include more reliable intake data and then, if required, additional toxicological data. 
For comparison of the MSDI and mTAMDI values, see Table 6.1 
 
Table 6.1 Estimated intakes based on the MSDI approach and the mTAMDI approach 
FL-no EU Register name MSDI 
(μg/capita/day) 
mTAMDI 
(μg/person/day) 
Structural 
class 
Threshold of concern 
(µg/person/day) 
12.103 Butane-1,4-dithiol 0.3 78 Class I 1800 
12.104 Butane-2-thiol 0.18 78 Class I 1800 
12.106 S-2-Butyl 3-methylbutanethioate 0.8 240 Class I 1800 
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Table 6.1 Estimated intakes based on the MSDI approach and the mTAMDI approach 
FL-no EU Register name MSDI 
(μg/capita/day) 
mTAMDI 
(μg/person/day) 
Structural 
class 
Threshold of concern 
(µg/person/day) 
12.111 Dibutyl disulfide 0.37 78 Class I 1800 
12.112 Dibutyl trisulfide 0.12 78 Class I 1800 
12.116 Dimethyl tetrasulfide 0.016 46 Class I 1800 
12.117 Dipentyl sulfide 0.0037 74 Class I 1800 
12.124 Ethyl butyl sulfide 0.037 190 Class I 1800 
12.125 Ethyl propanethioate 0.012 160 Class I 1800 
12.127 Ethyl propyl sulfide 0.085 78 Class I 1800 
12.129 3-(Ethylthio)propan-1-ol 0.12 190 Class I 1800 
12.135 3-Mercapto-2-methylpropionic acid 0.12 78 Class I 1800 
12.151 Methyl butyl disulfide 0.0061 78 Class I 1800 
12.152 Methyl butyl sulfide 0.0024 78 Class I 1800 
12.158 Methyl isoprenyl sulfide 0.0012 78 Class I 1800 
12.163 Methyl prop-1-enyl sulfide 0.0097 78 Class I 1800 
12.164 Methyl prop-1-enyl trisulfide 0.0061 78 Class I 1800 
12.165 S-Methyl propanethioate 0.012 110 Class I 1800 
12.166 Methyl propyl sulfide 0.0024 78 Class I 1800 
12.167 Methyl propyl tetrasulfide 0.0037 78 Class I 1800 
12.178 3-(Methylthio)butyric acid 0.12 160 Class I 1800 
12.180 1-(Methylthio)ethane-1-thiol 0.12 78 Class I 1800 
12.181 1-(Methylthio)pentan-3-one 0.12 70 Class I 1800 
12.182 2-(Methylthio)propionic acid 0.011 160 Class I 1800 
12.183 3-(Methylthio)propionic acid 0.21 160 Class I 1800 
12.189 S-(Methylthiomethyl) 2-methylpropanethioate 0.061 160 Class I 1800 
12.191 Pentane-1-thiol 0.12 78 Class I 1800 
12.196 S-Prenyl thioisobutyrate 0.012 160 Class I 1800 
12.199 Ethanethioic acid 0.0012 160 Class I 1800 
12.200 1,1-bis(Ethylthio)-ethane 0.0012 46 Class I 1800 
12.205 Mercaptoacetaldehyde 0.011 160 Class I 1800 
12.214 Isobutyl-3-(methylthio)butyrate 0.12 160 Class I 1800 
12.221 S-Prenyl thioisopentanoate 0.012 150 Class I 1800 
12.250 3-Mercaptohexanal 0.012 1900 Class I 1800 
12.266 Methyl-2-mercaptopropionate 0.12  Class I 1800 
12.277 3-(Methylthio)propyl butyrate 6.1 1400 Class I 1800 
12.278 3-Acetyl-mercaptohexyl acetate 1.2  Class I 1800 
12.282 (S)-Methyl octanethioate 0.24 8000 Class I 1800 
12.298 Di-(1-propenyl)-sulfid (mixture) 0.12 28 Class I 1800 
12.172 2-Methylbutane-2-thiol 0.15 78 Class I 1800 
12.174 2-Methylpropane-2-thiol 0.0012 78 Class I 1800 
12.268 3-Mercaptooctanal   Class I 1800 
12.269 3-Mercaptodecanal   Class I 1800 
12.271 Methanedithiol diacetate   Class I 1800 
12.093 Diallyl hexasulfide 0.011 78 Class II 540 
12.094 Diallyl heptasulfide 0.011 78 Class II 540 
12.096 Allyl methyl sulfide 0.99 78 Class II 540 
12.097 Allyl methyl tetrasulfide 0.012 78 Class II 540 
12.098 Allyl prop-1-enyl disulfide 0.17 78 Class II 540 
12.099 Allyl propyl sulfide 1.6 78 Class II 540 
12.100 Allyl propyl trisulfide 0.12 78 Class II 540 
12.177 8-(Methylthio)-p-menthan-3-one 0.37 78 Class II 540 
15.047 3,5-Di-isobutyl-1,2,4-trithiolane 0.024 46 Class II 540 
15.048 3,5-Di-isopropyl-1,2,4-trithiolane 0.0061 46 Class II 540 
15.056 3,6-Dimethyl-1,2,4,5-tetrathiane 0.0024 78 Class II 540 
15.083 3-Methyl-1,2,4-trithiolane 0.0024 78 Class II 540 
15.102 Tetrahydrothiophene 0.024 78 Class II 540 
15.103 1,2,4,5-Tetrathiane 0.073 78 Class II 540 
15.110 2,4,6-Trimethyl-1,3,5-trithiane 0.0061 78 Class II 540 
15.111 1,2,4-Trithiolane 2.4 78 Class II 540 
15.125 4-Tetrahydrothiopyranone 0.12  Class II 540 
12.295 3,5-Dimethyl-1,2-dithiolane-4-one   Class II 540 
16.057 2,4,4-Trimethyl-1,3-oxathiane 0.0012 78 Class II 540 
12.120 2,8-Epithio-p-menthane 3.7 370 Class III 90 
12.136 3-Mercapto-2-oxopropionic acid 0.24 160 Class III 90 
15.081 Lenthionine 0.012 78 Class III 90 
15.134 2,5-Dihydroxy-1,4-dithiane 6.1 500 Class III 90 
16.114 2-Pentyl-4-propyl-1,3-oxathiane 0.12 290 Class III 90 
15.007 spiro(2,4-Dithia-1-methyl-8-oxa-
bicyclo[3.3.0]octane-3,3'-(1'-oxa-2'-methyl)-
cyclopentane) and spiro(Dithia-6-methyl-7-
oxa-bicyclo 
6.1  Class III 90 
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Table 6.1 Estimated intakes based on the MSDI approach and the mTAMDI approach 
FL-no EU Register name MSDI 
(μg/capita/day) 
mTAMDI 
(μg/person/day) 
Structural 
class 
Threshold of concern 
(µg/person/day) 
12.159 Methyl methanethiosulfonate 0.061 160 Class III 90 
7. Considerations of Combined Intakes from Use as Flavouring Substances 
Because of structural similarities of candidate and supporting substances, it can be anticipated that 
many of the flavourings are metabolised through the same metabolic pathways and that the 
metabolites may affect the same target organs. Further, in case of combined exposure to structurally 
related flavourings, the pathways could be overloaded. Therefore, combined intake should be 
considered. As flavourings not included in this FGE may also be metabolised through the same 
pathways, the combined intake estimates presented here are only preliminary. Currently, the combined 
intake estimates are only based on MSDI exposure estimates, although it is recognised that this may 
lead to underestimation of exposure. After completion of all FGEs, this issue should be readdressed. 
The total estimated combined daily per capita intake of structurally related flavourings is estimated by 
summing the MSDI for individual substances. 
On the basis of the reported annual production volumes in Europe (EFFA, 2002h), the combined 
estimated daily per capita intakes as flavourings of the candidate substances evaluated using the 
Procedure and assigned to structural class I (39 of 44 substances), structural class II (17 of 19 
substances), and structural class III (six of seven substances) are 11, 6 and 16 microgram, respectively. 
These values do not exceed the thresholds of concern for a substance belonging to structural class I, II 
or III of 1800, 540 or 90 microgram/person/day, respectively. 
The 62 candidate substances, to which the Procedure has been applied, are structurally related to 127 
supporting substances evaluated by the JEFCA at its 53th JECFA meetings (JECFA, 2000b). Based on 
reported production volumes, European per capita intakes (MSDI) could be estimated for 68 of the 
127 supporting substances (distributed as 43 supporting substances in structural class I, 24 supporting 
substances in structural class II and one supporting substance in structural class III). Production 
volumes in Europe were not reported for 59 of the supporting substances. 
The total estimated combined estimated daily per capita intake as flavourings of the candidate 
substances evaluated using the Procedure and the supporting substances (for which there are European 
intake data) assigned to structural class I, II and III are 648, 115 and 16 microgram, respectively. 
These values do not exceed the thresholds of concern for substances belonging to structural class I, II 
or III of 1800, 540 or 90 microgram/person/day, respectively. 
8. Toxicity 
8.1. Acute Toxicity 
Data are available on four candidate substances: butane-2-thiol [FL-no: 12.104], 2-methylbutane-2-
thiol [FL-no: 12.172] and 2-methylpropane-2-thiol [FL-no: 12.174] belonging to subgroup III and 
tetrahydrothiophene [FL-no: 15.102], included in subgroup II. In addition data are available on 35 
supporting substances. The LD50 values varied from 100 to more than 2000 mg/kg bw. 
The acute toxicity data are summarised in Annex IV, Table IV.1. 
8.2. Subacute, Subchronic, Chronic and Carcinogenicity Studies 
Data from repeated-dose toxicity studies were available for one candidate substance, 3-
(methylthio)propionic acid [FL-no: 12.183] included in subgroup I and for 2,8-Epithio-p-menthane 
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[FL-no: 12.120] included in subgroup II and for 33 supporting substances included in subgroup I (2), 
II (1), III (11), IV (2), V (5), VI (2), VII (5), VIII (4), X (1) (see Annex IV, Table IV.2). In most of the 
subchronic studies no effects were observed at the highest dose tested, which in the majority of cases 
was the only tested dose. Due to different kinds of limitations (see Table IV.2) several of these studies 
could not be used for derivation of a No Observed Adverse Effect Level (NOAEL). 
Subgroup II (Acyclic sulphides); For the candidate substance, 3-(methylthio)propionic acid [FL-no: 
12.183] included in subgroup I, a two-week oral study is available. Only one dose is tested at which 
effects were reported. The study could not be used for derivation of a NOAEL.  
Subgroup II (Cyclic sulphides); For the candidate substance, 2,8-Epithio-p-menthane [FL-no: 12.120] 
included in subgroup II, a 28-day oral study in rats has been made available since the adoption of 
FGE.08Rev2. Only one dose (10 mg /kg bw) is tested at which effects were reported for male rats. No 
NOAEL could be allocated for male rats, based on urine casts, increased kidney weights and the 
presence of renal focal tubular degeneration/regeneration. These effects were not seen in female rats. It 
is not considered appropriate to use this study for derivation of a NOAEL. Otherwise there is only a 
study on a supporting substance from subgroup II [FL-no: 15.012]. This is an unpublished and 
uncompleted report in which histopathology results are not available (Morgareidge & Oser, 1970a). 
The study could not be used for derivation of a NOAEL. No NOAEL is available for subgroup II. 
Subgroup VI (Acyclic polysulphides); For two supporting substances in subgroup VI, diallyl 
trisulphide [FL-no: 12.009] and dipropyl trisulphide [FL-no: 12.023], 90-day studies are available as 
unpublished reports (Morgareidge & Oser, 1970c; Morgareidge & Oser, 1970d). In these studies 15 
male and 15 female rats were given the test substances in feed, at one dose level, control rats, 15 male 
and 15 female, received basal diet. Diets were blended with test substances prepared as 1 % solutions 
in acetone. Weekly supplies of feed were stored in sealed jars in a “cool, dark place”. There is 
however no data on stability of test substances during storage. Nominal dose was 4.16 mg/kg bw per 
day for both test substances, but actual dose was 4.6 for diallyl trisulphide and 4.8 for dipropyl 
sulphide. No abnormal or remarkable findings were made concerning weight gain, food utilization or 
on the haematological, biochemical or urinary parameters that were measured. However, there are no 
data on stability of test substances; and since no results are reported from histopathological 
examinations it is not possible to derive NOAELs from these studies. No NOAEL is available for 
subgroup VI.  
Subgroup IX (Thioic acid); There are no supporting substances in subgroup IX, and there are no 
studies available for the one candidate substance [FL-no: 12.199] in this subgroup. No NOAEL is 
available for subgroup IX.  
Subgroup X (Sulphoxides/sulphones and sulphonates); There are three long term studies available for 
one supporting substance [FL-no: 12.175] in subgroup X. Due to limitations of these studies, such as 
lack of report on histopathology or confounding effects of solvents, no NOAELs could be derived. 
There are no NOAELs available for subgroup X.  
Subgroup XI (Cyclic thioketal with fused oxolane rings); There is a 90-day study in rats available for 
the candidate substance [FL-no: 15.007] (Wheldon et al., 1970). The Panel noted that JECFA (JECFA, 
2005c) has evaluated the same study and derived a NOAEL. However, some of the study details that 
are described in the JECFA report are not in accordance with the data that have been submitted to the 
Panel. Due to limitations of the study available to EFSA and due to dose-dependent findings of 
toxicity also at the lowest dose used, this study was not considered appropriate for derivation of a 
NOAEL. 
Consequently no NOAELs are available for subgroups II, VI, IX, X and XI.  
 
Studies on supporting substances used for NOAEL derivation for the application of the Procedure 
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Subgroup I (Acyclic sulphides) 
Dimethyl sulfide [FL-no:12.006]  
Four groups of 15 Wistar rats per sex were given dimethyl sulphide by daily oral gavage in corn oil at 
dose levels of 2.5, 25 or 250 mg/kg bw for 14 weeks; the control group received the same volume of 
corn oil only. An additional two groups (five/sex/dose) were given daily doses of 0.25 or 250 mg/kg 
bw for two or six weeks, respectively. The animals were weighed on day 0 and then weekly 
throughout the study. Food and water consumption were measured over a 24 hours period preceding 
the day of weighing. Urine samples were collected during weeks 2, 6 and 14, and examined for 
volume, appearance, specific gravity, microscopic constituents, and content of glucose, ketones, bile 
salts and blood. At sacrifice, blood was taken for haematological examinations. Gross abnormalities 
were noted and organ weights taken. Histological examinations were also performed. There was no 
adverse effect at any level in dosed rats and therefore, 250 mg/kg bw/day was considered as the 
NOAEL derived from the study (Butterworth et al., 1975b). 
Subgroup III (Monothiols) 
2,6-Dimethylthiophenol [FL-no: 12.082] 
2,6-Dimethylthiophenol was administered in corn oil by gavage to Sprague-Dawley rats 
(16/sex/group) at an average daily intake of 0.43 mg/kg bw for 13 weeks. Control animals received the 
same volume of corn oil only. Weekly measurements of body weight and food intake were taken. 
Haematological examination and blood chemical determinations as well as urine analysis were 
performed at weeks 4 and 13. Organ weights, gross pathology and histological examinations were 
performed at the time of necropsy. There were no significant differences between the treated animals 
and the control group. The NOAEL derived from the study is concluded to be 0.43 mg/kg bw/day 
(Peano et al., 1981). 
Cyclopentanethiol [FL-no: 12.029] 
Cyclopentanethiol, dissolved in acetone and blended into a basal laboratory diet to yield an actual 
daily dose of 0.56 mg/kg, was administered to Sprague-Dawley rats (15/sex/group) for 90 days. 
Control animals received basal laboratory diet admixed with acetone. Dietary acetone was fully 
evaporated before presentation to the animals. Samples of each treatment diet were taken weekly for 
assessment of stability and concentration of the test substance. Clinical signs and mortality were 
recorded daily. Body weights and food consumption were measured weekly. Haematological 
examinations, blood chemistry determinations and urine analyses were performed at weeks 6 and 12 
on 8 males and 8 females from each group. At necropsy, organ weights were recorded and 
histopathological examinations were performed. No differences between control and treated animals 
were observed in any of the tested parameters. The NOAEL derived from the study is concluded to be 
0.56 mg/kg bw per day (Morgareidge & Oser, 1970b). 
2,3- and 10- mercaptopinane [FL-no: 12.035] 
2,3- and 10- mercaptopinane, blended into a basal laboratory diet to yield an actual daily dose of 0.06 
mg/kg, was administered to Sprague-Dawley rats (17/sex/group) for 90 days. Control animals received 
basal laboratory diet. Samples of each treatment diet were taken weekly for assessment of stability and 
concentration of the test substance. Clinical signs and mortality were recorded daily. Body weights 
and food consumption were controlled weekly. Haematological examinations, blood chemistry 
determinations and urine analyses were performed at weeks 6 and 12. At necropsy, organ weights 
were recorded and histopathological examinations were performed. No differences between control 
and treated animals were observed in any of the tested parameters. The NOAEL derived from the 
study is concluded to be 0.06 mg/kg bw per day (Oser, 1966). 
2-Mercapto-3-butanol [FL-no: 12.024] 
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2-Mercapto-3-butanol was administered to Sprague-Dawley rats (15/sex/group) for 90 days, dissolved 
in acetone and blended into a basal laboratory diet to yield an actual daily dose of 0.705 mg/kg. 
Control animals received basal laboratory diet admixed with acetone. Dietary acetone was fully 
evaporated before presentation to the animals. Samples of each treatment diet were taken weekly for 
assessment of stability and concentration of the test substance. Clinical signs and mortality were 
recorded daily. Body weights and food consumption were measured weekly. Haematological 
examinations, blood chemistry determinations and urine analyses were performed at weeks 6 and 12. 
At necropsy, organ weights were recorded and histopathological examinations were performed. No 
differences between control and treated animals were observed in any of the tested parameters. The 
NOAEL for 2-mercapto-3-butanol is concluded to be 0.705 mg/kg bw per day (Cox et al., 1974a). 
Subgroup IV (Dithiols) 
2,3-Butanedithiol [FL-no: 12.022] and 1,8-Octanedithiol [FL-no: 12.034] 
2,3-Butanedithiol and 1,8-octanedithiol were administered to Sprague-Dawley rats (15/sex/group) for 
90 days, following the study design used by Cox et al. (Cox et al., 1974a). The test item was dissolved 
in acetone and blended into a basal laboratory diet to yield an actual daily dose of 0.703 and 0.705 
mg/kg, respectively. Control animals received basal laboratory diet admixed with acetone. Dietary 
acetone was fully evaporated before presentation to the animals. Samples of each treatment diet were 
taken weekly for assessment of stability and concentration of the test substance. Clinical signs and 
mortality were recorded daily. Body weights and food consumption were measured weekly. 
Haematological examinations, blood chemistry determinations and urine analyses were performed at 
weeks 6 and 12. At necropsy, organ weights were recorded and histopathological examinations were 
performed. No differences between control and treated animals were observed in any of the tested 
parameters. The NOAEL for 2,3-butanedithiol and for 1,8-octanedithiol is concluded to be 0.705 
mg/kg bw per day (Cox et al., 1974c; Cox et al., 1974d). 
Subgroup V (Acyclic and cyclic disulphides) 
Dicyclohexyl disulfide [FL-no: 12.028] and benzyl methyl disulfide [FL-no: 12.068] 
The two supporting substances were administered to Sprague-Dawley rats (15/sex/group) for 90 days, 
following the study design used by Cox et al., 1974a.  
The test item was dissolved in acetone and blended into a basal laboratory diet to yield an actual daily 
dose of 0.232 mg/kg and 1.15 mg/kg dicyclohexyl disulfide and benzyl methyl disulfide, respectively. 
Control animals received basal laboratory diet admixed with acetone. Dietary acetone was fully 
evaporated before presentation to the animals. Samples of each treatment diet were taken weekly for 
assessment of stability and concentration of the test substance. Clinical signs and mortality were 
recorded daily. Body weights and food consumption were measured weekly. Haematological 
examinations, blood chemistry determinations and urine analyses were performed at weeks 6 and 12. 
At necropsy, organ weights were recorded and histopathological examinations were performed. No 
differences between control and treated animals were observed in any of the tested parameters. The 
NOAEL for dicyclohexyl disulfide and for benzyl methyl disulfide is concluded to be 0.232 and 1.15 
mg/kg bw per day, respectively (Cox et al., 1974e; Gallo et al., 1976a). 
NOAELs for dithiols (subgroup IV) may be utilised for the evaluation of the cyclic disulphide 3,5-
dimethyl-1,2-dithiolane-4-one [FL-no: 12.295] which is proposed to be ring opened and oxidised to a 
dithiol; there are however no intake data for this candidate substance, and it is consequently not taken 
through the procedure, as is stated in Section 5. 
Subgroup VII (Mono-, di-,tri- and poly-sulphides with thioacetal structure) 
3,5-Dimethyl-1,2,4-trithiolane [FL-no: 15.025] and 2-methyl-4-propyl-1,3-oxathiane [FL-no: 16.030] 
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3,5-dimethyl-1,2,4-trithiolane and 2-methyl-4-propyl-1,3-oxathiane dissolved in corn oil were 
administered by oral intubation to Wistar rats (15/sex/group) for 90 days, following the same study 
design. The daily dose was 1.88 mg/kg bw and 0.44 mg/kg bw for 3,5-dimethyl-1,2,4-trithiolane and 
2-methyl-4-propyl-1,3-oxathiane, respectively. Control rats were given corn oil alone. Body weight 
and food intake were regularly recorded throughout the study. Blood was collected at 6 and 12 weeks, 
for haemoglobin concentration, packed cell volume and erythrocyte plus leukocyte counts analysis. 
Urea concentration was also measured. At study termination, organ weights were recorded, gross 
necropsy observations and histological evaluations were conducted. Although a slight increase in food 
intake was noted, there were no significant differences between treated and control rats for body 
weight. Some sporadic differences between control and treated animals were observed but none was 
statistically significant. The NOAEL for 3,5-dimethyl-1,2,4-trithiolane and for 2-methyl-4-propyl-1,3-
oxathiane is concluded to be 1.88 and 0.44 mg/kg bw per day, respectively (BIBRA, 1976). 
3-Methyl-1,2,4-trithiane [FL-no: 15.036] 
3-Methyl-1,2,4-trithiane was administered in corn oil orally to Sprague-Dawley rats (16/sex/group) at 
a dose of 0.3 mg/kg bw/day for 13 weeks. Weekly body weight and food intake measurements were 
taken. Haematological examinations and blood urea determinations were conducted at weeks 4 and 13. 
At necropsy, organ weights were taken and histopathology was performed. No adverse effects were 
observed. The NOAEL is concluded to be 0.3 mg/kg bw per day for 3-methyl-1,2,4-trithiane 
(Mondino, 1981a). 
2-Methyl-1,3-dithiolane [FL-no: 15.034] 
Thirty-two (16/sex) Sprague-Dawley rats received an aqueous propylene glycol solution (0.2 % w/w) 
containing 7 mg/kg bw of 2-methyl-1,3-dithiolane daily by oral intubation for 91 days. Control 
animals received 0.02 % propylene glycol only. Body weight and food consumption were regularly 
recorded during the study. Haematological examinations and blood chemical determinations were 
performed at weeks 4 and 13. At study termination gross pathology, organ weights and histological 
examinations were carried out. There were no differences between the control and treatment groups 
for any parameters, except for a slight non-significant reduction in haemoglobin levels in the treated 
females only. The NOAEL was therefore concluded to be 7 mg/kg bw/day (Griffiths et al., 1979a). 
Trithioacetone [FL-no: 15.009] 
Trithioacetone was administered to Sprague-Dawley rats (15/sex/group) for 90 days, dissolved in 
acetone and blended into a basal laboratory diet to yield an actual daily dose of 0.2 mg/kg. Control 
animals received basal laboratory diet admixed with acetone. Dietary acetone was fully evaporated 
before presentation to the animals. Samples of each treatment diet were taken weekly for assessment 
of stability and concentration of the test substance. Clinical signs and mortality were recorded daily. 
Body weights and food consumption were measured weekly. Haematological examinations, blood 
chemistry determinations and urine analyses were performed at weeks 6 and 12. At necropsy, organ 
weights were recorded and histopathological examinations were performed. No differences between 
control and treated animals were observed in any of the tested parameters. The NOAEL is concluded 
to be 0.2 mg/kg bw per day for trithioacetone (Cox et al., 1973b). 
Subgroup VIII (Thioesters) 
Ethyl thioacetate [FL-no: 12.018] 
Ethyl thioacetate was administered to rats (12/sex/group) in the diet for 90 days at a daily actual dose 
of 6.63 mg/kg bw/day. A control group received basal diet alone. The animals were observed daily for 
clinical signs. Body weights and food consumption were recorded weekly. During weeks 6 and 13, 
urine samples were collected for complete analysis. Haematological analysis was carried out at 6 
weeks (on 8 animals/group) and at 13 weeks. At study termination animals were necropsied and their 
tissues examined for gross pathological changes. Organs were weighed and tissues retained for 
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histological evaluations. There were no significant differences between treated and control animals in 
any of the tested parameters. The NOAEL is concluded to be 6.63 mg/kg bw per day for ethyl 
thioacetate (Shellenberger, 1970b). 
The repeated-dose toxicity data are summarised in Annex IV, Table IV.2. 
8.3. Developmental / Reproductive Toxicity Studies 
Data were available on two supporting substances included in subgroup III. However, for one of them, 
1-butanethiol [FL-no: 12.010], data were obtained after inhalation, a route of exposure with limited 
value for flavouring substances. For the available data it may be concluded that effects on 
development or reproduction were only observed at exposure levels associated with maternal toxicity. 
Developmental/reproductive toxicity data are summarised in Annex IV, Table IV.3. 
8.4. Genotoxicity Studies 
Genotoxicity in vitro data are available for five of the 70 candidate substances: di-(1-propenyl)-sulfid 
(mixture) [FL-no: 12.298] (subgroup I), tetrahydrothiophene [FL-no: 15.102] (subgroup II); 2-
methylpropane-2-thiol [FL-no: 12.174] (subgroup III); dibutyl disulfide [FL-no: 12.111] (subgroup 
V), and methyl methanethiosulfonate [FL-no: 12.159] (subgroup X). In addition studies are available 
on 14 supporting substances from subgroups I (1), II (1), III (4), IV (1), V (4), VIII (2) and IX (1). 
In vivo data are available for one candidate substance [FL-no: 12.159] (subgroup X) and for four 
supporting substances from subgroups I (1), III (1), V (1) and VI (1).  
Subgroup I (Acyclic sulphides) 
In vitro data are available for the candidate substance, di-(1-propenyl)-sulfide [FL-no: 12.298]; Ames 
test: S. typhimurium TA98, TA100, TA102, TA1535, TA1537, 1-100 microg/plate. Result was 
negative with and without metabolic activation (Stien, 2005c). 
For supporting substances, only data on diallyl sulfide [FL-no: 12.088] are available: diallyl sulfide 
was negative in a limited bacterial reversion assay using one strain only (TA100) and provided 
equivocal results in an in vitro cytogenetic test in which increased incidences of cells with 
chromosomal aberrations and sister chromatid exchanges (SCEs), statistically significant but not dose 
related, were observed. In vivo diallyl sulfide was evaluated as negative in a micronucleus test in 
mouse bone marrow, which was, however, not designed to evaluate the genotoxicity of the substance 
itself as it was tested in a mixture. Overall the data available do not allow evaluation of the 
genotoxicity of the substances of this subgroup.  
Subgroup II (Cyclic sulphides) 
For this group, data on only one candidate substance tetrahydrothiophene [FL-no: 15.102] are 
available. The substance is reported to be negative in an Ames test, a cytogenetic assay in human 
lymphocytes, a gene mutation (HPRT) assay in Chinese hamster ovary (CHO) cells, a SCE assay in 
CHO cells and an unscheduled DNA synthesis (UDS) test in human epithelial cells. It is stated that the 
Ames test, the cytogenetic assay and the HPRT assay were performed according to OECD protocols. 
These studies are reported as abstracts in the IUCLID dataset (Pennwalt Corporation, 1987a-d; 
Pennwalt Corporation, 1987e).  
In addition, limited in vitro data on the supporting substance 1,4-dithiane [FL-no: 15.066] provide 
some indication of concern for genotoxicity: the substance was shown to be mutagenic in S. 
typhimurium strains TA98 and TA100, however, the mutagenic activity was completely abolished in 
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the presence of S9. In the same study the substance was reported to be negative in a SCE assay, with 
and without S9. 
Subgroup III (Monothiols) 
2-Methylpropane-2-thiol [FL-no: 12.174] is reported to be negative in an Ames test. It is reported to 
be positive in a mouse lymphoma assay without metabolic activation and negative in the test with 
metabolic activation, and it is reported to be negative in an in vitro SCE assay. However, these studies 
are reported only as summaries (Phillips Petroleum Company, 1990a). Some details are available for 
methods but not for the results. Although the validity of these studies cannot be fully evaluated, the 
positive result in the mouse lymphoma assay raises concern with respect to the potential for 
genotoxicity of this tertiary thiol and structurally related compounds, i.e. candidate substance 2-
methylbutane-2-thiol [FL-no: 12.172] and the five supporting substances [FL-no: 12.038, 12.085, 
12.137, 12.138 and 12.145]. 
The in vitro data available for the other substances in this subgroup do not provide indication of 
concern for genotoxicity.   
Subgroup IV (Dithiols) 
Equivocal results were reported for the only supporting substance tested. 1,2-Ethanedithiol [FL-no: 
12.066] was evaluated positive for induction of gene mutations and SCEs in vitro in a poorly reported 
study. However, increased mutation frequencies were associated with unacceptably high toxicity, and 
the relevance of SCEs for genotoxicity assessment is unclear. Moreover, the validity of the latter data 
set is questionable, as the distinct effect of S9 on toxicity observed in the other mammalian cell 
mutation study was not replicated. 1,2-Ethanedithiol [FL-no: 12.066] was reported in an abstract to be 
negative in the Ames test. 
Subgroup V (Acyclic and cyclic disulphides) 
Dibutyl disulfide [FL-no: 12.111] is reported to be negative in a mouse lymphoma assay (Dooley et 
al., 1987). However, the study is reported only as abstract, and thus, the validity cannot be evaluated.  
Further data are available for the supporting substances diallyl disulfide [FL-no: 12.008], 
dimethyldisulfide [FL-no: 12.026], phenyl disulfide [FL-no: 12.043] and benzyl disulfide [FL-no: 
12.081]. All substances were negative in the Ames test. In addition, diallyl disulfide was reported to be 
positive in a chromosomal aberration assay in vitro, with and without metabolic activation, and weakly 
positive in a SCE assay. However, the validity of these findings is doubtful as chromosomal 
aberrations were only increased in conditions associated with extensive (> 90 %) lethality, and 
because of the limitation of SCE in genotoxic hazard identification. 
Subgroup VII (Mono-, di-, tri- and polysulphides with thioacetal structure) 
There are no data available on genotoxicity for the substances in this group. However, one of the 
hydrolysis products of the candidate substance 2,4,4-trimethyl-1,3-oxathiane [FL-no: 16.057] is 
structurally related to the above-mentioned tertiary thiols, raising concern with respect to the 
genotoxicity of this candidate. Therefore, in the absence of further genotoxicity data, the Panel 
concluded that the Procedure could not be applied to 2,4,4-trimethyl-1,3-oxathiane [FL-no: 16.057]. 
Subgroup VIII (Thioesters) 
The in vitro data available on supporting substances provide no indication of concern for genotoxicity. 
Subgroup IX (Thioic acids) 
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No data are available for the candidate substance of this group. Moreover, there are no supporting 
substances. 
Subgroup X (Sulphoxides/sulphones and sulphonates) 
Methyl methanethiosulfonate (MMTS) [FL-no: 12.159] is structurally similar to methyl 
methanesulfonate (MMS), a direct acting genotoxic carcinogen. However, the presence of an 
additional sulphur is expected to decrease the electrophilicity and therefore the possible genotoxicity 
of the candidate substance. MMTS is reported to be negative in an Ames test and in a mitotic 
recombination/mutagenicity assay with Saccharomyces cerevisiae (Dorange et al., 1983). However, as 
pointed out by the authors, thiosulphonates in general, and MMTS in particular, are non-specific 
antimicrobial agents that are active at low concentrations on bacteria, as well as on yeast and other 
fungi. Therefore, bacterial test systems and yeast assays are not appropriate to evaluate genotoxicity of 
thiosulphonates. MMTS [FL-no: 12.159] has also been shown to be negative in an assay performed 
with Nicotiana tabacum seeds (Dorange et al., 1983), but the relevance of this test is unknown.  
Antimutagenic activity has been shown for MMTS, which occurs naturally in some vegetables from 
Cruciferae and Liliaceae species (Marks et al., 1993; Nakamura et al., 1993; Nakamura et al., 1996; Ito 
et al., 1997; Nakamura et al., 1997a). However, antimutagenicity studies per se are not specifically 
designed to evaluate the genotoxic potential of chemicals. 
In conclusion, the limited relevance of the tests carried out so far in bacteria and yeasts and the lack of 
tests on mammalian cells do not allow an adequate evaluation of the genotoxic potential of MMTS. In 
addition, the similarity with MMS raises concern with respect to the genotoxicity of this candidate 
substance. 
Methylsulfinyl methane [FL-no: 12.175] (synonym: dimethylsulphoxide, DMSO) was reported to be 
positive in an Ames test at high doses, which resulted in reduced bacterial survival. The validity of this 
finding is highly questionable compared to the overwhelming evidence on absence of genotoxic 
properties provided by the wide use of DMSO as solvent for test material in genotoxicity assays 
including controls for solvent activity. Further data on other supporting substances are of limited or 
insufficient quality and cannot be evaluated. 
Subgroup XI Cyclic thioketal with fused oxolane ring  
No data are available for the candidate substance of this group. Moreover, there are no supporting 
substances.  
 
Conclusion on genotoxicity 
Most in vitro and in vivo studies are of limited or insufficient quality and provide only limited 
information.  
The available data raise concern with respect to genotoxicity of two tertiary thiols [FL-no: 12.172 and 
12.174], included as candidate substances in subgroup III. Hydrolysis of the candidate substance 
2,4,4-trimethyl-1,3-oxathiane [FL-no: 16.057], included in subgroup VII, leads to the formation of a 
tertiary thiol structurally related to the above-mentioned compounds. Therefore, there is also concern 
with respect to genotoxicity of this candidate substance. The Panel noted that in FGE.08 five of the 
supporting substances were tertiary thiols [FL-no: 12.038, 12.085, 12.137, 12.138 and 12.145] for 
which a concern for genotoxicity has been raised in the FGE.08Rev1. These supporting substances 
have been evaluated by the JECFA at the 53rd meeting (JECFA, 2000b; JECFA, 2000c) and are not 
scheduled for evaluation by EFSA. However, these substances should be considered by Panel based 
on the outcome of the evaluation of the two candidate tertiary thiols [FL-no: 12.172 and 12.174]. 
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In addition, genotoxicity of the candidate substance MMTS [FL-no: 12.159], included in subgroup X, 
could not be assessed from the data available. However, due to the similarity with MMS, a direct 
acting mutagen and carcinogen, there is concern with respect to genotoxic potential of this candidate 
substance.  
Therefore, the Panel decided that the Procedure could not be applied to the four candidate substances 
[FL-no: 12.159, 12.172, 12.174 and 16.057] until adequate in vivo genotoxicity data become available. 
The other in vitro/in vivo genotoxicity data available, often from limited or poorly reported studies, do 
not provide clear indication of concern for genotoxicity for the remaining candidate substances 
included in the present evaluation. 
Genotoxicity data are summaries in Annex IV, Table IV.4 and Table IV.5. 
9. Conclusions 
The FGE.08Rev3 includes the assessment of three additional candidate substances [FL-no: 15.007, 
15.134 and 16.114] compared to FGE.08Rev2. Therefore, the present FGE.08Rev3 deals with 70 
flavouring substances in total.  
 
The total 70 candidate substances in FGE.08Rev3 are divided into 11 subgroups:  
Subgroup I: Acyclic sulphides: 18 candidate substances [FL-no: 12.096, 12.099, 12.117, 12.124, 
12.127, 12.129, 12.152, 12.158, 12.163, 12.166, 12.177, 12.178, 12.181, 12.182, 12.183, 12.214, 
12.277 and 12.298],  
Subgroup II: Cyclic sulphides: Three candidate substances [FL-no: 12.120, 5.102 and 15.125],  
Subgroup III: Monothiols: 12 candidate substances [FL-no: 12.104, 12.135, 12.136, 12.172, 12.174, 
12.180, 12.191, 12.205, 12.250, 12.266, 12.268 and 12.269],  
Subgroup IV: Dithiols: One candidate substance [FL-no: 12.103],  
Subgroup V: Acyclic and cyclic disulphides: four candidate substances: [FL-no: 12.098, 12.111, 
12.151 and 12.295],  
Subgroup VI: Acyclic polysulphides: Eight candidate substances [FL-no: 12.093, 12.094, 12.097, 
12.100, 12.112, 12.116, 12.164 and 12.167],  
Subgroup VII: Mono-, di-, tri- and polysulphides with thioacetal structure: 12 candidate substances 
[FL-no: 12.200, 15.047, 15.048, 15.056, 15.081, 15.083, 15.103, 15.110, 15.111, 15.134, 16.057 and 
16.114],  
Subgroup VIII: Thioesters: Nine candidate substances [FL-no: 12.106, 12.125, 12.165, 12.189, 
12.196, 12.221, 12.271, 12.278 and 12.282],  
Subgroup IX: Thioic acids: One candidate substance [FL-no: 12.199],   
Subgroup X: Sulphoxides/sulphones and sulphonates: One candidate substance [FL-no: 12.159] and  
Subgroup XI: Cyclic thioketal with fused oxolane ring: One candidate substance [FL-no: 15.007]. 
Twenty-two of the 70 flavouring substances possess one or more chiral centres [FL-no: 12.104, 
12.106, 12.120, 12.135, 12.177, 12.178, 12.180, 12.182, 12.214, 12.250, 12.266, 12.268, 12.269, 
12.278, 12.295, 15.007, 15.047, 15.048, 15.083, 15.134, 16.057 and 16.114]. The stereoisomeric 
composition has not been specified sufficiently for nine of these 22 substances [FL-no: 12.120, 
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12.250, 12.266, 12.268, 12.269, 12.278, 15.007, 15.134 and 16.114] for these 22 substances. Six of 
the 70 substances can exist as geometrical isomers [FL-no: 12.098, 12.163, 12.164, 12.298, 15.056 
and 15.110]. Industry has informed that these substances occurs as mixtures of geometrical isomers, 
however, the composition of the mixtures have not been  specified sufficiently, as the actual ratio has 
to be given.  Composition of mixture should be clarified for [FL-no: 12.298 and 15.007]. 
Forty-four of the candidate substances belong to structural class I, 19 belong to structural class II and 
seven belong to structural class III. 
Forty-five of the flavouring substances in the present group have been reported to occur naturally in a 
wide range of food items. 
According to the default MSDI approach, the 66 of the 70 flavouring substances for which Flavour 
Industry have submitted data, have intakes in Europe ranging from 0.0012 to 6.1 
microgram/capita/day, which are below the threshold of concern value for structural class I (1800 
microgram/person/day), structural class II (540 microgram/person/day), and structural class III (90 
microgram/person/day) substances. 
On the basis of the reported annual production volumes in Europe (MSDI approach), the combined 
intake of the 39 of 44 candidate substances belonging to class I for which data were submitted and the 
substance evaluated through the Procedure, the 17 of the 19 candidate substances belonging to class II 
for which data were submitted and the substance evaluated through the Procedure, and the six of seven 
candidate substances belonging to class III and evaluated through the Procedure, would result in total 
intakes of approximately 11, 6 and 16, respectively, which do not exceed the thresholds of concern. 
Based on reported production volumes, European per capita intakes (MSDI) could be estimated for 68 
of the 127 supporting substances. The total combined intakes of the candidate and supporting 
substances (for which there are European intake data) are approximately 648, 115 and 16 
microgram/capita/day for structural class I, II and III, respectively, which do not exceed the thresholds 
of concern for structural class I, II or III of 1800, 540 or 90 microgram/person/day, respectively.  
Data on genotoxicity of the candidate substances are limited and the genotoxicity could not be 
adequately assessed. The data available, however, give rise to some concern of a genotoxic potential 
of two of the candidate substances 2-methylpropane-2-thiol [FL-no: 12.174] and methyl 
methanethiosulphonate [FL-no: 12.159]. The Panel, therefore, concluded that the Procedure could not 
be applied to these two substances, nor to the two to [FL-no: 12.174] structurally related candidate 
substances, 2-methylbutane-2-thiol [FL-no: 12.172] and 2,4,4-trimethyl-1,3-oxathiane [FL-no: 16.057] 
until adequate in vivo genotoxicity data become available. The Panel noted that in FGE.08 five of the 
supporting substances were tertiary thiols [FL-no: 12.038, 12.085, 12.137, 12.138 and 12.145] for 
which a concern for genotoxicity has been raised in the FGE.08Rev1. These supporting substances 
have been evaluated by the JECFA at the 53rd meeting and are not scheduled for evaluation by EFSA. 
However, these substances should be considered by Panel based on the outcome of the evaluation of 
the two candidate substances being tertiary thiols [FL-no: 12.172 and 12.174]. 
The genotoxicity data available for the remaining candidate substances do not preclude their 
evaluation through the Procedure.  
For three substances in structural class I, 3-mercaptooctanal, 3-mercaptodecanal, methanedithiol 
diacetate [FL-no: 12.268, 12.269 and 12.271] and for one substance, 3,5-dimethyl-1,2-dithiolane-4-
one in structural class II [FL-no: 12.295] no data on use as flavouring substances in Europe are 
available, therefore no intakes can be estimated and accordingly these substances can not be evaluated 
through the procedure. 
The candidate substances and supporting substances are expected to share common routes of 
absorption, distribution and metabolism and exhibit similar toxicological properties. These metabolic 
pathways are unlikely to be saturated, given the low levels of exposure from their use as flavouring 
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substances. However, due to the reactivity of the metabolites, the candidate substances cannot be 
predicted to be metabolised to innocuous products. 
Except for subgroups II [FL-no: 12.120, 15.102 and 15.125], VI [FL-no: 12.093, 12.094, 12.097, 
12.100, 12.112, 12.116, 12.164 and 12.167], IX [FL-no: 12.199] and XI [FL-no: 15.007], and one 
candidate substance in subgroup VII [FL-no: 15.134], adequate repeated-dose toxicity studies are 
available for supporting substances from the different subgroups, allowing derivation of adequate 
margins of safety by comparing the NOAEL values with the MSDI.  
It is considered that on the basis of the default MSDI approach the 48 of the 62 candidate substances 
evaluated through the Procedure would not give rise to safety concerns at the estimated levels of 
intake arising from their use as flavouring substances. Additional toxicity data are required for the 
three candidate substances in subgroup II [FL-no: 12.120, 15.102 and 15.125], for the eight candidate 
substances in subgroup VI [FL-no: 12.093, 12.094, 12.097, 12.100, 12.112, 12.116, 12.164 and 
12.167], for one candidate substance in subgroup VII [FL-no: 15.134], for the candidate substance in 
subgroup IX [FL-no: 12.199] and for the candidate substance in subgroup XI [FL-no: 15.007].  
Additional in vivo data on genotoxicity are required for candidate substances 2-methylpropane-2-thiol 
[FL-no: 12.174], methyl methanethiosulphonate [FL-no: 12.159], 2-methylbutane-2-thiol [FL-no: 
12.172] and 2,4,4-trimethyl-1,3-oxathiane [FL-no: 16.057].  
When the estimated intakes were based on the mTAMDI they ranged from 28 to 8000 
microgram/person/day for the 39 of the 44 candidate substances from structural class I for which 
intake data have been submitted and the substances have been evaluated through the Procedure. These 
intakes were below the threshold of concern for structural I of 1800 microgram/person/day, except for 
two candidate substances [FL-no: 12.250 and 12.282]. The estimated intakes for the 16 of the 19 
candidate substances assigned to structural class II for which intake data have been submitted and the 
substances evaluated through the Procedure, based on the mTAMDI, ranged from 46 to 78 
microgram/person/day, which are below the threshold of concern for structural class II of 540 
microgram/person/day. For one substance assigned to structural class III [FL-no: 15.007], mTAMDI 
could not be calculated since data on use levels was not provided. The estimated intakes for the 
remaining five candidate substances assigned to structural class III and evaluated through the 
Procedure, based on the mTAMDI, are in the range of 78 to 500 microgram/person/day. For one of the 
substances [FL-no: 15.081] the mTAMDI is below the threshold of concern of 90 
microgram/person/day. The 52 candidate substances which have mTAMDI intake estimates below the 
threshold of concern for structural class I, II and III, are also expected to be metabolised to innocuous 
products. 
For the six flavouring substances [FL-no: 12.120, 12.136, 12.250, 12.282, 15.134 and 16.114] 
evaluated through the Procedure, for which the intakes, estimated on the basis of the mTAMDI, 
exceed the relevant threshold for their structural class more reliable exposure data are required, as well 
as for the substances for which use levels have not been provided. On the basis of such additional data, 
these flavouring substances should be re-evaluated using the Procedure. Subsequently, additional 
toxicological data might become necessary. 
In order to determine whether the conclusion for the 62 candidate substances evaluated through the 
Procedure can be applied to the material of commerce, it is necessary to consider the available 
specifications. Specifications including complete purity criteria and identity for the materials of 
commerce have been provided for 68 of the 70 candidate substances. For two substances [FL-no: 
12.266 and 15.125] have specifications not been provided. Information on chirality has not been 
specified sufficiently for nine of the substances [FL-no: 12.120, 12.250, 12.266, 12.268, 12.269, 
12.278, 15.007, 15.134 and 16.114] and composition of the mixture of the geometrical isomers is 
lacking for six of the substances [FL-no: 12.098, 12.163, 12.164 12.298, 15.056 and 15.110], and 
composition of mixture should be clarified for [FL-no: 12.298 and 15.007]. For four substances is an 
identity test missing [FL-no: 12.268, 12.269, 12.271 and 12.282]. Additional toxicity data are required 
Flavouring Group Evaluation 08, Revision 3
 
 
36 EFSA Journal 2011; 9(5):1988 
for the three candidate substances in subgroup II [FL-no: 12.120, 15.102 and 15.125], for the eight 
candidate substances in subgroup VI [FL-no: 12.093, 12.094, 12.097, 12.100, 12.112, 12.116, 12.164 
and 12.167], for one candidate substance in subgroup VII [FL-no: 15.134], for the candidate substance 
in subgroup IX [FL-no: 12.199] and the candidate substance in subgroup XI [FL-no: 15.007]. 
Additional in vivo data on genotoxicity are required for candidate substances 2-methylpropane-2-thiol 
[FL-no: 12.174], methyl methanethiosulphonate [FL-no: 12.159], 2-methylbutane-2-thiol [FL-no: 
12.172] and 2,4,4-trimethyl-1,3-oxathiane [FL-no: 16.057]. For four substances, 3-mercaptooctanal 
[FL-no: 12.268], 3-mercaptodecanal [FL-no: 12.269], methanedithiol diacetate [FL-no: 12.271] and 
3,5-dimethyl-1,2-dithiolane-4-one [FL-no: 12.295] data on use as flavouring substances in Europe are 
required. 
Thus, the final evaluation of the materials of commerce cannot be performed for 32 of the 70 
substances [FL-no: 12.093, 12.094, 12.097, 12.098, 12.100, 12.112, 12.116, 12.120, 12.159, 12.163, 
12.164, 12.167, 12.172, 12.174, 12.199, 12.250, 12.266, 12.268, 12.269, 12.271, 12.278, 12.282, 
12.295, 12.298, 15.007, 15.056, 15.102, 15.110, 15.125, 15.134, 16.057 and 16.114], pending further 
information.  
The remaining 38 flavouring substances evaluated through the Procedure [FL-no: 12.096, 12.099, 
12.103, 12.104, 12.106, 12.111, 12.117, 12.124, 12.125, 12.127, 12.129, 12.135, 12.136, 12.151, 
12.152, 12.158, 12.165, 12.166, 12.177, 12.178, 12.180, 12.181, 12.182, 12.183, 12.189, 12.191, 
12.196, 12.200, 12.205, 12.214, 12.221, 12.277, 15.047, 15.048, 15.081, 15.083, 15.103 and 15.111] 
would present no safety concern at the levels of intake estimated on the basis of the MSDI approach. 
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TABLE 1: SPECIFICATION SUMMARY OF THE SUBSTANCES IN THE FLAVOURING GROUP EVALUATION 8, REVISION 3 
Table 1: Specification Summary of the Substances in the Flavouring Group Evaluation 8, Revision 3 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
Specification comments 
12.093 
 
Diallyl hexasulfide S
S
S
S
S
S  
3533 
11912 
 
Solid 
C6H10S6 
274.50 
Practically insoluble 
or insoluble 
Freely soluble 
470 
76 
NMR 
95 % 
n.a. 
n.a. 
 
CASrn 137443-18-6 to be 
introduced in the Register. 
12.094 
 
Diallyl heptasulfide S
S
S
S
S
S
S
 
3533 
11912 
 
Solid 
C6H10S7 
306.60 
Practically insoluble 
or insoluble 
Freely soluble 
539 
121 
NMR 
95 % 
n.a. 
n.a. 
 
CASrn 139693-24-6 to be 
introduced in the Register. 
12.096 
 
Allyl methyl sulfide S
 
 
11429 
10152-76-8 
Liquid 
C4H8S 
88.17 
Practically insoluble 
or insoluble 
Freely soluble 
93 
 
MS 
95 % 
1.468-1.474 
0.874-0.880 
 
 
12.097 
 
Allyl methyl tetrasulfide 
S
S
S
S
 
 
 
90195-83-8 
Solid 
C4H8S4 
184.37 
Practically insoluble 
or insoluble 
Freely soluble 
267 
23 
MS 
95 % 
n.a. 
n.a. 
 
 
12.098 
 
Allyl prop-1-enyl disulfide   6) 
S
S
 
 
11433 
33368-82-0 
Liquid 
C6H10S2 
146.28 
Practically insoluble 
or insoluble 
Freely soluble 
205 
 
NMR 
95 % 
1.541-1.547 
1.004-1.010 
 
Stereoisomeric composition 
to be specified. (Z)- or (E)-
isomer not specified by 
CASrn in Register. 
12.099 
 
Allyl propyl sulfide S
 
 
11434 
27817-67-0 
Liquid 
C6H12S 
148.29 
Practically insoluble 
or insoluble 
Freely soluble 
144 
 
MS 
95 % 
1.474-1.480 
0.860-0.866 
 
 
12.100 
 
Allyl propyl trisulfide S
S
S
 
 
11435 
33922-73-5 
Liquid 
C6H12S3 
180.36 
Practically insoluble 
or insoluble 
Freely soluble 
253 
 
MS 
95 % 
1.584-1.590 
1.050-1.056 
 
 
12.103 
 
Butane-1,4-dithiol 
HS
SH
 
 
 
1191-08-8 
Liquid 
C4H10S2 
122.24 
Slightly soluble 
Freely soluble 
73 (13 hPa) 
 
MS 
95 % 
1.524-1.530 
1.041-1.047 
 
 
12.104 
 
Butane-2-thiol SH
 
 
 
513-53-1 
Liquid 
C4H10S 
90.18 
Slightly soluble 
Freely soluble 
85 
 
MS 
95 % 
1.431-1.437 
0.826-0.832 
 
Racemate (EFFA, 2010a). 
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Table 1: Specification Summary of the Substances in the Flavouring Group Evaluation 8, Revision 3 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
Specification comments 
12.106 
 
S-2-Butyl 3-methylbutanethioate O
S  
 
 
2432-91-9 
Liquid 
C9H18OS 
174.30 
Practically insoluble 
or insoluble 
Freely soluble 
181 
 
MS 
98 % 
1.452-1.459 
0.898-0.906 
 
Racemate (EFFA, 2010a). 
12.111 
 
Dibutyl disulfide 
S
S
 
 
 
629-45-8 
Liquid 
C8H18S2 
178.35 
Practically insoluble 
or insoluble 
Freely soluble 
101 (13 hPa) 
 
MS 
95 % 
1.488-1.494 
0.934-0.940 
 
 
12.112 
 
Dibutyl trisulfide 
S
S
S  
 
 
5943-31-7 
Liquid 
C8H18S3 
210.41 
Practically insoluble 
or insoluble 
Freely soluble 
139 (16 hPa) 
 
NMR 
95 % 
1.525-1.531 
1.015-1.021 
 
 
12.116 
 
Dimethyl tetrasulfide S
S
S
S  
 
11459 
5756-24-1 
Liquid 
C2H6S4 
158.31 
Practically insoluble 
or insoluble 
Freely soluble 
60 (1.3 hPa) 
 
MS 
95 % 
1.658-1.664 
1.303-1.309 
 
 
12.117 
 
Dipentyl sulfide S
 
 
 
872-10-6 
Liquid 
C10H22S 
174.34 
Practically insoluble 
or insoluble 
Freely soluble 
108 (20 hPa) 
 
MS 
95 % 
1.450-1.456 
0.836-0.842 
 
 
12.120 
1685 
2,8-Epithio-p-menthane   6) 
S
 
 
68398-18-5 
Liquid 
C10H18S 
170.31 
Practically insoluble 
or insoluble 
Freely soluble 
114 (31 hPa) 
 
MS 
95 % 
1.511-1.517 
0.999-1.005 
 
Stereoisomeric composition 
to be specified. (R)- or (S)-
enantiomer not specified by 
CASrn in Register. 
12.124 
 
Ethyl butyl sulfide 
S  
 
 
638-46-0 
Liquid 
C6H14S 
118.24 
Practically insoluble 
or insoluble 
Freely soluble 
144 
 
MS 
95 % 
1.443-1.449 
0.834-0.840 
 
 
12.125 
 
Ethyl propanethioate 
S
O
 
 
 
2432-42-0 
Liquid 
C5H10OS 
118.19 
Practically insoluble 
or insoluble 
Freely soluble 
136 
 
MS 
95 % 
1.452-1.458 
0.957-0.963 
 
 
12.127 
 
Ethyl propyl sulfide 
S  
 
11479 
4110-50-3 
Liquid 
C5H12S 
104.21 
Practically insoluble 
or insoluble 
Freely soluble 
118 
 
MS 
95 % 
1.440-1.446 
0.836-0.842 
 
 
12.129 
 
3-(Ethylthio)propan-1-ol 
HO S  
 
 
18721-61-4 
Liquid 
C5H12OS 
120.21 
Slightly soluble 
Freely soluble 
99 (13 hPa) 
 
NMR 
95 % 
1.480-1.486 
0.989-0.995 
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Table 1: Specification Summary of the Substances in the Flavouring Group Evaluation 8, Revision 3 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
Specification comments 
12.135 
 
3-Mercapto-2-methylpropionic 
acid 
HSHO
O  
 
26473-47-2 
Solid 
C4H8O2S 
120.17 
Soluble 
Freely soluble 
113 (13 hPa) 
43 
NMR 
95 % 
n.a. 
n.a. 
 
Racemate (EFFA, 2010a). 
12.136 
 
3-Mercapto-2-oxopropionic acid 
HSHO
O
O
 
 
2464-23-5 
Solid 
C3H4O3S 
120.12 
Soluble 
Freely soluble 
253 
97 
NMR 
95 % 
n.a. 
n.a. 
 
 
12.151 
 
Methyl butyl disulfide 
S
S
 
 
 
60779-24-0 
Liquid 
C5H12S2 
136.27 
Practically insoluble 
or insoluble 
Freely soluble 
58 (13 hPa) 
 
MS 
95 % 
1.497-1.503 
0.984-0.990 
 
 
12.152 
 
Methyl butyl sulfide S
 
 
 
628-29-5 
Liquid 
C5H12S 
104.21 
Practically insoluble 
or insoluble 
Freely soluble 
123 
 
MS 
95 % 
1.442-1.448 
0.839-0.845 
 
 
12.158 
 
Methyl isoprenyl sulfide 
S  
 
 
5897-45-0 
Liquid 
C6H12S 
116.22 
Practically insoluble 
or insoluble 
Freely soluble 
145 
 
NMR 
95 % 
1.478-1.484 
0.862-0.868 
 
Register name to be changed 
to Methyl 3-methyl-2-
butenylsulphide. 
12.159 
 
Methyl methanethiosulfonate 
S
O
O
S
 
11520 
2949-92-0 
Liquid 
C2H6O2S2 
126.19 
Slightly soluble 
Freely soluble 
104 (13 hPa) 
 
MS 
95 % 
1.507-1.513 
1.315-1.321 
 
 
12.163 
 
Methyl prop-1-enyl sulfide   6) S
 
 
11538 
10152-77-9 
Liquid 
C4H8S 
88.17 
Practically insoluble 
or insoluble 
Freely soluble 
103 
 
NMR 
95 % 
1.487-1.493 
0.867-0.873 
 
Stereoisomeric composition 
to be specified. (Z)- or (E)-
isomer not specified by 
CASrn in Register. 
12.164 
 
Methyl prop-1-enyl trisulfide   6) 
S
SS
 
 
11539 
33368-80-8 
Liquid 
C4H8S3 
152.17 
Practically insoluble 
or insoluble 
Freely soluble 
223 
 
NMR 
95 % 
1.586-1.592 
1.112-1.118 
 
Stereoisomeric composition 
to be specified. (Z)- or (E)-
isomer not specified by 
CASrn in Register. 
12.165 
1678 
S-Methyl propanethioate 
S
O
 
 
 
5925-75-7 
Liquid 
C4H8OS 
104.17 
Practically insoluble 
or insoluble 
Freely soluble 
120 
 
MS 
95 % 
1.459-1.465 
0.891-0.897 
 
 
12.166 
 
Methyl propyl sulfide S
 
 
11541 
Liquid 
C4H10S 
Practically insoluble 
or insoluble 
96 
 
1.438-1.444 
0.834-0.840 
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Table 1: Specification Summary of the Substances in the Flavouring Group Evaluation 8, Revision 3 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
Specification comments 
3877-15-4 90.18 Freely soluble MS 
95 % 
12.167 
 
Methyl propyl tetrasulfide S
S
S
S  
 
 
87148-08-1 
Liquid 
C4H10S4 
186.18 
Practically insoluble 
or insoluble 
Freely soluble 
259 
 
NMR 
95 % 
1.622-1.628 
1.197-1.203 
 
 
12.172 
 
2-Methylbutane-2-thiol 
HS
 
 
1679-09-0 
Liquid 
C5H12S 
104.21 
Practically insoluble 
or insoluble 
Freely soluble 
99 
 
MS 
95 % 
1.432-1.438 
0.809-0.815 
 
 
12.174 
 
2-Methylpropane-2-thiol SH  
11537 
75-66-1 
Liquid 
C4H10S 
90.18 
Slightly soluble 
Freely soluble 
64 
 
MS 
95 % 
1.417-1.423 
0.797-0.803 
 
 
12.177 
 
8-(Methylthio)-p-menthan-3-one O
S
 
 
 
32637-94-8 
Liquid 
C11H20OS 
200.34 
Practically insoluble 
or insoluble 
Freely soluble 
72 (0.1 hPa) 
 
NMR 
95 % 
1.495-1.501 
0.951-0.957 
 
Mixture of isomers ((R/R), 
(R/S), (S/R) & (S/S) at equal 
ratio, i.e. 25 % of each) 
(EFFA, 2010a). CASrn in 
Register refers to (Z) 
isomer. CASrn to be 
changed. 
12.178 
 
3-(Methylthio)butyric acid O
HO S  
 
 
16630-65-2 
Liquid 
C5H10O2S 
134.19 
Soluble 
Freely soluble 
127 (13 hPa) 
 
MS 
95 % 
1.479-1.486 
1.102-1.108 
 
Racemate (EFFA, 2010a). 
12.180 
 
1-(Methylthio)ethane-1-thiol SH
S  
 
 
31331-53-0 
Liquid 
C3H8S2 
108.22 
Slightly soluble 
Freely soluble 
58 (35 hPa) 
 
NMR 
95 % 
1.522-1.528 
0.879-0.885 
 
Racemate (EFFA, 2010a). 
12.181 
 
1-(Methylthio)pentan-3-one 
S
O
 
 
 
66735-69-1 
Liquid 
C6H12OS 
132.22 
Practically insoluble 
or insoluble 
Freely soluble 
88 (16 hPa) 
 
MS 
95 % 
1.467-1.473 
0.987-0.993 
 
 
12.182 
 
2-(Methylthio)propionic acid 
S
HO
O  
 
58809-73-7 
Solid 
C4H8O2S 
120.17 
Practically insoluble 
or insoluble 
Freely soluble 
110 (13 hPa) 
48 
MS 
95 % 
n.a. 
n.a. 
 
Racemate (EFFA, 2010a). 
12.183 
 
3-(Methylthio)propionic acid 
SHO
O
 
 
 
646-01-5 
Liquid 
C4H8O2S 
120.17 
Soluble 
Freely soluble 
125 (16 hPa) 
 
MS 
95 % 
1.485-1.491 
1.155-1.161 
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Table 1: Specification Summary of the Substances in the Flavouring Group Evaluation 8, Revision 3 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
Specification comments 
12.189 
 
S-(Methylthiomethyl) 2-
methylpropanethioate 
S S
O  
 
77974-85-7 
Liquid 
C6H12OS2 
164.03 
Practically insoluble 
or insoluble 
Freely soluble 
273 
 
NMR 
95 % 
1.452-1.456 
1.031-1.037 
 
 
12.191 
1662 
Pentane-1-thiol 
SH  
 
 
110-66-7 
Liquid 
C5H12S 
104.21 
Slightly soluble 
Freely soluble 
126 
 
MS 
95 % 
1.441-1.450 
0.831-0.844 
 
 
12.196 
 
S-Prenyl thioisobutyrate 
S
O  
 
53626-94-1 
Liquid 
C9H16OS 
172.28 
Practically insoluble 
or insoluble 
Freely soluble 
100 (20 hPa) 
 
NMR 
95 % 
1.483-1.489 
1.109-1.115 
 
 
12.199 
1676 
Ethanethioic acid 
HS
O
 
 
 
507-09-5 
Liquid 
C2H4OS 
76.11 
Slightly soluble 
Freely soluble 
88 
 
MS 
95 % 
1.459-1.465 
1.066-1.072 
 
 
12.200 
 
1,1-bis(Ethylthio)-ethane 
S S  
 
 
14252-42-7 
Liquid 
C6H14S2 
150.30 
Practically insoluble 
or insoluble 
Freely soluble 
80 (13 hPa) 
 
MS 
95 % 
1.499-1.505 
0.967-0.973 
 
 
12.205 
 
Mercaptoacetaldehyde 
SH
O
 
 
 
4124-63-4 
Liquid 
C2H4OS 
76.11 
Slightly soluble 
Freely soluble 
84 
 
NMR 
95 % 
1.495-1.501 
1.112-1.118 
 
 
12.214 
1677 
Isobutyl-3-(methylthio)butyrate 
S
O
O
 
 
127931-21-9 
Liquid 
C9H18O2S 
190.30 
Practically insoluble 
or insoluble 
Freely soluble 
224 
 
NMR 
95 % 
1.458-1.464 
0.875-0.881 
 
Racemate (EFFA, 2010a). 
12.221 
 
S-Prenyl thioisopentanoate 
S
O
 
 
 
75631-91-3 
Liquid 
C10H18OS 
186.28 
Practically insoluble 
or insoluble 
Freely soluble 
248 
 
MS 
95 % 
1.475-1.481 
1.003-1.009 
 
 
12.250 
 
3-Mercaptohexanal   6) OSH
 
 
 
51755-72-7 
Liquid 
C6H12OS 
132.22 
Soluble 
Soluble 
 
 
GC 
92 % 
1.515-1.525 
 
BP 8),  SG 13). 
Stereoisomeric composition 
to be specified. Secondary 
components:  
‹ 5 % Trans-2-hexenal, 
‹ 1 % 3-mercaptohexenal 
diethyl ether, 
‹ 1 % dimers. 
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Table 1: Specification Summary of the Substances in the Flavouring Group Evaluation 8, Revision 3 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
Specification comments 
12.266 
 
Methyl-2-mercaptopropionate   6) 
SH
O
O
 
 
 
53907-46-3 
 
 
 
 
 
 
 
 
 
 
 
AV 7), BP 8), ID 9), MP 
10), PF 11), RI 12), SG 13), 
SE 14), SW 15). 
Stereoisomeric composition 
to be specified. CASrn in 
Register refers to the 
racemate. 
12.268 
 
3-Mercaptooctanal   6) SHO
 
 
 
473438-39-0 
Liquid 
C8H16OS 
160.28 
Slightly soluble 
Freely soluble 
220 
 
 
> 93 % 
1.459 
0.930 
ID 9). 
Stereoisomeric composition 
to be specified. CASrn in 
Register refers to the 
racemate. 
12.269 
 
3-Mercaptodecanal   6) SHO
 
 
 
 
Liquid 
C10H20OS 
188.33 
Slightly soluble 
Freely soluble 
260 
 
 
95 % 
1.460 
0.917 
ID 9). 
Stereoisomeric composition 
to be specified. CASrn is 
missing. 
12.271 
 
Methanedithiol diacetate 
S S
O O
 
 
 
2506-35-6 
Liquid 
C5H8O2S2 
164.25 
Slightly soluble 
Freely soluble 
211 
 
 
> 95 % 
1.530 
1.232 
ID 9). 
 
12.277 
 
3-(Methylthio)propyl butyrate 
O S
O
 
4160 
 
16630-60-7 
Liquid 
C8H16O2S 
176.20 
Slightly soluble 
 
232 
 
IR NMR MS 
99.9 % 
1.4609-
1.4611 
0.9076-
0.9080 
 
 
12.278 
 
3-Acetyl-mercaptohexyl acetate   
6) 
O
O
S
O  
 
136954-25-1 
Liquid 
C8H18O3S 
218.3 
 
 
212 
 
MS 
98 % 
1.4681 
1.0352 
 
Stereoisomeric composition 
to be specified. CASrn in 
Register refers to the 
racemate. 
12.282 
 
(S)-Methyl octanethioate O
S  
 
 
2432-83-9 
Liquid 
C9H18OS 
174 
Insoluble 
Soluble 
165 (35 hPa) 
 
 
> 97 % 
1.464-1.465 
0.922-0.924 
ID 9). 
 
12.295 
 
3,5-Dimethyl-1,2-dithiolane-4-one S S
O
 
 
122152-29-8 
Liquid 
C5H8OS2 
148.25 
 
 
235 
 
NMR 
95% 
1.552 
1.194 
 
Mixture of isomers ((R/R), 
(R/S), (S/R) & (S/S) at equal 
ratio, i.e. 25 % of each) 
(EFFA, 2010a). 
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Table 1: Specification Summary of the Substances in the Flavouring Group Evaluation 8, Revision 3 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
Specification comments 
12.298 
 
Di-(1-propenyl)-sulfid (mixture)   
6) 
S
S
S
4386 
 
 
Liquid 
C6H10S 
114.211 
 
 
 
 
MS 
95 % 
1.512-1.514 
0.9048-
0.9058 
BP 8). 
Mixture of isomers with 
CASrn: 65819-74-1, 37981-
37-6, 37981-36-5.  
Stereoisomeric composition 
to be specified. Composition 
of mixture to be specified.  
15.007 
 
Spiro(2,4-Dithia-1-methyl-8-oxa-
bicyclo[3.3.0]octane-3,3’-(1’- oxa-
2’-methyl)-cyclopentane) and 
spiro(Dithia-6-methyl-7-oxa-
bicyclo[3.3.0]octane-3,3’-
spiro(2,4-(1’-oxa-2-
methyl)cyclopentane) 
6) 
O
S
S
O
O
S
S
O
3270 
2325 
38325-25-6 
Liquid 
C10H16O2S2 
232.20 
Insoluble 
Soluble 
135-140 
 
IR MS 
95 % 
1.559-1.565 
1.200-1.208 
 
Stereoisomeric composition 
to be specified. Composition 
of mixture to be specified. 
 
15.047 
 
3,5-Di-isobutyl-1,2,4-trithiolane 
SS
S
 
 
 
92900-67-9 
Solid 
C10H20S3 
236.40 
Practically insoluble 
or insoluble 
Freely soluble 
295 
156 
NMR 
95 % 
n.a. 
n.a. 
 
Mixture of isomers ((R/R), 
(R/S), (S/R) & (S/S) at equal 
ratio, i.e. 25 % of each) 
(EFFA, 2010a). 
15.048 
 
3,5-Di-isopropyl-1,2,4-trithiolane 
SS
S
 
 
54934-99-5 
Solid 
C8H16S3 
208.39 
Practically insoluble 
or insoluble 
Freely soluble 
263 
133 
MS 
95 % 
n.a. 
n.a. 
 
Mixture of isomers ((R/R), 
(R/S), (S/R) & (S/S) at equal 
ratio, i.e. 25 % of each) 
(EFFA, 2010a). 
15.056 
 
3,6-Dimethyl-1,2,4,5-tetrathiane   
6) 
SS
S S
 
 
 
67411-27-2 
Solid 
C4H8S4 
184.35 
Practically insoluble 
or insoluble 
Freely soluble 
264 
198 
MS 
95 % 
n.a. 
n.a. 
 
Stereoisomeric composition 
to be specified. CASrn in 
Register does not specify 
stereoisomeric composition. 
15.081 
 
Lenthionine 
S S
S S
S
 
11619 
292-46-6 
Solid 
C2H4S5 
188.35 
Practically insoluble 
or insoluble 
Freely soluble 
287 
61 
MS 
95 % 
n.a. 
n.a. 
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Table 1: Specification Summary of the Substances in the Flavouring Group Evaluation 8, Revision 3 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
Specification comments 
15.083 
 
3-Methyl-1,2,4-trithiolane 
SS
S
 
 
 
51647-38-2 
Solid 
C3H6S3 
138.28 
Practically insoluble 
or insoluble 
Freely soluble 
198 
111 
MS 
95 % 
n.a. 
n.a. 
 
Racemate (EFFA, 2010a). 
15.102 
 
Tetrahydrothiophene S
 
 
 
110-01-0 
Liquid 
C4H8S 
88.17 
Slightly soluble 
Freely soluble 
120 
 
MS 
95 % 
1.499-1.505 
0.995-1.001 
 
 
15.103 
 
1,2,4,5-Tetrathiane 
S
S
S
S  
 
291-22-5 
Solid 
C2H4S4 
156.29 
Practically insoluble 
or insoluble 
Freely soluble 
239 
126 
MS 
95 % 
n.a. 
n.a. 
 
 
15.110 
 
2,4,6-Trimethyl-1,3,5-trithiane   6) 
S
S S
 
 
2765-04-0 
Solid 
C6H12S3 
180.34 
Practically insoluble 
or insoluble 
Freely soluble 
246 
125 
MS 
95 % 
n.a. 
n.a. 
 
Stereoisomeric composition 
to be specified. CASrn in 
Register does not specify 
stereoisomeric composition. 
15.111 
 
1,2,4-Trithiolane 
S
S S
 
 
 
289-16-7 
Solid 
C2H4S3 
124.23 
Practically insoluble 
or insoluble 
Freely soluble 
102 (13 hPa) 
104 
MS 
95 % 
n.a. 
n.a. 
 
 
15.125 
 
4-Tetrahydrothiopyranone S
O
 
 
1072-72-6 
 
 
 
 
 
 
 
 
 
 
 
AV 7), BP 8), ID 9), MP 
10), PF 11), RI 12), SG 13), 
SE 14), SW 15). 
 
15.134 
550 
2,5-Dihydroxy-1,4-dithiane   6) 
S
S
HO
OH  
3826 
 
40018-26-6 
Solid 
C4H8O2S2 
152.23 
Slightly soluble 
 
n.a. 
130 
IR NMR 
97% 
n.a. 
n.a. 
SE 14). 
Stereoisomeric composition 
to be specified. CASrn in 
Register does not specify 
stereoisomeric composition. 
16.057 
 
2,4,4-Trimethyl-1,3-oxathiane 
O
S
 
 
72472-02-7 
Solid 
C7H14OS 
146.25 
Practically insoluble 
or insoluble 
Freely soluble 
70 (25 hPa) 
32 
NMR 
95 % 
n.a. 
n.a. 
 
Racemate (EFFA, 2010a). 
16.114 
 
2-Pentyl-4-propyl-1,3-oxathiane   
6) 
S
O
4499 
 
59323-81-8 
Liquid 
C12H24OS 
216.38 
Almost insoluble 
Soluble 
299 
n.a. 
NMR MS 
97% 
1.475-1.481 
0.936-0.942 
 
Stereoisomeric composition 
to be specified. CASrn in 
Register does not specify 
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Table 1: Specification Summary of the Substances in the Flavouring Group Evaluation 8, Revision 3 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. 
Index 4) 
Spec.gravity 
5) 
Specification comments 
stereoisomeric composition. 
1) Solubility in water, if not otherwise stated. 
2) Solubility in 95 %  ethanol, if not otherwise stated. 
3) At 1013.25 hPa, if not otherwise stated. 
4) At 20°C, if not otherwise stated. 
5) At 25°C, if not otherwise stated. 
6) Stereoisomeric composition not specified. 
7) AV: Missing minimum assay value. 
8) BP: Missing boiling point. 
9) ID: Missing identification test. 
10) MP: Missing melting point. 
11) PF: Missing data on physical form. 
12) RI: Missing refractive index. 
13) SG: Missing specific gravity. 
14) SE: Missing data on solubility in ethanol. 
15) SW: Missing data on solubility. 
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TABLE 2A: SUMMARY OF SAFETY EVALUATION APPLYING THE PROCEDURE (BASED ON INTAKES CALCULATED BY THE MSDI APPROACH) 
Table 2a: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach) 
FL-no EU Register name Structural formula MSDI 1) 
(μg/capita/day
) 
Class 2) 
Evaluation procedure path 
3) 
Outcome on the named 
compound 
[ 4) or 5] 
Outcome on the 
material of 
commerce [6), 7), 
or 8)] 
Evaluation remarks 
12.103 
 
Butane-1,4-dithiol 
HS
SH
 
0.3 
 
Class I 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 6)  
12.104 
 
Butane-2-thiol SH 0.18 
 
Class I 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 6)  
12.106 
 
S-2-Butyl 3-methylbutanethioate O
S
0.8 
 
Class I 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 6)  
12.111 
 
Dibutyl disulfide 
S
S
 
0.37 
 
Class I 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 6)  
12.112 
 
Dibutyl trisulfide 
S
S
S  
0.12 
 
Class I 
B3: Intake below threshold, 
B4: No adequate NOAEL 
Additional data required   
12.116 
 
Dimethyl tetrasulfide S
S
S
S  
0.016 
 
Class I 
B3: Intake below threshold, 
B4: No adequate NOAEL 
Additional data required   
12.117 
 
Dipentyl sulfide S
 
0.0037 
 
Class I 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 6)  
12.124 
 
Ethyl butyl sulfide 
S  
0.037 
 
Class I 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 6)  
12.125 
 
Ethyl propanethioate 
S
O 0.012 
 
Class I 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 6)  
12.127 
 
Ethyl propyl sulfide 
S  
0.085 
 
Class I 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 6)  
12.129 
 
3-(Ethylthio)propan-1-ol 
HO S  
0.12 
 
Class I 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 6)  
12.135 
 
3-Mercapto-2-methylpropionic 
acid 
HSHO
O 0.12 
 
Class I 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 6)  
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Table 2a: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach) 
FL-no EU Register name Structural formula MSDI 1) 
(μg/capita/day
) 
Class 2) 
Evaluation procedure path 
3) 
Outcome on the named 
compound 
[ 4) or 5] 
Outcome on the 
material of 
commerce [6), 7), 
or 8)] 
Evaluation remarks 
12.151 
 
Methyl butyl disulfide 
S
S
 
0.0061 
 
Class I 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 6)  
12.152 
 
Methyl butyl sulfide S
 
0.0024 
 
Class I 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 6)  
12.158 
 
Methyl isoprenyl sulfide 
S
0.0012 
 
Class I 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 6)  
12.163 
 
Methyl prop-1-enyl sulfide S
 
0.0097 
 
Class I 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 7)  
12.164 
 
Methyl prop-1-enyl trisulfide 
S
SS
 
0.0061 
 
Class I 
B3: Intake below threshold, 
B4: No adequate NOAEL 
Additional data required   
12.165 
1678 
S-Methyl propanethioate 
S
O 0.012 
 
Class I 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 6)  
12.166 
 
Methyl propyl sulfide S
 
0.0024 
 
Class I 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 6)  
12.167 
 
Methyl propyl tetrasulfide S
S
S
S  
0.0037 
 
Class I 
B3: Intake below threshold, 
B4: No adequate NOAEL 
Additional data required   
12.178 
 
3-(Methylthio)butyric acid O
HO S
0.12 
 
Class I 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 6)  
12.180 
 
1-(Methylthio)ethane-1-thiol SH
S
0.12 
 
Class I 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 6)  
12.181 
 
1-(Methylthio)pentan-3-one 
S
O 0.12 
 
Class I 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 6)  
12.182 
 
2-(Methylthio)propionic acid 
S
HO
O 0.011 
 
Class I 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 6)  
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Table 2a: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach) 
FL-no EU Register name Structural formula MSDI 1) 
(μg/capita/day
) 
Class 2) 
Evaluation procedure path 
3) 
Outcome on the named 
compound 
[ 4) or 5] 
Outcome on the 
material of 
commerce [6), 7), 
or 8)] 
Evaluation remarks 
12.183 
 
3-(Methylthio)propionic acid 
SHO
O 0.21 
 
Class I 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 6)  
12.189 
 
S-(Methylthiomethyl) 2-
methylpropanethioate 
S S
O 0.061 
 
Class I 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 6)  
12.191 
1662 
Pentane-1-thiol 
SH  
0.12 
 
Class I 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 6)  
12.196 
 
S-Prenyl thioisobutyrate 
S
O 0.012 
 
Class I 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 6)  
12.199 
1676 
Ethanethioic acid 
HS
O
 
0.0012 
 
Class I 
B3: Intake below threshold, 
B4: No adequate NOAEL 
Additional data required   
12.200 
 
1,1-bis(Ethylthio)-ethane 
S S
0.0012 
 
Class I 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 6)  
12.205 
 
Mercaptoacetaldehyde 
SH
O 0.011 
 
Class I 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 6)  
12.214 
1677 
Isobutyl-3-(methylthio)butyrate 
S
O
O
0.12 
 
Class I 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 6)  
12.221 
 
S-Prenyl thioisopentanoate 
S
O 0.012 
 
Class I 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 6)  
12.250 
 
3-Mercaptohexanal OSH 0.012 
 
Class I 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 7)  
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Table 2a: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach) 
FL-no EU Register name Structural formula MSDI 1) 
(μg/capita/day
) 
Class 2) 
Evaluation procedure path 
3) 
Outcome on the named 
compound 
[ 4) or 5] 
Outcome on the 
material of 
commerce [6), 7), 
or 8)] 
Evaluation remarks 
12.266 
 
Methyl-2-mercaptopropionate 
SH
O
O 0.12 
 
Class I 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 8)  
12.277 
 
3-(Methylthio)propyl butyrate 
O S
O 6.1 
 
Class I 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 6)  
12.278 
 
3-Acetyl-mercaptohexyl acetate 
O
O
S
O 1.2 
 
Class I 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 7)  
12.282 
 
(S)-Methyl octanethioate O
S
0.24 
 
Class I 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 7)  
12.298 
 
Di-(1-propenyl)-sulfid (mixture) S
S
S
0.12 
 
Class I 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 7)  
12.172 
 
2-Methylbutane-2-thiol 
HS
0.15 
 
Class I 
No evaluation 
  a) 
12.174 
 
2-Methylpropane-2-thiol SH
 
0.0012 
 
Class I 
No evaluation 
  a) 
12.268 
 
3-Mercaptooctanal SHO  
 
Class I 
No evaluation 
  b) 
12.269 
 
3-Mercaptodecanal SHO  
 
Class I 
No evaluation 
  b) 
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Table 2a: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach) 
FL-no EU Register name Structural formula MSDI 1) 
(μg/capita/day
) 
Class 2) 
Evaluation procedure path 
3) 
Outcome on the named 
compound 
[ 4) or 5] 
Outcome on the 
material of 
commerce [6), 7), 
or 8)] 
Evaluation remarks 
12.271 
 
Methanedithiol diacetate 
S S
O O  
 
Class I 
No evaluation 
  b) 
12.093 
 
Diallyl hexasulfide S
S
S
S
S
S  
0.011 
 
Class II 
B3: Intake below threshold, 
B4: No adequate NOAEL 
Additional data required   
12.094 
 
Diallyl heptasulfide S
S
S
S
S
S
S
 
0.011 
 
Class II 
B3: Intake below threshold, 
B4: No adequate NOAEL 
Additional data required   
12.096 
 
Allyl methyl sulfide S
 
0.99 
 
Class II 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 6)  
12.097 
 
Allyl methyl tetrasulfide 
S
S
S
S
 
0.012 
 
Class II 
B3: Intake below threshold, 
B4: No adequate NOAEL 
Additional data required   
12.098 
 
Allyl prop-1-enyl disulfide 
S
S
 
0.17 
 
Class II 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 7)  
12.099 
 
Allyl propyl sulfide S
 
1.6 
 
Class II 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 6)  
12.100 
 
Allyl propyl trisulfide S
S
S
 
0.12 
 
Class II 
B3: Intake below threshold, 
B4: No adequate NOAEL 
Additional data required   
12.177 
 
8-(Methylthio)-p-menthan-3-one O
S
0.37 
 
Class II 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 6)  
15.047 
 
3,5-Di-isobutyl-1,2,4-trithiolane 
SS
S 0.024 
 
Class II 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 6)  
15.048 
 
3,5-Di-isopropyl-1,2,4-
trithiolane 
SS
S
0.0061 
 
Class II 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 6)  
15.056 
 
3,6-Dimethyl-1,2,4,5-tetrathiane 
SS
S S 0.0024 
 
Class II 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 7)  
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Table 2a: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach) 
FL-no EU Register name Structural formula MSDI 1) 
(μg/capita/day
) 
Class 2) 
Evaluation procedure path 
3) 
Outcome on the named 
compound 
[ 4) or 5] 
Outcome on the 
material of 
commerce [6), 7), 
or 8)] 
Evaluation remarks 
15.083 
 
3-Methyl-1,2,4-trithiolane 
SS
S 0.0024 
 
Class II 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 6)  
15.102 
 
Tetrahydrothiophene S
 
0.024 
 
Class II 
B3: Intake below threshold, 
B4: No adequate NOAEL 
Additional data required   
15.103 
 
1,2,4,5-Tetrathiane 
S
S
S
S
 
0.073 
 
Class II 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 6)  
15.110 
 
2,4,6-Trimethyl-1,3,5-trithiane 
S
S S
0.0061 
 
Class II 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 7)  
15.111 
 
1,2,4-Trithiolane 
S
S S
 
2.4 
 
Class II 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 6)  
15.125 
 
4-Tetrahydrothiopyranone S
O  
0.12 
 
Class II 
B3: Intake below threshold, 
B4: No adequate NOAEL 
Additional data required   
12.295 
 
3,5-Dimethyl-1,2-dithiolane-4-
one 
S S
O
 
 
Class II 
No evaluation 
  b) 
16.057 
 
2,4,4-Trimethyl-1,3-oxathiane 
O
S
0.0012 
 
Class II 
No evaluation 
  a) 
12.120 
1685 
2,8-Epithio-p-menthane 
S
 
3.7 
 
Class III 
B3: Intake below threshold, 
B4: No adequate NOAEL 
Additional data required   
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Table 2a: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach) 
FL-no EU Register name Structural formula MSDI 1) 
(μg/capita/day
) 
Class 2) 
Evaluation procedure path 
3) 
Outcome on the named 
compound 
[ 4) or 5] 
Outcome on the 
material of 
commerce [6), 7), 
or 8)] 
Evaluation remarks 
12.136 
 
3-Mercapto-2-oxopropionic acid 
HSHO
O
O
0.24 
 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 6)  
15.081 
 
Lenthionine 
S S
S S
S
0.012 
 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 6)  
15.134 
550 
2,5-Dihydroxy-1,4-dithiane 
S
S
HO
OH
6.1 
 
Class III 
B3: Intake below threshold, 
B4: No adequate NOAEL 
Additional data required    
16.114 
 
2-Pentyl-4-propyl-1,3-oxathiane 
S
O
0.12 
 
Class III 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4) 7)  
15.007 
 
Spiro(2,4-Dithia-1-methyl-8-
oxa-bicyclo[3.3.0]octane-3,3’-
(1’- oxa-2’-methyl)-
cyclopentane) and spiro(Dithia-
6-methyl-7-oxa-
bicyclo[3.3.0]octane-3,3’-
spiro(2,4-(1’-oxa-2-
methyl)cyclopentane) 
O
S
S
O
O
S
S
O
6.1 
2 
Class III 
B4: No adequate NOAEL 
 
Additional data required   
12.159 
 
Methyl methanethiosulfonate 
S
O
O
S
0.061 
 
Class III 
No evaluation 
  a) 
1) EU MSDI: Amount added to food as flavour in (kg / year) x 10E9 / (0.1 x population in Europe (= 375 x 10E6) x 0.6 x 365)  =  µg/capita/day. 
2) Thresholds of concern: Class I = 1800 µg/person/day, Class II = 540 µg/person/day, Class III = 90 µg/person/day. 
3) Procedure path A substances can be predicted to be metabolised to innocuous products.  Procedure path B substances cannot. 
4) No safety concern based on intake calculated by the MSDI approach of the named compound. 
5) Data must be available on the substance or closely related substances to perform a safety evaluation. 
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6) No safety concern at estimated level of intake of the material of commerce meeting the specification of Table 1 (based on intake calculated by the MSDI approach). 
7) Tentatively regarded as presenting no safety concern (based on intake calculated by the MSDI approach) pending further information on the purity of the material of commerce and/or information on stereoisomerism. 
8) No conclusion can be drawn due to lack of information on the purity of the material of commerce. 
a) Evaluation deferred pending in vivo genotoxicity data. 
b) Evaluation deferred pending tonnage data. 
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TABLE 2B: EVALUATION STATUS OF HYDROLYSIS PRODUCTS OF CANDIDATE THIOESTERS AND ESTERS AS WELL AS THIOACETALS (POTENTIAL) 
TABLE 2B: EVALUATION STATUS OF HYDROLYSIS PRODUCTS OF CANDIDATE THIOESTERS AND ESTERS AS WELL AS THIOACETALS (POTENTIAL) 
FL-no EU Register name 
JECFA no 
Structural formula SCF status 1) 
JECFA status 2) 
CoE status 3) 
EFSA status 
Structural class 4) 
Procedure path (JECFA) 5) 
Comments 
 3-Methylthio-propanol 
HO S
Not evaluated as flavouring substance  Not in EU-Register 
 Proprionic acid 
OH
O Not evaluated as flavouring substance  Not in EU-Register 
 Methanesulfonic acid 
S
OH
O
O  
Not evaluated as flavouring substance  Not in EU-Register 
 Methanethiosulfonic acid 
S
SH
O
O  
 
Not evaluated as flavouring substance  Not in EU-Register 
 Hydrogensulfide H2S  
Not evaluated as flavouring substance  Not in EU-Register 
 3-Methylbutanaldehyde O Not evaluated as flavouring substance  Not in EU-Register 
 Formaldehyde O
H H  
Not evaluated as flavouring substance  Not in EU-Register 
 Methanol OH  
Not evaluated as flavouring substance  Not in EU-Register 
02.001 2-Methylpropan-1-ol 
251 
OH
 
Category 1 a) 
No safety concern b) 
Category A c) 
 
Class I 
A3: Intake below threshold 
 
05.001 Acetaldehyde 
80 O  
Category 1 a) 
No safety concern b) 
Category A c) 
 
Class I 
A3: Intake above threshold, A4: 
Endogenous 
 
05.004 2-Methylpropanal 
252 O
Category 1 a) 
No safety concern b) 
Category A c) 
Class I 
A3: Intake below threshold 
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TABLE 2B: EVALUATION STATUS OF HYDROLYSIS PRODUCTS OF CANDIDATE THIOESTERS AND ESTERS AS WELL AS THIOACETALS (POTENTIAL) 
FL-no EU Register name 
JECFA no 
Structural formula SCF status 1) 
JECFA status 2) 
CoE status 3) 
EFSA status 
Structural class 4) 
Procedure path (JECFA) 5) 
Comments 
 
05.008 Hexanal 
92 O  
Category 1 a) 
No safety concern b) 
Category A c) 
 
Class I 
A3: Intake below threshold 
 
08.002 Acetic acid 
81 
O
OH  
Category 1 a) 
No safety concern b) 
Category A c) 
 
Class I 
A3: Intake above threshold, A4: 
Endogenous 
 
08.005 Butyric acid 
87 
OH
O
 
Category 1 a) 
No safety concern b) 
Category A c) 
 
Class I 
A3: Intake above threshold, A4: 
Endogenous 
 
08.006 2-Methylpropionic acid 
253 
O
OH
Category 1 a) 
No safety concern b) 
Category A c) 
 
Class I 
A3: Intake below threshold 
 
08.008 3-Methylbutyric acid 
259 
OH
O
 
Category 1 a) 
No safety concern b) 
Category A c) 
 
Class I 
A3: Intake below threshold 
 
08.010 Octanoic acid 
99 
OH
O
 
Category 1 a) 
No safety concern b) 
Category A c) 
 
Class I 
A3: Intake above threshold, A4: 
Endogenous 
 
12.003 Methanethiol 
508 
SH   
No safety concern d) 
Category B c) 
 
Class I 
B3: Intake below threshold, B4: Adequate 
NOAEL exists 
 
12.017 Ethanethiol 
1659 
SH
 
 
No safety concern e) 
Category B c) 
 
Class I 
B3: Intake below threshold, B4: Adequate 
NOAEL exists 
 
12.039 2-Mercaptopropionic acid 
551 
HO
O
SH  
No safety concern d) 
 
 
Class I 
B3: Intake below threshold, B4: Adequate 
NOAEL exists 
 
12.062 3-(Methylthio)propan-1-ol 
461 HO S  
 
No safety concern d) 
 
 
Class I 
B3: Intake below threshold, B4: Adequate 
NOAEL exists 
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TABLE 2B: EVALUATION STATUS OF HYDROLYSIS PRODUCTS OF CANDIDATE THIOESTERS AND ESTERS AS WELL AS THIOACETALS (POTENTIAL) 
FL-no EU Register name 
JECFA no 
Structural formula SCF status 1) 
JECFA status 2) 
CoE status 3) 
EFSA status 
Structural class 4) 
Procedure path (JECFA) 5) 
Comments 
12.104 Butane-2-thiol 
 
SH
 
 
 
 
FGE.08 
Class I 
B3: Intake below threshold, B4: Adequate 
NOAEL exists 
 
12.137 3-Mercapto-3-methylbutan-1-
ol 
544 HO
SH
 
No safety concern d) 
 
 
Class I 
B3: Intake below threshold, B4: Adequate 
NOAEL exists 
 
12.170 3-Methylbut-2-ene-1-thiol 
522 
SH  
 
No safety concern d) 
 
 
Class I 
B3: Intake below threshold, B4: Adequate 
NOAEL exists 
 
12.178 3-(Methylthio)butyric acid 
 
O
HO S  
 
 
 
FGE.08 
Class I 
B3: Intake below threshold, B4: Adequate 
NOAEL exists 
 
12.205 Mercaptoacetaldehyde 
 
SH
O
 
 
 
 
FGE.08 
Class I 
B3: Intake below threshold, B4: Adequate 
NOAEL exists 
 
12.217 3-Mercaptohexan-1-ol 
545 
OHSH
 
 
No safety concern d) 
 
 
Class I 
B3: Intake below threshold, B4: Adequate 
NOAEL exists 
 
12.242 Methylthiomethylmercaptan 
1675 
SHS
 
 
No safety concern e) 
 
 
Class I 
B3: Intake below threshold, B4: Adequate 
NOAEL exists 
 
1) Category 1: Considered safe in use   Category 2: Temporarily considered safe in use   Category 3: Insufficient data to provide assurance of safety in use   Category 4): Not acceptable due to evidence of toxicity. 
2) No safety concern at estimated levels of intake. 
3) Category A: Flavouring substance, which may be used in foodstuffs Category B: Flavouring substance which can be used provisionally in foodstuffs. 
4) Threshold of concern: Class I = 1800 µg/person/day., Class II = 540 µg/person/day., Class III = 90 µg/person/day. 
5) Procedure path A substances can be predicted to be metabolised to innocuous products. Procedure path B substances cannot. 
a) (SCF, 1995). 
b) (JECFA, 1999b). 
c) (CoE, 1992). 
d) (JECFA, 2000b). 
e) (JECFA, 2007c). 
ND: Not detected. 
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TABLE 3: SUPPORTING SUBSTANCES SUMMARY 
Table 3: Supporting Substances Summary 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
JECFA no  
Specification available 
MSDI (EU) 1) 
(μg/capita/day) 
SCF status 2) 
JECFA status 3) 
CoE status 4) 
Comments 
12.001 3-
(Methylthio)propionaldehyde O S  
2747 
125 
3268-49-3 
466 
JECFA specification (JECFA, 
2000d) 
28  
No safety concern a) 
Category B b) 
 
12.002 Methyl 3-
(methylthio)propionate 
O S
O 2720 
428 
13532-18-8 
472 
JECFA specification (JECFA, 
1999c) 
94  
No safety concern a) 
Category B b) 
 
12.003 Methanethiol SH  2716 
475 
74-93-1 
508 
JECFA specification (JECFA, 
2000d) 
54  
No safety concern a) 
Category B b) 
 
12.004 Allylthiol 
SH  
2035 
476 
870-23-5 
521 
JECFA specification (JECFA, 
2000d) 
0.16  
No safety concern a) 
Category B b) 
 
12.005 Phenylmethanethiol SH 2147 
477 
100-53-8 
526 
JECFA specification (JECFA, 
1999c) 
1.2  
No safety concern a) 
Deleted b) 
 
12.006 Dimethyl sulfide S
 
2746 
483 
75-18-3 
452 
JECFA specification (JECFA, 
1999c) 
380  
No safety concern a) 
Category A b) 
 
12.007 Dibutyl sulfide 
S  
2215 
484 
544-40-1 
455 
JECFA specification (JECFA, 
2002d) 
2.3  
No safety concern a) 
Category A b) 
 
12.008 Diallyl disulfide 
S
S
 
2028 
485 
2179-57-9 
572 
JECFA specification (JECFA, 
2000d) 
58  
No safety concern a) 
Category B b) 
 
12.009 Diallyl trisulfide S
S
S
 
3265 
486 
2050-87-5 
587 
JECFA specification (JECFA, 
2000d) 
3.5  
No safety concern a) 
Category B b) 
 
12.010 Butane-1-thiol 
SH  
3478 
526 
109-79-5 
511 
JECFA specification (JECFA, 
1999c) 
0.39  
No safety concern a) 
Category B b) 
 
12.013 Dimethyl trisulfide S
S
S
 
3275 
539 
3658-80-8 
582 
JECFA specification (JECFA, 
2000d) 
1.1  
No safety concern a) 
Category A b) 
 
12.014 Dipropyl disulfide 
S
S
 
3228 
540 
629-19-6 
566 
JECFA specification (JECFA, 
2002d) 
3.4  
No safety concern a) 
Category B b) 
 
12.018 S-Ethyl acetothioate O
S
3282 
11665 
625-60-5 
483 
JECFA specification (JECFA, 
2002d) 
0.012  
No safety concern a) 
Deleted b) 
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Table 3: Supporting Substances Summary 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
JECFA no  
Specification available 
MSDI (EU) 1) 
(μg/capita/day) 
SCF status 2) 
JECFA status 3) 
CoE status 4) 
Comments 
12.019 Methyl propyl disulfide 
S
S
 
3201 
585 
2179-60-4 
565 
JECFA specification (JECFA, 
2000d) 
3.9  
No safety concern a) 
Category B b) 
 
12.020 Methyl propyl trisulfide 
S
SS
 
3308 
586 
17619-36-2 
584 
JECFA specification (JECFA, 
2000d) 
0.21  
No safety concern a) 
Category A b) 
 
12.022 Butane-2,3-dithiol 
HS
SH
3477 
725 
4532-64-3 
539 
JECFA specification (JECFA, 
1999c) 
0.049  
No safety concern a) 
Category A b) 
 
12.023 Dipropyl trisulfide S
S
S
 
3276 
726 
6028-61-1 
585 
JECFA specification (JECFA, 
2000d) 
7.3  
No safety concern a) 
Category A b) 
 
12.024 3-Mercaptobutan-2-ol 
SH
HO
3502 
760 
37887-04-0 
546 
JECFA specification (JECFA, 
2000d) 
4.0  
No safety concern a) 
Category A b) 
 
12.026 Dimethyl disulfide 
S
S
 
3536 
2175 
624-92-0 
564 
JECFA specification (JECFA, 
2002d) 
6.9  
No safety concern a) 
Category B b) 
 
12.027 2-Methylbenzene-1-thiol 
SH
3240 
2272 
137-06-4 
528 
JECFA specification (JECFA, 
2000d) 
17  
No safety concern a) 
Category A b) 
 
12.028 Dicyclohexyl disulfide 
S
S
3448 
2320 
2550-40-5 
575 
JECFA specification (JECFA, 
2000d) 
0.012  
No safety concern a) 
Category A b) 
 
12.029 Cyclopentanethiol SH 3262 
2321 
1679-07-8 
516 
JECFA specification (JECFA, 
2000d) 
ND  
No safety concern a) 
Category B b) 
 
12.031 3-Mercaptopentan-2-one SH
O
3300 
2327 
67633-97-0 
560 
JECFA specification (JECFA, 
2000d) 
ND  
No safety concern a) 
Category A b) 
 
12.032 S-Methyl butanethioate 
S
O 3310 
2328 
2432-51-1 
484 
JECFA specification (JECFA, 
2000d) 
2.9  
No safety concern a) 
Category A b) 
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Table 3: Supporting Substances Summary 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
JECFA no  
Specification available 
MSDI (EU) 1) 
(μg/capita/day) 
SCF status 2) 
JECFA status 3) 
CoE status 4) 
Comments 
12.034 Octane-1,8-dithiol 
HS
SH
 
3514 
2331 
1191-62-4 
541 
JECFA specification (JECFA, 
1999c) 
2.1  
No safety concern a) 
Category A b) 
 
12.035 2-,3- and 10-Mercaptopinane 
HS
2-Mercaptopinane
HS
3-Mercaptopinane
SH
10-Mercaptopinane
3503 
2332 
 
520 
JECFA specification (JECFA, 
2000d) 
0.037  
No safety concern a) 
Category A b) 
 
12.036 3-[(2-Mercapto-1-
methylpropyl)thio]butan-2-ol 
S
OH SH 3509 
2353 
54957-02-7 
547 
JECFA specification (JECFA, 
1999c) 
ND  
No safety concern a) 
Category A b) 
 
12.037 Allyl methyl disulfide S
S  
3127 
11866 
2179-58-0 
568 
JECFA specification (JECFA, 
2003b) 
0.0012  
No safety concern a) 
 
 
12.038 8-Mercapto-p-menthan-3-one O
SH
3177 
11789 
38462-22-5 
561 
JECFA specification (JECFA, 
2000d) 
10  
No safety concern a) 
 
 
12.039 2-Mercaptopropionic acid 
HO
O
SH 3180 
11790 
79-42-5 
551 
JECFA specification (JECFA, 
2002d) 
2.1  
No safety concern a) 
 
 
12.040 2-Methylthioacetaldehyde 
S
O
 
3206 
11686 
23328-62-3 
465 
JECFA specification (JECFA, 
2003b) 
ND  
No safety concern a) 
 
 
12.041 1-(Methylthio)butan-2-one 
S
O 3207 
11543 
13678-58-5 
496 
JECFA specification (JECFA, 
1999c) 
0.0037  
No safety concern a) 
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Table 3: Supporting Substances Summary 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
JECFA no  
Specification available 
MSDI (EU) 1) 
(μg/capita/day) 
SCF status 2) 
JECFA status 3) 
CoE status 4) 
Comments 
12.042 2-(Methylthio)phenol 
S
OH 3210 
11553 
1073-29-6 
503 
JECFA specification (JECFA, 
2000d) 
0.61  
No safety concern a) 
 
 
12.043 Diphenyl disulfide 
S
S
3225 
11757 
882-33-7 
578 
JECFA specification (JECFA, 
1999c) 
ND  
No safety concern a) 
 
 
12.044 Prop-1-enyl propyl disulfide 
S
S
 
3227 
11699 
5905-46-4 
570 
JECFA specification (JECFA, 
2005b) 
ND  
No safety concern a) 
 
 
12.045 Methyl allyl trisulfide 
S
SS
 
3253 
11867 
34135-85-8 
586 
JECFA specification (JECFA, 
2003b) 
ND  
No safety concern a) 
 
 
12.046 Ethyl 2-mercaptopropionate O
O
SH
3279 
11469 
19788-49-9 
552 
JECFA specification (JECFA, 
2000d) 
0.39  
No safety concern a) 
 
 
12.047 3-Mercaptobutan-2-one 
O
SH 3298 
11497 
40789-98-8 
558 
JECFA specification (JECFA, 
2000d) 
3.2  
No safety concern a) 
 
 
12.048 2-Methylbutane-1-thiol 
SH
3303 
11509 
1878-18-8 
515 
JECFA specification (JECFA, 
1999c) 
0.3  
No safety concern a) 
 
 
12.049 3-Methylbutane-2-thiol SH 3304 
11510 
2084-18-6 
517 
JECFA specification (JECFA, 
1999c) 
0.012  
No safety concern a) 
 
 
12.052 Di-(3-oxobutyl) sulfide 
S
O O 3335 
11441 
40790-04-3 
502 
JECFA specification (JECFA, 
2003b) 
ND  
No safety concern a) 
 
 
12.053 Ethyl 3-
(methylthio)propionate 
O S
O 3343 
11476 
13327-56-5 
476 
JECFA specification (JECFA, 
2002d) 
24  
No safety concern a) 
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Table 3: Supporting Substances Summary 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
JECFA no  
Specification available 
MSDI (EU) 1) 
(μg/capita/day) 
SCF status 2) 
JECFA status 3) 
CoE status 4) 
Comments 
12.054 2-(Ethylthio)phenol S
OH
3345 
11666 
4500-58-7 
529 
JECFA specification (JECFA, 
2000d) 
0.00012  
No safety concern a) 
 
 
12.055 4-Mercaptobutan-2-one O
SH
3357 
11498 
34619-12-0 
559 
JECFA specification (JECFA, 
2003b) 
ND  
No safety concern a) 
 
 
12.056 3-(Methylthio)butanal SO 3374 
11687 
16630-52-7 
467 
JECFA specification (JECFA, 
2000d) 
0.085  
No safety concern a) 
 
 
12.057 4-(Methylthio)butan-2-one O
S
3375 
11688 
34047-39-7 
497 
JECFA specification (JECFA, 
2000d) 
0.012  
No safety concern a) 
 
 
12.058 4-(Methylthio)-4-
methylpentan-2-one 
S
O 3376 
11551 
23550-40-5 
500 
JECFA specification (JECFA, 
2000d) 
0.024  
No safety concern a) 
 
 
12.059 Propyl thioacetate 
S
O 3385 
11576 
2307-10-0 
485 
JECFA specification (JECFA, 
1999c) 
0.27  
No safety concern a) 
 
 
12.060 Methyl 4-(methylthio)butyrate O
O
S
3412 
11526 
53053-51-3 
474 
JECFA specification (JECFA, 
1999c) 
0.061  
No safety concern a) 
 
 
12.061 4-(Methylthio)butanal 
O
S
 
3414 
11542 
42919-64-2 
468 
JECFA specification (JECFA, 
2003b) 
ND  
No safety concern a) 
 
 
12.062 3-(Methylthio)propan-1-ol 
HO S  
3415 
11554 
505-10-2 
461 
JECFA specification (JECFA, 
2001c) 
2.8  
No safety concern a) 
 
 
12.063 3-(Methylthio)hexan-1-ol SHO 3438 
11548 
51755-66-9 
463 
JECFA specification (JECFA, 
1999c) 
3.2  
No safety concern a) 
 
 
12.064 Thiogeraniol 
SH
3472 
11583 
39067-80-6 
524 
JECFA specification (JECFA, 
2000d) 
1.1  
No safety concern a) 
 
 
12.065 2,8-Dithianon-4-en-4-
carboxaldehyde 
S S
O
 
3483 
11904 
59902-01-1 
471 
JECFA specification (JECFA, 
2005b) 
0.012  
JECFA adopted at step B5 
(1.5 microgram/person/day) 
a) 
 
JECFA adopted at step 
B5 (1.5 
microgram/person/day) 
(JECFA, 2000b). 
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Table 3: Supporting Substances Summary 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
JECFA no  
Specification available 
MSDI (EU) 1) 
(μg/capita/day) 
SCF status 2) 
JECFA status 3) 
CoE status 4) 
Comments 
12.066 Ethane-1,2-dithiol 
HS
SH
 
3484 
11467 
540-63-6 
532 
JECFA specification (JECFA, 
1999c) 
0.0012  
No safety concern a) 
 
 
12.067 Hexane-1,6-dithiol SH
HS  
3495 
11486 
1191-43-1 
540 
JECFA specification (JECFA, 
2002d) 
1.6  
No safety concern a) 
 
 
12.068 Benzyl methyl disulfide 
S
S
3504 
11508 
699-10-5 
577 
JECFA specification (JECFA, 
1999c) 
0.012  
No safety concern a) 
 
 
12.069 Nonane-1,9-dithiol 
HS SH  
3513 
11558 
3489-28-9 
542 
JECFA specification (JECFA, 
2002d) 
0.0012  
No safety concern a) 
 
 
12.070 Propane-1,2-dithiol 
SH
HS
3520 
11564 
814-67-5 
536 
JECFA specification (JECFA, 
2000d) 
ND  
No safety concern a) 
 
 
12.071 1-Propane-1-thiol 
SH  
3521 
11816 
107-03-9 
509 
JECFA specification (JECFA, 
2000d) 
2.2  
No safety concern a) 
 
 
12.072 Butane-1,2-dithiol 
SH
SH
3528 
11909 
16128-68-0 
537 
JECFA specification (JECFA, 
1999c) 
ND  
No safety concern a) 
 
 
12.073 Butane-1,3-dithiol 
HS SH
3529 
11910 
24330-52-7 
538 
JECFA specification (JECFA, 
1999c) 
ND  
No safety concern a) 
 
 
12.074 Diallyl polysulfides 
SX
X=2,3,4 or 5
3533 
11912 
72869-75-1 
588 
JECFA specification (JECFA, 
2000d) 
1.2  
No safety concern a) 
 
 
12.075 Methyl prop-1-enyl disulfide 
S
S
 
3576 
11712 
5905-47-5 
569 
JECFA specification (JECFA, 
2003b) 
ND  
No safety concern a) 
 
 
12.076 Propane-1,3-dithiol 
HS SH  
3588 
11929 
109-80-8 
535 
JECFA specification (JECFA, 
1999c) 
0.85  
No safety concern a) 
 
 
12.077 Benzyl methyl sulfide 
S
 
3597 
 
766-92-7 
460 
JECFA specification (JECFA, 
1999c) 
0.13  
JECFA adopted at step B5 
(1.5 microgram/person/day) 
a) 
 
JECFA adopted at step 
B5 (1.5 
microgram/person/day) 
(JECFA, 2000b). 
12.078 4-(Methylthio)butan-1-ol 
HO
S
 
3600 
 
20582-85-8 
462 
JECFA specification (JECFA, 
2000d) 
0.012  
No safety concern a) 
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Table 3: Supporting Substances Summary 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
JECFA no  
Specification available 
MSDI (EU) 1) 
(μg/capita/day) 
SCF status 2) 
JECFA status 3) 
CoE status 4) 
Comments 
12.080 Thiophenol 
SH
3616 
11585 
108-98-5 
525 
JECFA specification (JECFA, 
1999c) 
0.73  
No safety concern a) 
 
 
12.081 Dibenzyl disulfide 
S
S
3617 
 
150-60-7 
579 
JECFA specification (JECFA, 
2000d) 
0.012  
No safety concern a) 
 
 
12.082 2,6-(Dimethyl)thiophenol 
SH
3666 
 
118-72-9 
530 
JECFA specification (JECFA, 
1999c) 
1.3  
No safety concern a) 
 
 
12.083 Ethyl 3-mercaptopropionate O
O
SH 3677 
 
5466-06-8 
553 
JECFA specification (JECFA, 
2002d) 
0.073  
No safety concern a) 
 
 
12.084 Ethyl 4-(methylthio)butyrate O
O
S
3681 
 
22014-48-8 
477 
JECFA specification (JECFA, 
1999c) 
ND  
No safety concern a) 
 
 
12.085 p-Menth-1-ene-8-thiol 
SH
 
3700 
 
71159-90-5 
523 
JECFA specification (JECFA, 
2000d) 
0.34  
No safety concern a) 
 
 
12.086 Methyl 2-(methylthio)butyrate 
S
O
O
3708 
 
51534-66-8 
486 
JECFA specification (JECFA, 
2000d) 
0.097  
No safety concern a) 
 
JECFA evaluated S-
methyl 2-
methylbutanethioate 
(CASrn 42075-45-6). 
12.088 Diallyl sulfide S
 
2042 
11846 
592-88-1 
458 
JECFA specification (JECFA, 
2000d) 
ND  
JECFA adopted at step B5 
(1.5 microgram/person/day) 
a) 
 
JECFA adopted at step 
B5 (1.5 
microgram/person/day) 
(JECFA, 2000b). 
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Table 3: Supporting Substances Summary 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
JECFA no  
Specification available 
MSDI (EU) 1) 
(μg/capita/day) 
SCF status 2) 
JECFA status 3) 
CoE status 4) 
Comments 
12.089 Ethyl 3-(methylthio)butyrate 
S
O
O
3836 
11475 
 
480 
JECFA specification (JECFA, 
2003b) 
ND  
No safety concern a) 
 
 
12.101 Allyl thiopropionate 
S
O 3329 
11436 
41820-22-8 
490 
JECFA specification (JECFA, 
2002d) 
ND  
No safety concern a) 
 
 
12.109 Di-isopropyl disulfide 
S
S
3827 
11455 
4253-89-8 
567 
JECFA specification (JECFA, 
1999c) 
ND  
No safety concern a) 
 
 
12.113 Diethyl sulfide 
S  
3825 
11450 
352-93-2 
454 
JECFA specification (JECFA, 
1999c) 
ND  
No safety concern a) 
 
 
12.118 2,4-Dithiapentane 
SS  
3878 
 
1618-26-4 
533 
JECFA specification (JECFA, 
2000d) 
ND  
No safety concern a) 
 
 
12.121 Ethyl 2-
(methyldithio)propionate 
O
O
S
S
3834 
11471 
23747-43-5 
581 
JECFA specification (JECFA, 
2001c) 
ND  
No safety concern a) 
 
 
12.122 Ethyl 2-(methylthio)acetate O
O
S
3835 
 
4455-13-4 
475 
JECFA specification (JECFA, 
2000d) 
ND  
No safety concern a) 
 
 
12.128 2-Ethylhexane-1-thiol 
HS
3833 
 
7341-17-5 
519 
JECFA specification (JECFA, 
2003b) 
ND  
No safety concern a) 
 
 
12.132 Hexane-1-thiol 
SH  
3842 
11487 
111-31-9 
518 
JECFA specification (JECFA, 
2000d) 
ND  
No safety concern a) 
 
 
12.137 3-Mercapto-3-methylbutan-1-
ol 
HO
SH
3854 
 
34300-94-2 
544 
JECFA specification (JECFA, 
2000d) 
ND  
No safety concern a) 
 
 
12.138 3-Mercapto-3-methylbutyl 
formate 
O O
SH
3855 
 
50746-10-6 
549 
JECFA specification (JECFA, 
1999c) 
ND  
No safety concern a) 
 
 
12.143 1-Mercaptopropan-2-one O
SH
3856 
 
24653-75-6 
557 
JECFA specification (JECFA, 
2005b) 
ND  
No safety concern a) 
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Table 3: Supporting Substances Summary 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
JECFA no  
Specification available 
MSDI (EU) 1) 
(μg/capita/day) 
SCF status 2) 
JECFA status 3) 
CoE status 4) 
Comments 
12.145 4-Methoxy-2-methylbutane-2-
thiol 
SH
O
3785 
 
94087-83-9 
548 
JECFA specification (JECFA, 
2003b) 
ND  
No safety concern a) 
 
 
12.148 S-Methyl 4-
methylpentanethioate 
O
S
3867 
 
61122-71-2 
488 
JECFA specification (JECFA, 
2003b) 
ND  
No safety concern a) 
 
 
12.149 S-Methyl acetothioate O
S
3876 
 
1534-08-3 
482 
JECFA specification (JECFA, 
2000d) 
ND  
No safety concern a) 
 
 
12.150 S-Methyl benzothioate 
O
S
3857 
11505 
5925-68-8 
504 
Tentative JECFA specification 
(JECFA, 1999c) 
ND  
No safety concern a) 
 
 
12.154 Methyl ethyl sulfide 
S  
3860 
11474 
624-89-5 
453 
JECFA specification (JECFA, 
1999c) 
ND  
No safety concern a) 
 
 
12.155 Methyl ethyl trisulfide 
S
S S
 
3861 
 
31499-71-5 
583 
JECFA specification (JECFA, 
2003b) 
ND  
No safety concern a) 
 
 
12.156 S-Methyl hexanethioate O
S
3862 
11515 
20756-86-9 
489 
JECFA specification (JECFA, 
2003b) 
ND  
No safety concern a) 
 
 
12.157 S-Methyl isopentanethioate O
S
3864 
11506 
23747-45-7 
487 
JECFA specification (JECFA, 
2000d) 
ND  
No safety concern a) 
 
 
12.161 Methyl phenyl disulfide 
S
S
3872 
11532 
14173-25-2 
576 
JECFA specification (JECFA, 
1999c) 
ND  
No safety concern a) 
 
 
12.162 Methyl phenyl sulfide 
S  
3873 
11533 
100-68-5 
459 
JECFA specification (JECFA, 
1999c) 
ND  
JECFA adopted at step B5 
(1.5 microgram/person/day) 
a) 
 
JECFA adopted at step 
B5 (1.5 
microgram/person/day) 
(JECFA, 2000b) 
12.168 2-Methyl-2-
(methyldithio)propanal O
S S
3866 
 
67952-60-7 
580 
JECFA specification (JECFA, 
2001c) 
ND  
No safety concern a) 
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Table 3: Supporting Substances Summary 
FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
JECFA no  
Specification available 
MSDI (EU) 1) 
(μg/capita/day) 
SCF status 2) 
JECFA status 3) 
CoE status 4) 
Comments 
12.170 3-Methylbut-2-ene-1-thiol 
SH
3896 
11511 
5287-45-6 
522 
JECFA specification (JECFA, 
1999c) 
ND  
No safety concern a) 
 
 
12.171 3-Methylbutane-1-thiol 
SH
3858 
 
541-31-1 
513 
JECFA specification (JECFA, 
2000d) 
ND  
No safety concern a) 
 
 
12.173 2-Methylpropane-1-thiol 
SH
 
11536 
513-44-0 
512 
JECFA specification (JECFA, 
2000d) 
ND  
No safety concern a) 
 
 
12.175 Methylsulfinylmethane 
S
O
 
3875 
 
67-68-5 
507 
JECFA specification (JECFA, 
2000d) 
ND  
No safety concern a) 
 
 
12.176 4-(Methylthio)-2-oxobutyric 
acid 
S
NaO
O
O 3881 
 
583-92-6 
501 
JECFA specification (JECFA, 
1999c) 
ND  
No safety concern a) 
 
JECFA CASrn 51828-
97-8. 
12.187 Methylthiomethyl butyrate O
O S
3879 
 
74758-93-3 
473 
JECFA specification (JECFA, 
2003b) 
ND  
No safety concern a) 
 
 
12.188 Methylthiomethyl hexanoate O
O S
3880 
 
74758-91-1 
479 
JECFA specification (JECFA, 
2003b) 
ND  
No safety concern a) 
 
 
12.192 Pentane-2-thiol SH 3792 
 
2084-19-7 
514 
JECFA specification (JECFA, 
2000d) 
1.5  
No safety concern a) 
 
 
12.194 2-Phenylethane-1-thiol 
SH
3894 
11561 
4410-99-5 
527 
JECFA specification (JECFA, 
1999c) 
ND  
No safety concern a) 
 
 
12.195 S-Prenyl thioacetate 
S
O 3895 
 
33049-93-3 
491 
JECFA specification (JECFA, 
1999c) 
ND  
No safety concern a) 
 
 
12.197 Propane-2-thiol 
SH
 
3897 
11565 
75-33-2 
510 
JECFA specification (JECFA, 
2001c) 
ND  
No safety concern a) 
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FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
JECFA no  
Specification available 
MSDI (EU) 1) 
(μg/capita/day) 
SCF status 2) 
JECFA status 3) 
CoE status 4) 
Comments 
12.203 Methylthio 2-
(acetyloxy)propionate 
S
O
O
O
3788 
 
74586-09-7 
492 
JECFA specification (JECFA, 
2002d) 
ND  
No safety concern a) 
 
 
12.211 But-1-enyl methyl sulphide S
 
3820 
 
 
457 
JECFA specification (JECFA, 
2001c) 
ND  
No safety concern a) 
 
JECFA evaluated (1-
Buten-1-yl) methyl 
sulfide (CASrn 32951-
19-2). 
12.217 3-Mercaptohexan-1-ol OHSH 3850 
 
 
545 
JECFA specification (JECFA, 
1999c) 
ND  
No safety concern a) 
 
JECFA evaluated 3-
mercaptohexan-1-ol 
(CASrn 51755-83-0). 
12.218 Methyl-3-methyl-1-butenyl 
disulphide 
S
S
3865 
 
 
571 
JECFA specification (JECFA, 
2003b) 
ND  
No safety concern a) 
 
 
12.227 Methylthio-2-
(propionyloxy)propionate 
S
O
O
O 3790 
 
 
493 
JECFA specification (JECFA, 
2002d) 
ND  
No safety concern a) 
 
 
12.234 3-Mercaptohexyl acetate O
O
SH 3851 
 
136954-20-6 
554 
JECFA specification (JECFA, 
1999c) 
ND  
No safety concern a) 
 
 
12.235 3-Mercaptohexyl butyrate O
O
SH 3852 
 
136954-21-7 
555 
JECFA specification (JECFA, 
1999c) 
ND  
No safety concern a) 
 
 
12.236 3-(Methylthio)hexyl acetate 
O O
S
3789 
 
51755-85-2 
481 
JECFA specification (JECFA, 
2000d) 
ND  
No safety concern a) 
 
 
12.237 3-(Methylthio)propyl acetate 
O SO
3883 
 
16630-55-0 
478 
JECFA specification (JECFA, 
2001c) 
ND  
No safety concern a) 
 
 
15.006 2,5-Dihydroxy-2,5-dimethyl-
1,4-dithiane 
S
S
HO
OH
3450 
2322 
55704-78-4 
562 
JECFA specification (JECFA, 
2001c) 
0.15  
No safety concern a) 
Category B b) 
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FL-no EU Register name Structural formula FEMA no 
CoE no 
CAS no 
JECFA no  
Specification available 
MSDI (EU) 1) 
(μg/capita/day) 
SCF status 2) 
JECFA status 3) 
CoE status 4) 
Comments 
15.009 Trithioacetone 
S
S S
3475 
2334 
828-26-2 
543 
JECFA specification (JECFA, 
2001c) 
1.5  
No safety concern a) 
Category B b) 
 
15.012 4,5-Dihydrothiophen-3(2H)-
one 
S
O 3266 
2337 
1003-04-9 
498 
JECFA specification (JECFA, 
2000d) 
0.44  
No safety concern a) 
Category B b) 
 
15.023 4,5-Dihydro-2-
methylthiophene-3(2H)-one 
S
O
 
3512 
11601 
13679-85-1 
499 
JECFA specification (JECFA, 
2000d) 
12  
No safety concern a) 
 
 
15.025 3,5-Dimethyl-1,2,4-trithiolane 
SS
S 3541 
11883 
23654-92-4 
573 
JECFA specification (JECFA, 
2000d) 
0.024  
No safety concern a) 
 
 
15.034 2-Methyl-1,3-dithiolane S
S  
3705 
 
5616-51-3 
534 
JECFA specification (JECFA, 
1999c) 
0.061  
No safety concern a) 
 
 
15.036 3-Methyl-1,2,4-trithiane 
SS
S 3718 
 
43040-01-3 
574 
JECFA specification (JECFA, 
2000d) 
0.073  
No safety concern a) 
 
 
15.066 1,4-Dithiane 
SS
 
3831 
 
505-29-3 
456 
JECFA specification (JECFA, 
2000d) 
ND  
No safety concern a) 
 
 
16.030 2-Methyl-4-propyl-1,3-
oxathiane O
S
3578 
11540 
67715-80-4 
464 
JECFA specification (JECFA, 
2000d) 
1.3  
No safety concern a) 
 
 
1) EU MSDI: Amount added to food as flavouring substance in (kg / year) x 10E9 / (0.1 x population in Europe (= 375 x 10E6) x 0.6 x 365)  =  µg/capita/day 
2) Category 1: Considered safe in use, Category 2: Temporarily considered safe in use, Category 3: Insufficient data to provide assurance of safety in use, Category 4: Not acceptable due to evidence of toxicity 
3) No safety concern at estimated levels of intake 
4) Category A: Flavouring substance, which may be used in foodstuffs, Category B: Flavouring substance which can be used provisionally in foodstuffs 
a) (JECFA, 2000b) 
b) (CoE, 1992) 
ND) No intake data reported 
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ANNEX I: PROCEDURE FOR THE SAFETY EVALUATION 
The approach for a safety evaluation of chemically defined flavouring substances as referred to in 
Commission Regulation (EC) No 1565/2000 (EC, 2000a), named the "Procedure", is shown in schematic 
form in Figure I.1. The Procedure is based on the Opinion of the Scientific Committee on Food expressed on 
2 December 1999 (SCF, 1999a), which is derived from the evaluation Procedure developed by the Joint 
FAO/WHO Expert Committee on Food Additives at its 44th, 46th and 49th meetings (JECFA, 1995; JECFA, 
1996a; JECFA, 1997a; JECFA, 1999b). 
The Procedure is a stepwise approach that integrates information on intake from current uses, structure-
activity relationships, metabolism and, when needed, toxicity. One of the key elements in the Procedure is 
the subdivision of flavourings into three structural classes (I, II, III) for which thresholds of concern (human 
exposure thresholds) have been specified. Exposures below these thresholds are not considered to present a 
safety concern. 
Class I contains flavourings that have simple chemical structures and efficient modes of metabolism, which 
would suggest a low order of oral toxicity. Class II contains flavourings that have structural features that are 
less innocuous, but are not suggestive of toxicity. Class III comprises flavourings that have structural 
features that permit no strong initial presumption of safety, or may even suggest significant toxicity (Cramer 
et al., 1978). The thresholds of concern for these structural classes of 1800, 540 or 90 microgram/person/day, 
respectively, are derived from a large database containing data on subchronic and chronic animal studies 
(JECFA, 1996a). 
In Step 1 of the Procedure, the flavourings are assigned to one of the structural classes. The further steps 
address the following questions: 
• can the flavourings be predicted to be metabolised to innocuous products7 (Step 2)?  
• do their exposures exceed the threshold of concern for the structural class (Step A3 and B3)? 
• are the flavourings or their metabolites endogenous8 (Step A4)?  
• does a NOAEL exist on the flavourings or on structurally related substances (Step A5 and B4)? 
In addition to the data provided for the flavouring substances to be evaluated (candidate substances), 
toxicological background information available for compounds structurally related to the candidate 
substances is considered (supporting substances), in order to assure that these data are consistent with the 
results obtained after application of the Procedure.  
The Procedure is not to be applied to flavourings with existing unresolved problems of toxicity. Therefore, 
the right is reserved to use alternative approaches if data on specific flavourings warranted such actions. 
 
                                                     
 
7 “Innocuous metabolic products”: Products that are known or readily predicted to be harmless to humans at the 
estimated intakes of the flavouring agent” (JECFA, 1997a). 
 
8 “Endogenous substances”: Intermediary metabolites normally present in human tissues and fluids, whether free or 
conjugated; hormones and other substances with biochemical or physiological regulatory functions are not included 
(JECFA, 1997a). 
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Decision tree structural class 
Can the substance be predicted to be metabolised to innocuous products?
Procedure for Safety Evaluation of Chemically Defined Flavouring Substances 
Do the conditions of use result in an intake greater than the 
threshold of concern for the structural class?
Do the conditions of use result in an intake greater than the  
threshold of concern for the structural class? 
Data must be available on the  
substance or closely related  
substances to perform a safety 
evaluation
Does a NOAEL exist for the substance which provides an adequate 
margin of safety under conditions of intended use, or does a NOAEL 
exist for structurally related substances which is high enough to 
accommodate any perceived difference in toxicity between the 
substance and the related substances? 
Does a NOAEL exist for the substance which provides an adequate 
margin of safety under conditions of intended use, or does a NOAEL 
exist for structurally related substances which is  high enough to 
accommodate any perceived difference in toxicity between the 
substance and the related substances? 
  Substance would not be    
expected to be of safety concern
Is the substance or are its metabolites endogenous?
Additional data required 
Step 1. 
Step 2. 
Step A3. 
Step A4. 
Step A5. 
Step B3. 
Step B4.
 Yes No
 Yes 
 No 
No
No
Yes
No
Yes
Yes
Yes
 No
Figure I.1 Procedure for Safety Evaluation of Chemically Defined Flavouring Substances
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ANNEX II: USE LEVELS / MTAMDI 
II.1 Normal and Maximum Use Levels 
For each of the 18 Food categories (Table II.1.1) in which the candidate substances are used, Flavour 
Industry reports a “normal use level” and a “maximum use level” (EC, 2000a). According to the Industry the 
”normal use” is defined as the average of reported usages and ”maximum use” is defined as the 95th 
percentile of reported usages (EFFA, 2002i). The normal and maximum use levels in different food 
categories have been extrapolated from figures derived from 12 model flavouring substances (EFFA, 2004e). 
Table II.1.1 Food categories according to Commission Regulation (EC) No 1565/2000 (EC, 2000a) 
Food category Description 
01.0 Dairy products, excluding products of category 02.0 
02.0 Fats and oils, and fat emulsions (type water-in-oil) 
03.0 Edible ices, including sherbet and sorbet 
04.1 Processed fruit 
04.2 Processed vegetables (incl. mushrooms & fungi, roots & tubers, pulses and legumes), and nuts & seeds 
05.0 Confectionery 
06.0 Cereals and cereal products, incl. flours & starches from roots & tubers, pulses & legumes, excluding bakery 
07.0 Bakery wares 
08.0 Meat and meat products, including poultry and game 
09.0 Fish and fish products, including molluscs, crustaceans and echinoderms  
10.0 Eggs and egg products 
11.0 Sweeteners, including honey 
12.0 Salts, spices, soups, sauces, salads, protein products, etc. 
13.0 Foodstuffs intended for particular nutritional uses 
14.1 Non-alcoholic ("soft") beverages, excl. dairy products 
14.2 Alcoholic beverages, incl. alcohol-free and low-alcoholic counterparts 
15.0 Ready-to-eat savouries 
16.0 Composite foods (e.g. casseroles, meat pies, mincemeat) - foods that could not be placed in categories 01.0 - 15.0 
 
The “normal and maximum use levels” are provided by Industry for the 62 of the 70 candidate substances in 
the present flavouring group (Table II.1.2). 
Table II.1.2. Normal and Maximum use levels (mg/kg) for the candidate substances in FGE.08Rev3 (EFFA, 
2002g; EFFA, 2002h; EFFA, 2002i; EFFA, 2004ak; EFFA, 2007a; Flavour Industry, 2006q; Flavour Industry, 
2006r; Flavour Industry, 2009e; Flavour Industry, 2009o). 
FL-no Food Categories 
Normal use levels (mg/kg) 
Maximum use levels (mg/kg) 
01.0 02.0 03.0 04.1 04.2 05.0 06.0 07.0 08.0 09.0 10.0 11.0 12.0 13.0 14.1 14.2 15.0 16.0 
12.093 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.094 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.096 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.097 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.098 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.099 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.100 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.103 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
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Table II.1.2. Normal and Maximum use levels (mg/kg) for the candidate substances in FGE.08Rev3 (EFFA, 
2002g; EFFA, 2002h; EFFA, 2002i; EFFA, 2004ak; EFFA, 2007a; Flavour Industry, 2006q; Flavour Industry, 
2006r; Flavour Industry, 2009e; Flavour Industry, 2009o). 
FL-no Food Categories 
Normal use levels (mg/kg) 
Maximum use levels (mg/kg) 
01.0 02.0 03.0 04.1 04.2 05.0 06.0 07.0 08.0 09.0 10.0 11.0 12.0 13.0 14.1 14.2 15.0 16.0 
12.104 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.106 0,3 
10 
0,2 
1 
1 
5 
0,3 
1,5 
- 
- 
0,4 
10 
0,2 
1 
0,4 
10 
0,1 
0,4 
0,1 
0,4 
- 
- 
- 
- 
0,2 
1 
0,4 
2 
0,2 
5 
0,4 
10 
1 
5 
0,2 
1 
12.111 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.112 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.116 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
- 
- 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.117 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,2 
4 
0,1 
0,5 
12.120 2 
4 
0,2 
1 
0,4 
2 
0,3 
1,5 
- 
- 
0,4 
2 
0,2 
1 
0,4 
2 
0,1 
0,4 
0,1 
0,4 
- 
- 
- 
- 
0,2 
1 
0,4 
2 
0,2 
1 
0,4 
2 
1 
5 
0,2 
1 
12.124 1 
2 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.125 0,4 
2 
0,2 
1 
0,4 
2 
0,3 
1,5 
- 
- 
0,4 
2 
0,2 
1 
0,4 
2 
0,1 
0,4 
0,1 
0,4 
- 
- 
- 
- 
0,2 
1 
0,4 
2 
0,2 
1 
0,4 
2 
1 
5 
0,2 
1 
12.127 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
- 
- 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.129 0,4 
2 
0,2 
1 
0,4 
2 
0,3 
1,5 
- 
- 
1 
5 
0,2 
1 
0,4 
2 
0,1 
0,4 
0,1 
0,4 
- 
- 
- 
- 
0,2 
1 
0,4 
2 
0,2 
1 
1 
5 
1 
5 
0,2 
1 
12.135 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.136 0,4 
2 
0,2 
1 
0,4 
2 
0,3 
1,5 
- 
- 
0,4 
2 
0,2 
1 
0,4 
2 
0,1 
0,4 
0,1 
0,4 
- 
- 
- 
- 
0,2 
1 
0,4 
2 
0,2 
1 
0,4 
2 
1 
5 
0,2 
1 
12.151 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.152 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.158 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.159 0,4 
2 
0,2 
1 
0,4 
2 
0,3 
1,5 
- 
- 
0,4 
2 
0,2 
1 
0,4 
2 
0,1 
0,4 
0,1 
0,4 
- 
- 
- 
- 
0,2 
1 
0,4 
2 
0,2 
1 
0,4 
2 
1 
5 
0,2 
1 
12.163 0,2 
1 
0 
10,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.164 0,2 
1 
0 
10,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.165 0,4 
2 
0,2 
1 
0,4 
2 
0,3 
1,5 
- 
- 
0,4 
2 
0,2 
1 
0,4 
2 
0,1 
0,4 
0,1 
0,4 
- 
- 
- 
- 
0,24 
1 
0,4 
2 
0,1 
0,3 
0,4 
2 
- 
- 
0,2 
1 
12.166 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.167 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.172 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.174 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.177 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.178 0,4 
5 
0,2 
5 
0,4 
2 
0,3 
1,5 
- 
- 
0,4 
2 
0,2 
1 
0,4 
5 
0,1 
0,4 
0,1 
0,4 
- 
- 
- 
- 
0,2 
1 
0,4 
2 
0,2 
1 
0,4 
2 
1 
5 
0,2 
1 
12.180 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.181 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
- 
- 
0,1 
0,5 
12.182 0,4 
2 
0,2 
1 
0,4 
2 
0,3 
1,5 
- 
- 
0,4 
2 
0,2 
1 
0,4 
2 
0,1 
0,4 
0,1 
0,4 
- 
- 
- 
- 
0,2 
1 
0,4 
2 
0,2 
1 
0,4 
2 
1 
5 
0,2 
1 
12.183 0,4 
2 
0,2 
1 
0,4 
2 
0,3 
1,5 
- 
- 
0,4 
2 
0,2 
1 
0,4 
2 
0,1 
0,4 
0,1 
0,4 
- 
- 
- 
- 
0,2 
1 
0,4 
2 
0,2 
1 
0,4 
2 
1 
5 
0,2 
1 
12.189 0,4 
2 
0,2 
1 
0,4 
2 
0,3 
1,5 
- 
- 
0,4 
2 
0,2 
1 
0,4 
2 
0,1 
0,4 
0,1 
0,4 
- 
- 
- 
- 
0,2 
1 
0,4 
2 
0,2 
1 
0,4 
2 
1 
5 
0,2 
1 
12.191 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
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Table II.1.2. Normal and Maximum use levels (mg/kg) for the candidate substances in FGE.08Rev3 (EFFA, 
2002g; EFFA, 2002h; EFFA, 2002i; EFFA, 2004ak; EFFA, 2007a; Flavour Industry, 2006q; Flavour Industry, 
2006r; Flavour Industry, 2009e; Flavour Industry, 2009o). 
FL-no Food Categories 
Normal use levels (mg/kg) 
Maximum use levels (mg/kg) 
01.0 02.0 03.0 04.1 04.2 05.0 06.0 07.0 08.0 09.0 10.0 11.0 12.0 13.0 14.1 14.2 15.0 16.0 
12.196 0,4 
2 
0,2 
1 
0,4 
2 
0,3 
1,5 
- 
- 
0,4 
2 
0,2 
1 
0,4 
2 
0,1 
0,4 
0,1 
0,4 
- 
- 
- 
- 
0,2 
1 
0,4 
2 
0,2 
1 
0,4 
2 
1 
5 
0,2 
1 
12.199 0,4 
2 
0,2 
1 
0,4 
2 
0,3 
1,5 
- 
- 
0,4 
2 
0,2 
1 
0,4 
2 
0,1 
0,4 
0,1 
0,4 
- 
- 
- 
- 
0,2 
1 
0,4 
2 
0,2 
1 
0,4 
2 
1 
5 
0,2 
1 
12.200 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
- 
- 
0,2 
1 
0,4 
2 
0,1 
0,5 
12.205 0,4 
2 
0,2 
1 
0,4 
2 
0,3 
1,5 
- 
- 
0,4 
2 
0,2 
1 
0,4 
2 
0,1 
0,4 
0,1 
0,4 
- 
- 
- 
- 
0,2 
1 
0,4 
2 
0,2 
1 
0,4 
2 
1 
5 
0,2 
1 
12.214 0,4 
2 
0,2 
1 
0,4 
2 
0,3 
1,5 
- 
- 
0,4 
2 
0,2 
1 
0,4 
2 
0,1 
0,4 
0,1 
0,4 
- 
- 
- 
- 
0,2 
1 
0,4 
2 
0,2 
1 
0,4 
2 
1 
5 
0,2 
1 
12.221 0,4 
2 
0,2 
1 
0,4 
2 
0,3 
1,5 
- 
- 
0,2 
1 
- 
- 
0,4 
2 
0,1 
0,4 
0,1 
0,4 
- 
- 
- 
- 
0,2 
1 
0,4 
2 
0,2 
1 
0,2 
1 
1 
5 
0,2 
1 
12.250 0,05 
0,25 
0,05 
0,25 
0,5 
2,5 
0,05 
0,25 
0,05 
0,25 
5 
25 
- 
- 
0,5 
2,5 
0,05 
0,25 
0,05 
0,25 
- 
- 
- 
- 
0,05 
0,25 
- 
- 
5 
25 
5 
25 
0,05 
0,25 
0,05 
0,25 
12.277 5 
10 
10 
20 
1 
5 
0,5 
1 
- 
- 
1 
5 
5 
10 
5 
10 
5 
20 
1 
2 
- 
- 
- 
- 
0,1 
0,2 
- 
- 
0,2 
0,5 
0,5 
1 
- 
- 
0,5 
0,1 
12.282 0,2 
2,5 
0,2 
2,5 
1 
25 
0,2 
2,5 
0,2 
2,5 
20 
250 
4 
50 
2 
25 
0,2 
2,5 
0,2 
2,5 
- 
- 
- 
- 
0,2 
2,5 
- 
- 
20 
250 
20 
250 
0,2 
2,5 
0,2 
2,5 
12.298 0,1 
1 
0,1 
1 
- 
- 
0,05 
0,5 
0,05 
0,5 
- 
- 
- 
- 
0,2 
2 
0,05 
0,5 
- 
- 
- 
- 
- 
- 
0,05 
0,5 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
15.047 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
- 
- 
0,2 
1 
0,4 
2 
0,1 
0,5 
15.048 0,2 
1 
0,1 
0,5 
0,2 
1 
0,02 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
- 
- 
0,2 
1 
0,4 
2 
0,1 
0,5 
15.056 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
15.081 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
- 
- 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
15.083 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
15.102 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
15.103 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
15.110 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
15.111 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
- 
- 
15.134 - 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
0,02 
7,5 
0,02 
2 
- 
- 
- 
- 
- 
- 
0,02 
1 
- 
- 
- 
- 
- 
- 
25 
50 
- 
- 
16.057 0,2 
1 
0,1 
0,5 
0,2 
1 
0,2 
1 
- 
- 
0,2 
1 
0,1 
0,5 
0,2 
1 
0,1 
0,2 
0,1 
0,2 
- 
- 
- 
- 
0,1 
0,5 
0,2 
1 
0,1 
0,3 
0,2 
1 
0,4 
2 
0,1 
0,5 
16.114 - 
- 
- 
- 
0,5 
3 
- 
- 
- 
- 
1 
5 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
0,5 
3 
0,5 
3 
1 
5 
0,5 
3 
II.2 mTAMDI Calculations 
The method for calculation of modified Theoretical Added Maximum Daily Intake (mTAMDI) values is 
based on the approach used by SCF up to 1995 (SCF, 1995). The assumption is that a person may consume 
the amount of flavourable foods and beverages listed in Table II.2.1. These consumption estimates are then 
multiplied by the reported use levels in the different food categories and summed up.  
Table II.2.1 Estimated amount of flavourable foods, beverages, and exceptions assumed to be consumed per 
person per day (SCF, 1995) 
Class of product category Intake estimate (g/day) 
Beverages (non-alcoholic) 324.0 
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Table II.2.1 Estimated amount of flavourable foods, beverages, and exceptions assumed to be consumed per 
person per day (SCF, 1995) 
Class of product category Intake estimate (g/day) 
Foods 133.4 
Exception a: Candy, confectionery 27.0 
Exception b: Condiments, seasonings 20.0 
Exception c: Alcoholic beverages 20.0 
Exception d: Soups, savouries 20.0 
Exception e: Others, e.g. chewing gum e.g. 2.0 (chewing gum) 
 
The mTAMDI calculations are based on the normal use levels reported by Industry. The seven food 
categories used in the SCF TAMDI approach (SCF, 1995) correspond to the 18 food categories as outlined in 
Commission Regulation (EC) No 1565/2000 (EC, 2000a) and reported by the Flavour Industry in the 
following way (see Table II.2.2): 
• Beverages (SCF, 1995) correspond to food category 14.1 (EC, 2000a) 
• Foods (SCF, 1995) correspond to the food categories 1, 2, 3, 4.1, 4.2, 6, 7, 8, 9, 10, 13, and/or 16 
(EC, 2000a) 
• Exception a (SCF, 1995) corresponds to food category 5 and 11 (EC, 2000a) 
• Exception b (SCF, 1995) corresponds to food category 15 (EC, 2000a) 
• Exception c (SCF, 1995) corresponds to food category 14.2 (EC, 2000a) 
• Exception d (SCF, 1995) corresponds to food category 12 (EC, 2000a) 
• Exception e (SCF, 1995) corresponds to others, e.g. chewing gum. 
Table II.2.2 Distribution of the 18 food categories listed in Commission Regulation (EC) No 1565/2000 (EC, 
2000a) into the seven SCF food categories used for TAMDI calculation (SCF, 1995) 
 Food categories according to Commission Regulation 1565/2000 Distribution of the seven SCF food categories 
Key Food category Food Beverages Exceptions 
01.0 Dairy products, excluding products of category 02.0 Food   
02.0 Fats and oils, and fat emulsions (type water-in-oil) Food   
03.0 Edible ices, including sherbet and sorbet Food   
04.1 Processed fruit Food   
04.2 Processed vegetables (incl. mushrooms & fungi, roots & tubers, pulses and legumes), 
and nuts & seeds 
Food   
05.0 Confectionery   Exception a 
06.0 Cereals and cereal products, incl. flours & starches from roots & tubers, pulses & 
legumes, excluding bakery 
Food   
07.0 Bakery wares Food   
08.0 Meat and meat products, including poultry and game Food   
09.0 Fish and fish products, including molluscs, crustaceans and echinoderms  Food   
10.0 Eggs and egg products Food   
11.0 Sweeteners, including honey   Exception a 
12.0 Salts, spices, soups, sauces, salads, protein products, etc.    Exception d 
13.0 Foodstuffs intended for particular nutritional uses Food   
14.1 Non-alcoholic ("soft") beverages, excl. dairy products  Beverages  
14.2 Alcoholic beverages, incl. alcohol-free and low-alcoholic counterparts   Exception c 
15.0 Ready-to-eat savouries   Exception b 
16.0 Composite foods (e.g. casseroles, meat pies, mincemeat) - foods that could not be 
placed in categories 01.0 - 15.0 
Food   
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The mTAMDI values (see Table II.2.3) are presented for each of the 62 of the 70 flavouring substances in 
the present flavouring group, for which Industry has provided use and use levels (EFFA, 2002g; EFFA, 
2002h; EFFA, 2002i; EFFA, 2004ak; Flavour Industry, 2006q; Flavour Industry, 2006r; Flavour Industry, 
2009e; Flavour Industry, 2009o). The mTAMDI values are only given for the highest reported normal use 
levels (see Table II.2.3). 
Table II.2.3 Estimated intakes based on the mTAMDI approach 
FL-no EU Register name mTAMDI 
(μg/person/day) 
Structural class Threshold of concern 
(µg/person/day) 
12.103 Butane-1,4-dithiol 78 Class I 1800 
12.104 Butane-2-thiol 78 Class I 1800 
12.106 S-2-Butyl 3-methylbutanethioate 240 Class I 1800 
12.111 Dibutyl disulfide 78 Class I 1800 
12.112 Dibutyl trisulfide 78 Class I 1800 
12.116 Dimethyl tetrasulfide 46 Class I 1800 
12.117 Dipentyl sulfide 74 Class I 1800 
12.124 Ethyl butyl sulfide 190 Class I 1800 
12.125 Ethyl propanethioate 160 Class I 1800 
12.127 Ethyl propyl sulfide 78 Class I 1800 
12.129 3-(Ethylthio)propan-1-ol 190 Class I 1800 
12.135 3-Mercapto-2-methylpropionic acid 78 Class I 1800 
12.151 Methyl butyl disulfide 78 Class I 1800 
12.152 Methyl butyl sulfide 78 Class I 1800 
12.158 Methyl isoprenyl sulfide 78 Class I 1800 
12.163 Methyl prop-1-enyl sulfide 78 Class I 1800 
12.164 Methyl prop-1-enyl trisulfide 78 Class I 1800 
12.165 S-Methyl propanethioate 110 Class I 1800 
12.166 Methyl propyl sulfide 78 Class I 1800 
12.167 Methyl propyl tetrasulfide 78 Class I 1800 
12.178 3-(Methylthio)butyric acid 160 Class I 1800 
12.180 1-(Methylthio)ethane-1-thiol 78 Class I 1800 
12.181 1-(Methylthio)pentan-3-one 70 Class I 1800 
12.182 2-(Methylthio)propionic acid 160 Class I 1800 
12.183 3-(Methylthio)propionic acid 160 Class I 1800 
12.189 S-(Methylthiomethyl) 2-methylpropanethioate 160 Class I 1800 
12.191 Pentane-1-thiol 78 Class I 1800 
12.196 S-Prenyl thioisobutyrate 160 Class I 1800 
12.199 Ethanethioic acid 160 Class I 1800 
12.200 1,1-bis(Ethylthio)-ethane 46 Class I 1800 
12.205 Mercaptoacetaldehyde 160 Class I 1800 
12.214 Isobutyl-3-(methylthio)butyrate 160 Class I 1800 
12.221 S-Prenyl thioisopentanoate 150 Class I 1800 
12.250 3-Mercaptohexanal 1900 Class I 1800 
12.266 Methyl-2-mercaptopropionate  Class I 1800 
12.277 3-(Methylthio)propyl butyrate 1400 Class I 1800 
12.278 3-Acetyl-mercaptohexyl acetate  Class I 1800 
12.282 (S)-Methyl octanethioate 8000 Class I 1800 
12.298 Di-(1-propenyl)-sulfid (mixture) 28 Class I 1800 
12.172 2-Methylbutane-2-thiol 78 Class I 1800 
12.174 2-Methylpropane-2-thiol 78 Class I 1800 
12.268 3-Mercaptooctanal  Class I 1800 
12.269 3-Mercaptodecanal  Class I 1800 
12.271 Methanedithiol diacetate  Class I 1800 
12.093 Diallyl hexasulfide 78 Class II 540 
12.094 Diallyl heptasulfide 78 Class II 540 
12.096 Allyl methyl sulfide 78 Class II 540 
12.097 Allyl methyl tetrasulfide 78 Class II 540 
12.098 Allyl prop-1-enyl disulfide 78 Class II 540 
12.099 Allyl propyl sulfide 78 Class II 540 
12.100 Allyl propyl trisulfide 78 Class II 540 
12.177 8-(Methylthio)-p-menthan-3-one 78 Class II 540 
15.047 3,5-Di-isobutyl-1,2,4-trithiolane 46 Class II 540 
15.048 3,5-Di-isopropyl-1,2,4-trithiolane 46 Class II 540 
15.056 3,6-Dimethyl-1,2,4,5-tetrathiane 78 Class II 540 
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Table II.2.3 Estimated intakes based on the mTAMDI approach 
FL-no EU Register name mTAMDI 
(μg/person/day) 
Structural class Threshold of concern 
(µg/person/day) 
15.083 3-Methyl-1,2,4-trithiolane 78 Class II 540 
15.102 Tetrahydrothiophene 78 Class II 540 
15.103 1,2,4,5-Tetrathiane 78 Class II 540 
15.110 2,4,6-Trimethyl-1,3,5-trithiane 78 Class II 540 
15.111 1,2,4-Trithiolane 78 Class II 540 
15.125 4-Tetrahydrothiopyranone  Class II 540 
12.295 3,5-Dimethyl-1,2-dithiolane-4-one  Class II 540 
16.057 2,4,4-Trimethyl-1,3-oxathiane 78 Class II 540 
12.120 2,8-Epithio-p-menthane 370 Class III 90 
12.136 3-Mercapto-2-oxopropionic acid 160 Class III 90 
15.081 Lenthionine 78 Class III 90 
15.134 2,5-Dihydroxy-1,4-dithiane 500 Class III 90 
16.114 2-Pentyl-4-propyl-1,3-oxathiane 290 Class III 90 
15.007 spiro(2,4-Dithia-1-methyl-8-oxa-bicyclo[3.3.0]octane-3,3'-
(1'-oxa-2'-methyl)-cyclopentane) and spiro(Dithia-6-methyl-
7-oxa-bicyclo 
 Class III 90 
12.159 Methyl methanethiosulfonate 160 Class III 90 
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ANNEX III: METABOLISM 
III.1. Introduction 
The group comprises 70 straight, branched chain or heterogeneous ring aliphatic hydrocarbons containing 
one or more sulphur atoms. Depending on the type of sulphur-containing functional group(s), the candidate 
substances can be subdivided into 11 subgroups (see Table III.1). 
The candidate substances are structurally closely related to 127 supporting flavouring substances evaluated at 
the 53rd meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA) in the groups 
“Simple aliphatic and aromatic sulfides and thiols” (JECFA, 2000c; JECFA, 2000b). These supporting 
substances have been allocated to 11 subgroups in the same way as has been indicated for the candidate 
substances in Table III.1.  
Table III.1 Subgroups. The supporting substances are listed in brackets  
FL-no EU Register name Structural formula Structural Class 
I: ACYCLIC SULPHIDES 
12.096  Allyl methyl sulphide S II 
12.099 Allyl propyl sulphide S II 
12.117 Dipentyl sulphide S I 
12.124  Ethyl butyl sulphide 
S
I 
12.127 Ethyl propyl sulphide 
S
I 
12.129 3-(Ethylthio)propan-1-ol 
HO S
I 
12.152  Methyl butyl sulphide S I 
12.158  Methyl isoprenyl sulphide 
S
I 
12.163  Methyl prop-1-enyl sulfide   1) S I 
12.166 Methyl propyl sulphide S I 
12.177 8-(Methylthio)-p-menthan-3-one   1) O
S
II 
12.178  3-(Methylthio)butyric acid   1) O
OHS
I 
12.181  1-(Methylthio)pentan-3-one 
S
O I 
12.182 2-(Methylthio)propionic acid  1) 
OH
S
O I 
12.183  3-(Methylthio)propionic acid 
S OH
O I 
12.214 Isobutyl-3-(methylthio)butyrate   1) 
S
O
O
I 
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Table III.1 Subgroups. The supporting substances are listed in brackets  
FL-no EU Register name Structural formula Structural Class 
12.277 3-(Methylthio)propyl butyrate 
O S
O I 
12.298 Di-(1-propenyl)-sulfid (mixture) S
S
S
I 
(12.001) 3-(Methylthio)propionaldehyde 
O S
I 
(12.002) Methyl 3-(methylthio)propionate 
O S
O I 
(12.006) Dimethyl sulphide S I 
(12.007) Dibutyl sulphide 
S
I 
(12.040) 2-Methylthioacetaldehyde 
S
O I 
(12.041) 1-(Methylthio)butan-2-one 
S
O I 
(12.042) 2-(Methylthio)phenol 
S
OH II 
(12.052) Di-(3-oxobutyl) sulphide 
S
O O I 
(12.053) Ethyl 3-(methylthio)propionate 
OS
O I 
(12.056) 3-(Methylthio)butanal SO I 
(12.057) 4-(Methylthio)butan-2-one O
S
I 
(12.058) 4-(Methylthio)-4-methylpentan-2-one O
S
I 
(12.060) Methyl 4-(methylthio)butyrate O
O
S
I 
(12.061) 4-(Methylthio)butanal 
O
S I 
(12.062) 3-(Methylthio)propan-1-ol 
HO S
I 
(12.063) 3-(Methylthio)hexan-1-ol S OH I 
(12.065) 2,8-Dithianon-4-en-4-carboxaldehyde 
S S
O I 
(12.077) Benzyl methyl sulphide 
S
II 
(12.078) 4-(Methylthio)butan-1-ol 
HO
S I 
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Table III.1 Subgroups. The supporting substances are listed in brackets  
FL-no EU Register name Structural formula Structural Class 
(12.084) Ethyl 4-(methylthio)butyrate O
O
S
I 
(12.086) Methyl 2-(methylthio)butyrate 
S
O
O
II 
(12.088) Diallyl sulphide S II 
(12.089) Ethyl 3-(methylthio)butyrate 
O
O
S
I 
(12.113) Diethyl sulphide 
S
I 
(12.118) 2,4-Dithiapentane 
SS
I 
(12.122) Ethyl 2-(methylthio)acetate O
O
S
I 
(12.154) Methyl ethyl sulphide 
S
I 
(12.162) Methyl phenyl sulphide 
S
II 
(12.176) 4-(Methylthio)-2-oxobutyric acid 
S
ONa
O
O III 
(12.187) Methylthiomethyl butyrate O
O S
I 
(12.188) Methylthiomethyl hexanoate O
OS
I 
(12.211) But-1-enyl methyl sulphide S I 
(12.236) 3-(Methylthio)hexyl acetate 
OO
S
I 
(12.237) 3-(Methylthio)propyl acetate 
O SO
I 
II: CYCLIC SULPHIDES  
12.120 2,8-Epithio-p-menthane   1) 
S
 
III 
15.102 Tetrahydrothiophene S II 
15.125 4-Tetrahydrothiopyranone S
O
II 
(15.012) 4,5-Dihydrothiophen-3(2H)-one 
S
O II 
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Table III.1 Subgroups. The supporting substances are listed in brackets  
FL-no EU Register name Structural formula Structural Class 
(15.023) 4,5-Dihydro-2-methylthiophene-3(2H)-one 
S
O II 
(15.066) 1,4-Dithiane 
SS
II 
III: MONOTHIOLS 
12.104  Butane-2-thiol   1) SH I 
12.135 3-Mercapto-2-methylpropionic acid   1) 
SH OH
O I 
12.136 3-Mercapto-2-oxopropionic acid 
SH OH
O
O
III 
12.172  2-Methylbutane-2-thiol 
HS
I 
12.174  2-Methylpropane-2-thiol SH I 
12.180  1-(Methylthio)ethane-1-thiol   1) SH
S
I 
12.191 Pentane-1-thiol 
HS
I 
12.205 Mercaptoacetaldehyde O
SH
I 
12.250 3-Mercaptohexanal   1) OSH I 
12.266 Methyl-2-mercaptopropionate   1) 
HS
O
O
I 
12.268 3-Mercaptooctanal   1) 
O
SH I 
12.269 3-Mercaptodecanal   1) 
O
SH I 
(12.003) Methanethiol SH I 
(12.004) Allylthiol 
SH
II 
(12.005) Phenylmethanethiol SH II 
(12.010) Butane-1-thiol 
SH
I 
(12.024) 3-Mercaptobutan-2-ol 
HS
OH
I 
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Table III.1 Subgroups. The supporting substances are listed in brackets  
FL-no EU Register name Structural formula Structural Class 
(12.027) 2-Methylbenzene-1-thiol 
SH
II 
(12.029) Cyclopentanethiol SH II 
(12.031) 3-Mercaptopentan-2-one SH
O
I 
(12.035) 2-,3- and 10-Mercaptopinane 
HS
2-Mercaptopinane
HS
3-Mercaptopinane
SH
10-Mercaptopinane
II 
(12.036) 3-[(2-Mercapto-1-methylpropyl)thio]butan-
2-ol 
S
OHSH I 
(12.038) 8-Mercapto-p-menthan-3-one O
SH
II 
(12.039) 2-Mercaptopropionic acid 
OH
O
SH I 
(12.046) Ethyl 2-mercaptopropionate O
O
SH
I 
(12.047) 3-Mercaptobutan-2-one 
O
SH I 
(12.048) 2-Methylbutane-1-thiol 
SH
I 
(12.049) 3-Methylbutane-2-thiol SH I 
(12.054) 2-(Ethylthio)phenol 
SH
III 
(12.055) 4-Mercaptobutan-2-one O
HS
I 
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Table III.1 Subgroups. The supporting substances are listed in brackets  
FL-no EU Register name Structural formula Structural Class 
(12.064) Thiogeraniol 
SH
I 
(12.071) 1-Propane-1-thiol 
HS
I 
(12.080) Thiophenol 
HS
II 
(12.082) 2,6-(Dimethyl)thiophenol 
HS
II 
(12.083) Ethyl 3-mercaptopropionate O
O
SH I 
(12.085) p-Menth-1-ene-8-thiol 
SH
II 
(12.128) 2-Ethylhexane-1-thiol 
SH
I 
(12.132) Hexane-1-thiol 
HS
I 
(12.137) 3-Mercapto-3-methylbutan-1-ol 
HO
SH
I 
(12.138) 3-Mercapto-3-methylbutyl formate 
O O
SH
I 
(12.143) 1-Mercaptopropan-2-one O
SH
I 
(12.145) 4-Methoxy-2-methylbutane-2-thiol SH
O
I 
(12.170) 3-Methylbut-2-ene-1-thiol 
SH
I 
(12.171) 3-Methylbutane-1-thiol 
SH
I 
(12.173) 2-Methylpropane-1-thiol 
HS
I 
(12.192) Pentane-2-thiol SH I 
(12.194) 2-Phenylethane-1-thiol 
HS
II 
(12.197) Propane-2-thiol 
HS
I 
(12.217) 3-Mercaptohexan-1-ol OHSH I 
(12.234) 3-Mercaptohexyl acetate O
O
SH I 
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Table III.1 Subgroups. The supporting substances are listed in brackets  
FL-no EU Register name Structural formula Structural Class 
(12.235) 3-Mercaptohexyl butyrate O
O
SH I 
IV: DITHIOLS  
12.103 Butane-1,4-dithiol 
HS
SH I 
(12.022) Butane-2,3-dithiol 
HS
SH
I 
(12.034) Octane-1,8-dithiol 
HS
SH I 
(12.066) Ethane-1,2-dithiol 
HS
SH I 
(12.067) Hexane-1,6-dithiol SH
HS
I 
(12.069) Nonane-1,9-dithiol 
HS SH
I 
(12.070) Propane-1,2-dithiol 
SH
HS
I 
(12.072) Butane-1,2-dithiol 
HS
SH
I 
(12.073) Butane-1,3-dithiol 
HS
SH I 
(12.076) Propane-1,3-dithiol 
HS SH
I 
V: ACYCLIC AND CYCLIC DISULPHIDES 
12.098 Allyl prop-1-enyl disulfide   1) 
S
S II 
12.111 Dibutyl disulfide 
S
S I 
12.151 Methyl butyl disulfide 
S
S I 
12.295 3,5-Dimethyl-1,2-dithiolane-4-one  1) S S
O
II 
(12.008) Diallyl disulfide 
S
S II 
(12.014) Dipropyl disulfide 
S
S I 
(12.019) Methyl propyl disulfide 
S
S I 
(12.026) Dimethyl disulfide 
S
S I 
(12.028) Dicyclohexyl disulfide 
S
S
II 
(12.037) Allyl methyl disulfide S
S
II 
(12.043) Diphenyl disulfide 
S
S
III 
(12.044) Prop-1-enyl propyl disulfide 
S
S I 
(12.068) Benzyl methyl disulfide 
S
S
II 
(12.075) Methyl prop-1-enyl disulfide 
S
S I 
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Table III.1 Subgroups. The supporting substances are listed in brackets  
FL-no EU Register name Structural formula Structural Class 
(12.081) Dibenzyl disulfide 
S
S
II 
(12.109) Di-isopropyl disulfide 
S
S
I 
(12.121) Ethyl 2-(methyldithio)propionate O
O
S
S
I 
(12.161) Methyl phenyl disulfide 
S
S
II 
(12.168) 2-Methyl-2-(methyldithio)propanal 
O
S S
I 
(12.218) Methyl-3-methyl-1-butenyl disulphide 
S
S  
I 
VI: ACYCLIC POLYSULPHIDES 
12.093 Diallyl hexasulfide 
S
S
S
S
S
S II 
12.094 Diallyl heptasulfide 
S
S
S
S
S
S
S
II 
12.097 Allyl methyl tetrasulfide S
S
S
S
II 
12.100 Allyl propyl trisulfide S
S
S II 
12.112  Dibutyl trisulfide 
S
S
S
I 
12.116  Dimethyl tetrasulfide S
S
S
S
I 
12.164  Methyl prop-1-enyl trisulfide   1) 
S
SS I 
12.167 Methyl propyl tetrasulfide S
S
S
S
I 
(12.009) Diallyl trisulfide S
S
S II 
(12.013) Dimethyl trisulfide S
S
S I 
(12.020) Methyl propyl trisulfide 
S
SS I 
(12.023) Dipropyl trisulfide S
S
S I 
(12.045) Methyl allyl trisulfide 
S
SS II 
(12.074) Diallyl polysulfides 
SX
X=2,3,4 or 5
II 
(12.155) Methyl ethyl trisulfide 
S
S S
I 
VII: MONO-, DI- , TRI- AND POLYSULPHIDES WITH THIOACETAL STRUCTURE 
12.200 1,1-bis(Ethylthio)-ethane 
S S
I 
15.047  3,5-Di-isobutyl-1,2,4-trithiolane   1) 
SS
S II 
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Table III.1 Subgroups. The supporting substances are listed in brackets  
FL-no EU Register name Structural formula Structural Class 
15.048  3,5-Di-isopropyl-1,2,4-trithiolane   1) 
SS
S
II 
15.056  3,6-Dimethyl-1,2,4,5-tetrathiane   1) 
SS
S S II 
15.081 Lenthionine 
S S
S S
S
III 
15.083  3-Methyl-1,2,4-trithiolane   1) 
SS
S II 
15.103  1,2,4,5-Tetrathiane 
S
S
S
S II 
15.110 2,4,6-Trimethyl-1,3,5-trithiane   1) 
S
S S
II 
15.111 1,2,4-Trithiolane 
S
S S
II 
15.134 2,5-Dihydroxy-1,4-dithiane   1) 
S
S
HO
OH
III 
16.057 2,4,4-Trimethyl-1,3-oxathiane   1) 
O
S
II 
16.114 2-Pentyl-4-propyl-1,3-oxathiane   1) 
S
O
III 
(15.006) 2,5-Dihydroxy-2,5-dimethyl-1,4-dithiane S
S
HO
OH
I 
(15.009) Trithioacetone 
S
S S
II 
(15.025) 3,5-Dimethyl-1,2,4-trithiolane 
SS
S II 
(15.034) 2-Methyl-1,3-dithiolane S
S
II 
(15.036) 3-Methyl-1,2,4-trithiane 
SS
S II 
(16.030) 2-Methyl-4-propyl-1,3-oxathiane 
O
S
II 
VIII: THIOESTERS 
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Table III.1 Subgroups. The supporting substances are listed in brackets  
FL-no EU Register name Structural formula Structural Class 
12.106  S-2-Butyl 3-methylbutanethioate   1) 
O
S
I 
12.125  Ethyl propanethioate 
S
O I 
12.165  S-Methyl propanethioate 
S
O I 
12.189 S-(Methylthiomethyl) 2-
methylpropanethioate 
S S
O I 
12.196 S-Prenyl thioisobutyrate 
S
O I 
12.221  S-Prenyl thioisopentanoate 
S
O I 
12.271 Methanedithiol diacetate 
S S
O O I 
12.278 3-Acetyl-mercaptohexyl acetate   1) 
O
O
S
O I 
12.282 (S)-Methyl octanethioate O
S
I 
(12.018) S-Ethyl acetothioate O
S
I 
(12.032) S-Methyl butanethioate 
S
O I 
(12.059) Propyl thioacetate 
S
O I 
(12.101) Allyl thiopropionate 
S
O I 
(12.148) S-Methyl 4-methylpentanethioate O
S
I 
(12.149) S-Methyl acetothioate O
S
I 
(12.150) S-Methyl benzothioate 
O
S
II 
Flavouring Group Evaluation 08, Revision 3
 
 
87 EFSA Journal 2011; 9(5):1988 
Table III.1 Subgroups. The supporting substances are listed in brackets  
FL-no EU Register name Structural formula Structural Class 
(12.156) S-Methyl hexanethioate O
S
I 
(12.157) S-Methyl isopentanethioate O
S
I 
(12.195) S-Prenyl thioacetate 
S
O I 
(12.203) Methylthio 2-(acetyloxy)propionate 
S
O
O
O
I 
(12.227) Methylthio-2-(propionyloxy)propionate 
S
O
O
O I 
IX: THIOIC ACID 
12.199 Ethanethioic acid 
HS
O I 
X: SULPHOXIDES/SULPHONES AND SULPHONATES 
12.159 Methyl methanethiosulfonate 
S
O
O
S
III 
(12.175) Methylsulfinylmethane 
S
O III 
XI: CYCLIC THIOKETAL WITH FUSED OXOLANE RINGS 
15.007 spiro(2,4-Dithia-1-methyl-8-oxa-
bicyclo[3.3.0]octane-3,3’-(1’-oxa-2’-
methyl)-cyclopentane) and spiro(Dithia-6-
methyl-7-oxa-bicyclo[3.3.0]octane-3,3’-
spiro(2,4-(1’-oxa-2-methyl)cyclopentane) O
S
S
O
III 
1) Stereoisomeric composition not specified 
The general metabolic reactions that the candidate substances may be expected to undergo, and which are 
discussed below, are one or several of the following: 
• S-oxidation 
• reductions  
• carbon-sulphur bond formation and/or fission 
• oxidative desulphuration  
• oxidative dealkylation 
• S-methylation 
• conjugation with glutathione and/or glucuronic acid 
• hydrolysis 
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Very few data are available on candidate substances. However, based on data on structurally related 
compounds, both the supporting substances included in the present evaluation and others not used as 
flavouring substances, the following conclusion can be drawn.  
There are not sufficient data available to determine to what degree the candidate substances may be absorbed 
from the gastro-intestinal tract. Lipophilicity and water solubility of these substances indicate a varying 
degree of absorption efficiency. For the purpose of this evaluation it is assumed that all substances will be 
absorbed.  
Data on absorption of supporting substances are equally insufficient. However, available data on solubility 
and lipophilicity of both candidate and supporting substances outline that the supporting substances used for 
deriving NOAELs for the different subgroups of this evaluation have equal lipophilicity and equal or less 
water solubility than the corresponding candidate substances. This indicates that the candidate substances 
may be absorbed to the same degree as the corresponding supporting substances, and that the use of 
NOAELs from these supporting substances does not underestimate the toxicity of the candidate substances in 
this respect. 
III.2. Sulphides, Sulphoxides/Sulphones and Sulphonates 
The following description is pertinent to subgroups I, II, IX and X.  
All the sulphides (or thioethers) among the candidate substances are sufficiently lipophilic to be efficiently 
absorbed from the gastrointestinal (GI) tract. Oral doses of the drugs sulphinpyrazone and sulindac are 
completely absorbed and their metabolites excreted in the bile of humans (Renwick et al., 1982; Renwick et 
al., 1986; Strong et al., 1984b), while dimethyl sulphoxide and dimethyl sulphone are excreted in the urine as 
metabolites of methyl sulphide administered subcutaneously to rabbits (Williams et al., 1966).  
Once alkyl and aromatic sulphides enter systemic circulation, they are rapidly oxidised to sulphoxides, and, 
depending on the structure of the sulphide, may be further oxidised to the sulphone (Figure III.1). The 
products of S-oxidation reactions may react spontaneously with glutathione, and it is likely that they also 
exhibit reactivity towards nucleophilic sites in cellular macromolecules. The S-reaction is favoured by the 
presence of a lone reactive pair of electrons on divalent sulphur in monosulphides (Damani, 1987), as shown 
by the excretion in the urine of dimethyl sulphoxide and dimethyl sulphone after methyl sulphide 
subcutaneous administration to rabbits (Williams et al., 1966). 
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Figure III.1: Biotransformation of disulphides, thiols, and related sulphur substances (Excretion products in 
bold) 
Although S-oxidation generally yields mixtures of sulphone and sulphoxide metabolites, the relative 
amounts of excretion products are dependent upon the polarity of the sulphide. In rats, polar aliphatic 
sulphides give rise to higher proportion of the sulphoxide metabolites (Damani, 1987). This is probably due 
to the water-solubility of the sulphoxides, which presumably limits their partitioning into the catalytic sites 
on the microsomal monooxygenase systems (P450 and FMO), involved in the S-oxidation reaction (Damani, 
1987).  
The first oxidation from sulphide to sulphoxide is reversible, whereas the sulphone group is stable and is not 
reduced back to the sulphoxide; this latter irreversibility seems to be related to the substrate specificity of the 
reductase (Renwick, 1989). The reduction of sulphoxide is mediated by the GI tract microflora as well as by 
hepatic and extra hepatic mammalian reductase. In many cases the reversible nature of the sulphide-
sulphoxide reaction depends on the dynamic metabolising system provided by intestinal flora (1010 bacteria/g 
of gut content). Anaerobic organisms populate the upper intestines and stomach of mice and rats. Their 
distribution is concentrated in the lower intestines in rabbits and humans, possibly due to lower gastric pH. 
In all species, reduction predominates in the lower gut, mainly the cecum and colon. Therefore, if gut flora is 
involved in the metabolism of monosulphide- and thiol-containing flavouring substances, the sulphur 
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derivatives must either be incompletely absorbed or reach the lower gut as biliary metabolites (Renwick & 
George, 1989), then entering the enterohepatic circulation. 
In vitro under anaerobic conditions, the sulphoxide anti-inflammatory drug sulphinpyrazone is reduced 
approximately six times faster in cultures with cecum contents than with liver cell homogenates from either 
rats (Renwick et al., 1982) or rabbits (Strong et al., 1984a). Oral doses of the sulphoxide drugs sulindac and 
sulphinpyrazone, which are completely absorbed and excreted in the bile of humans, are bioactivated by 
reduction to the corresponding monosulphides (Renwick et al., 1982; Renwick et al., 1986; Strong et al., 
1984b). The gut microflora is considered the major site of reduction of sulphinpyrazone to its sulphide in 
man (Renwick et al., 1982; Renwick et al., 1986; Strong et al., 1984b), whereas the reduction of sulindac to 
its sulphide takes place mainly in the liver, although gut microflora is partially involved (Renwick, 1989).  
The metabolism of dipropyl sulphide (as supporting for compounds in subgroups I), dipropyl sulphoxide, 
and dipropyl sulphone has been studied extensively in rats (Nickson & Mitchell, 1994; Nickson et al., 1995). 
Dipropyl sulphide is metabolised mainly to the corresponding sulphoxide. Other excreted metabolites 
include small amounts of the sulphone and trace amounts of inorganic sulphate. Individual studies on the 
sulphoxide and sulphone indicate that these metabolites are relatively stable under physiologic conditions. 
Ten male Wistar rats were given a single oral dose of 513 mg/kg bw [35S]-dipropyl sulphide in corn oil by 
gavage. The majority of radioactivity (92.8 %) recovered over the following three days was in the urine (66 
%), with lesser amounts in exhaled air (17.7 %), faeces (4.6 %) and carcass (1.5 %). Plasma profiles showed 
a slow continuous absorption with peak plasma levels occurring at 12 - 15 hours. The sulphoxide was the 
only species detected in the plasma. In the urine, about 25 % of the radioactivity was accounted for on day 1 
and 39 % on day 2. This delayed urinary excretion was related to enterohepatic cycling of the major 
metabolite dipropyl sulphoxide. Approximately 25 % of the radioactivity passed through the bile duct over 
48 hours, with only 5 % being excreted in the faeces. The only biliary metabolites detected were the 
sulphoxide (80 %) and sulphone (20 %). Urinary metabolites collected during the first 24 hours included the 
sulphoxide (92.5 %), sulphone (5 %) and sulphate (3 %). On days 2 and 3, the sulphoxide accounted for 
more than 98 % of daily urinary metabolites (Nickson & Mitchell, 1994). 
In a parallel study, eight rats were each given 580 mg [35S]-dipropyl sulphoxide/kg bw. Essentially the entire 
administered radioactivity was recovered over the following three days in the urine (80 %), exhaled air 
(1.4%), faeces (5.0 %) and carcass (13.0 %). Peak plasma levels occurred slightly later (15 - 20 hours) for 
the sulphoxide compared to that for the sulphide (12 - 15 hours). In the urine, about 28 % of the radioactivity 
was accounted for on day 1 and 47 % on day 2. The delayed urinary excretion paralleled that for the sulphide 
and supports the conclusion that enterohepatic cycling of sulphoxide delays the urinary excretion. In the bile, 
radioactivity was excreted as the sulphoxide (70 %) and sulphone (30 %) (Nickson & Mitchell, 1994). The 
profile of urinary metabolites was the same after administration of the sulphoxide or the sulphide. The 
principal quantitative difference was that more sulphone (18 % on day 1) was excreted after sulphoxide 
administration.  
In rats, dipropyl sulphone is physiologically stable and is excreted unchanged in the urine (Nickson et al., 
1995). The pattern of absorption, distribution and excretion was similar to that of sulphide and sulphoxide. 
Urine was the major route of excretion (83 %), again with a greater percentage of radioactivity excreted on 
day two (47 %) than on day one (28 %). As with the sulphide and sulphoxide, biliary excretion played a key 
role with 33 % of the dose passing through the bile within 48 hours. The metabolism of the administered 
sulphone appeared quite limited. More than 98 % was excreted unchanged in the urine along with trace 
amounts of inorganic sulphate. No reduction of the sulphone group or oxidation of the hydrocarbon chain 
was observed. 
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Based on the results of these three studies, it can be concluded that dipropyl sulphide is metabolised in the rat 
via S-oxidation to dipropyl sulphoxide and, to a small extent, dipropyl sulphone. The sulphoxide and 
sulphone are physiologically stable, and for the most part excreted unchanged. 
The fate of sulphoxides in humans is similar to that in rats. Dimethyl sulphoxide (DMSO) is the primary 
metabolite of methyl sulphide (as supporting for compounds in subgroups I). When an oral dose of 1 g/kg 
bw DMSO was given to six subjects, peak serum concentrations (1 - 3 mg/ml) were observed approximately 
four hours after administration (Hucker et al., 1967). Peak dimethyl sulphone concentrations (1 - 5 mg/ml) 
were measured at 72 - 96 hours. Approximately 51 % of the dose was excreted in the urine unchanged over 
the first 120 hours. Up to 22 % of the dose was excreted as dimethyl sulphone beginning 20 hours after 
dosing. Repeated daily oral administration of 0.5 g/kg bw/day DMSO for 14 days to one adult human 
showed similar peak serum levels (2 mg/ml) of DMSO achieved by day 8 of the study. Urinary excretion of 
DMSO was linear throughout the dosing period. After day 14, the DMSO concentration decreased to non-
detectable levels. 
In Rhesus monkeys the absorption, metabolism and excretion of DMSO are similar, although more rapid, to 
that for humans. Three monkeys were given a daily oral dose of 3 mg DMSO/kg bw for 14 days (Layman & 
Jacob, 1985). DMSO was rapidly absorbed, reached peak serum concentration after about four hours, and 
was cleared from the blood within 72 hours after termination of treatment. Dimethyl sulphone was detected 
in the blood two hours after treatment and reached a steady state concentration after four days. It was cleared 
from the blood 120 hours after treatment ended. Urinary excretion of DMSO and dimethyl sulphone 
accounted for approximately 60 % and 16 %, respectively, of the total ingested dose. Neither DMSO nor 
dimethyl sulphone were detected in the faeces (Layman & Jacob, 1985). 
Aliphatic, heterocyclic and aryl sulphides participate in the same oxidation pathway. Ring sulphoxidation 
have been reported in some sulphur heterocyclic drugs (Damani, 1987). When the supporting substance 
methyl phenyl sulfide [FL-no: 12.162] was administered orally to rats, methyl phenyl sulphone and 
hydroxylated sulphones (i.e., hydroxy methyl phenyl sulphone and conjugates of hydroxy methyl phenyl 
sulphone) were detected in the urine (McBain & Menn, 1969). Similarly, 4-chlorophenyl sulphide was 
reported to be oxidised by FMO and P450 to the sulphoxide and sulphone derivatives in vitro (Nnane & 
Damani, 1995). The aromatic sulphoxide, diphenyl sulphoxide, perfused with intact guinea-pig liver is 
oxidised exclusively to the corresponding sulphone under normoxic conditions (Yoshihara & Tatsumi, 
1990). 
The oxidation to sulphoxides is mainly catalysed by two enzyme systems, P450 and FMO (Renwick, 1989). 
Any organosulphur compound may be a substrate for both the enzyme systems, although with different 
affinity, essentially dependent on the electromolecular environment in which the sulphur is located: the more 
nucleophilic divalent sulphur are primarily oxidised by FMO and to a lesser extent by P450. This is the case 
for simple aliphatic (e.g. the supporting diethyl sulfide [FL-no: 12.113]), alicyclic (e.g. thiolane) and 
aromatic (e.g., ethyl p-tolyl sulphide) sulphides (Hoodi & Damani, 1984; Damani, 1987). Moreover, another 
important determinant is the tissue-specific distribution of the two different enzymatic systems, especially in 
extrahepatic tissues, as well as the differential presence of single isoforms, with different catalytic activities.  
Both P450- and FMO-catalysed oxidations may be accompanied by stereoselectivity.  
A series of 2-aryl-1,3-dithiolanes incubated with rabbit lung microsomes, pulmonary FMO fractions or 
pulmonary P450 fractions were oxidised primarily to the trans sulphoxide isomer; the enantioselectivity 
produced by FMO was higher when compared to P450 (Cashman et al., 1990; Cashman & Williams, 1990). 
Different isoenzymes of FMO, c-DNA expressed in E.coli have been used to investigate further the 
stereochemistry of sulphoxidation in humans (Rettie et al., 1994). When methyl p-tolyl sulphide was 
incubated with human foetal liver and human kidney microsomes from which P450 had been inhibited, the 
resulting sulphoxide contained an enantiomeric excess (>86 %) of the (R)-isomer. Decreasing 
stereoselectivity was observed with increasing size of the alkyl group (i.e. ethyl, propyl or isopropyl) 
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(Sadeque et al., 1992) and increasing pH (i.e. 8.5 to 10) (Rettie et al., 1990). Stereoselectivity was also 
dependent on the isoform involved in the reaction: oxidation of the propyl and butyl p-tolyl sulphide with the 
dominant human liver FMO isozyme, FMO3, showed a preference for the (R)-enantiomer (73-88 %), 
whereas oxidation of the methyl or ethyl derivative by human FMO5 showed greater than 90 % preference 
for the formation of the (S)-stereoisomer of the sulphoxide (Sadeque et al., 1995). 
Oxidation of unsubstituted and methyl-substituted cyclic sulphides by a rabbit liver phenobarbital-type P450 
yielded corresponding sulphoxides, but corresponding sulphones were not detected (Takata et al., 1983). In a 
subsequent experiment to the Takata et al. (1983) study using rabbit liver phenobarbital-type P450, pig liver 
microsomal FMO was used to elucidate mechanisms involved in the oxygenation of simple aryl or alkyl 
sulphides. The experiment demonstrated that oxygenation of sulphide with pig liver microsomal FMO 
involves the nucleophilic attack of the divalent sulphur on the reactive oxygen atom at the enzyme active 
site, i.e. electrophilic oxygenation of sulphide; whereas the oxygenation with the rabbit liver phenobarbital-
type P450 is initiated by a single electron transfer from the sulphide to the enzyme active species (Oae et al., 
1985). P450 can also catalyse the dealkylation of sulphides, but only when S is bonded to an electronegative 
substituent (e.g. an acyl group) (Oae et al., 1985). 
Oxygenated functional groups provide additional sites for the biotransformation of sulphides. Therefore, 
when a substance contains both a sulphide and an oxygenated functional group (i.e. alcohol, aldehyde, acid 
or ketone function), C-oxidation and/or conjugation may compete with S-oxidation. However, even in the 
presence of oxygenated functional groups, sulphoxide formation is usually the major metabolic pathway.  
Examples of concurrent metabolism via both sulphur and oxygenated functional groups have been reported 
for various substrates (Gachon et al., 1988; Karim El Fatih et al., 1988; Feng & Solsten, 1991; Black et al., 
1993). In all of them, the predominance of S-oxidation pathway has been reported. As an example, when 40 
mg/kg bw of [13C4, 35S]-thiodiglycol (HOCH2CH2)2S was administered intraperitoneally to male Porton rats, 
the major urinary metabolites were the corresponding sulphoxide (90 %) and carboxylic acid, S-(2-
hydroxyethylthio)acetic acid (10 %). The corresponding sulphone and combined C- and S-oxidation product, 
S-(2-hydroxyethylsulphinyl) acetic acid, were only minor metabolites (Black et al., 1993). 
Analogously, the corresponding sulphoxide is the principal urinary metabolite of the mucolytic drug S-
carboxymethyl-L-cysteine (S-containing amino acid) (Damani, 1987); in the case of the histamine antagonist 
cimetidine (S-containing amidine) in humans, the unchanged compound and the sulphoxide were identified 
in faecal samples, whereas the urinary metabolites were the glucuronide, the sulphoxide and a very low 
amount of the 5-hydroxymethyl-cimetidine (Mitchell et al., 1982). 
In summary, sulphides undergo FMO and P450 catalysed oxidation to yield chiral sulphoxides. Subsequent 
oxidation of the sulphoxide to the sulphone is an irreversible reaction that is mainly catalysed by P450. The 
relative amounts of sulphoxide and sulphone excreted are dependent upon the stability and hydrophilicity of 
the sulphoxide (Damani, 1987). However, the sulphoxide is generally the predominant urinary metabolite of 
simple sulphides, such as methyl sulphide (Williams et al., 1966). 
Based on the numerous examples of successive oxidation of sulphides to sulphoxides and sulphones by FMO 
and P450 enzymes in a variety of test systems (Cashman & Williams, 1990; Cashman et al., 1990; Cashman 
et al., 1995a; Cashman et al., 1995b; Elfarra et al., 1995) and (Nnane & Damani, 1995; Rettie et al., 1990; 
Sadeque et al., 1992; Sadeque et al., 1995; Yoshihara & Tatsumi, 1990), it is concluded that the oxidation 
pathway is the major route of biotransformation of (mono)sulphides in humans (Ziegler, 1980; Nickson & 
Mitchell, 1994). The same applies to sulphides containing an oxygenated functional group (i.e., alcohol, 
aldehyde, acid or ketone function); indeed, although C-oxidation and/or conjugation may compete with S-
oxidation, sulphoxide formation is usually the major metabolic pathway. 
Two of the candidate substances from subgroup I are esters, isobutyl-3-(methylthio)butyrate [FL-no: 12.214] 
and 3-(methylthio)propyl butyrate [FL-no: 12.277], which are anticipated to be hydrolysed to 2-
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methylpropanol [FL-no: 02.001] and 3-(methylthio)butyric acid [FL-no: 12.178] and respectively to be 
hydrolysed to 3-(methylthio)propan-1-ol [FL-no: 12.062] and butyric acid [FL-no: 08.005]. The candidate 
substance methyl methanethiosulphonate [FL-no: 12.159] from subgroup X is anticipated to be hydrolysed to 
methanol and methanethiosulphonic acid. The substance from subgroup IX, ethanethioic acid [FL-no: 
12.199] converts to acetic acid [FL-no: 08.002]. See Table 2b. 
Studies for Candidate Substances 
3-(Methylthio)propionic acid [FL-no: 12.183] (Subgroup I) 
The metabolism of [methyl-14C]- and 3-methyl [35S]thiopropionate (the salt of 3-(methylthio)propionic acid) 
was studied in a rat liver homogenate system. In addition to carbon dioxide and sulphate, methanethiol and 
hydrogen sulphide are intermediary or excreted metabolites of the salt of the candidate substance 3-
(methylthio)propionic acid (Steele & Benevenga, 1979). The developmental changes for rats in the 
metabolism of the salt of 3-(methylthio)propionic acid were measured for animals from 1 to 400 days of age. 
The metabolic capacity of liver homogenates to produce methanethiol and hydrogen sulphide from 3-methyl 
[35S]thiopropionate increased six-fold during the first week of life, remained at that level through weaning, 
and gradually decreased to essentially the value observed in the one-day old rat by 400 days of age. 
This pattern is not altered when the data are expressed in relation to tissue O2 consumption, implying that the 
greater ability of young rats to produce methanethiol and hydrogen sulphide from 3-
methyl[35S]thiopropionate is not simply a reflection of greater metabolic rate (Finkelstein & Benevenga, 
1984). 
Methyl propyl sulfide [FL-no: 12.166] (Subgroup I) 
Information may be derived from a study on the biotransformation of methyl, ethyl, isopropyl and propyl 
thiols, studied in rabbit liver microsomes. The results demonstrate that the thiols are primarily converted to 
the sulphoxides; then rabbit liver catalyses the S-methylation of shortchain alkane to yield the corresponding 
methyl sulphides. The coenzyme in this process, as with most other methyltransferases, is S-adenosyl-L-
methionine. The resulting methyl sulphides, including the candidate substance methyl propyl sulfide [FL-no: 
12.166] are further transformed by formation of the corresponding sulphoxide and sulphone. The 
methylation of short-chain alkane thiols to methylthioethers acts as a detoxication mechanism for the reactive 
sulphhydryl group (Holloway et al., 1979). 
Allyl methyl sulfide [FL-no: 12.096] (Subgroup I) 
Expiration of human subjects was trapped and analysed by GC-MS for volatile sulphur derivatives after 
subjects chewed and ate 1000 mg of grated raw or grated heat-treated garlic for 30 seconds. Allyl methyl 
sulphide, allyl mercaptan and methyl mercaptan were determined to be the important volatile low-molecular 
weight sulphur compounds expired. Analytical concentrations for the candidate substance allyl methyl 
sulfide [FL-no: 12.096] for raw garlic and heated garlic at the first measurement time point (0 minutes) were 
about 0.03 ppm and 0.05 ppm, respectively, and after 30 minutes had decreased to approximately 0.01 and 
<0.05 (Tamaki & Sonoki, 1999). It was determined that the major volatile metabolite detected in breath and 
plasma from human subjects which had consumed dehydrated granular garlic and an enteric-coated garlic 
preparation is allyl methyl sulphide (Rosen et al., 2000; Rosen et al., 2001). Its formation is very likely due 
to the action of allicin, released by garlic preparations, which decomposes in the stomach or in the intestine 
to release allyl sulphides, disulphides and other volatile sulphur compounds.  
Primary rat hepatocytes prepared by collagenase perfusion were incubated with diallyl disulphide or diallyl 
sulphide and the metabolites were identified. Allyl mercaptan and allyl methyl sulphide are the metabolites 
of diallyl disulphide. The highest amount of allyl methyl sulfide (0.93 ± 0.08 µg/ml at 90 minutes) is much 
less than that of allyl mercaptan (46.2 ± 6.6 µg/ml at 60 minutes). (Sheen et al., 1999). 
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Tetrahydrothiophene [FL-no: 15.102] (Subgroup II) 
In a study on the metabolism of 1,4-dibromobutane, six rats were injected intraperitoneally with 20.3 mg of 
the test substance in arachis oil. Urine samples were collected during the 24-hour period prior to dosing, and 
at 24 and 48 hours after dosing. Tetrahydrothiophene [FL-no: 15.102] and the corresponding hydroxylated 
sulphone, 3-hydroxysulpholane, were the only stable sulphur-containing metabolites identified and they were 
quantified for the 0–24, 24–48 and 0–48 time intervals using GLC with FID detection. At 48 hours, 
tetrahydrothiophene and 3-hydroxysulpholane in excreted urine were determined to be 5.8 ± 1.1 and 57 ± 15 
% of the dose of the parent compound, respectively. The authors concluded that 1,4-dibromobutane is 
extensively metabolised via GSH conjugation, resulting in the efficient detoxification of the parent 
compound. The initial conjugation to GSH in the biotransformation leads to the formation of a relatively 
stable cyclic sulphonium ion, N-acetyl-S-(beta-alanyl) tetrahydrothiophenium salt. This sulphonium salt is 
excreted to a minor extent as such; however, the major fraction decomposes in vivo to tetrahydrothiophene, 
which is further metabolised to yield 3-hydroxysulpholane, and both metabolites are excreted in the urine 
(Onkenhout et al., 1986). 
III.3. Thiols 
The following discussion is pertinent to subgroups III and IV. 
Thiols are highly reactive in vivo, mainly because most thiols exist in the ionised form at physiologic pH. 
Metabolic options for thiols include oxidation to form unstable sulphenic acids (RSOH), which may be 
oxidised to the corresponding sulphinic (RSO2H) and sulphonic acids (RSO3H); methylation to yield methyl 
sulphides, which then form sulphoxides and sulphones; reaction with physiologic thiols (either present in 
small molecules such as cysteine and glutathione or in biomacromolecules) to form mixed disulphides, or 
conjugation with glucuronic acid; and/or oxidation of the alpha carbon, resulting in desulphuration and 
formation of an aldehyde intermediate (McBain & Menn, 1969; Dutton & Illing, 1972; Maiorino et al., 1989; 
Richardson et al., 1991). 
Oxidation to Sulphonic Acid 
Enzymatic oxygenation of thiols results in the reactive sulphenic acid, sulphinic acid and sulphonic acid (see 
Figure III.1). The sulphenic acid almost instantaneously react with thiols to produce disulphides. The 
resulting disulphides can either be reduced to yield thiols or be further oxidised to yield sulphonic acid 
derivatives via thiosulphinic and sulphinic acid intermediates. Alternatively, S-oxigenation of disulphide 
may be followed by hydrolytic cleavage of the S-S bond. Among thiols, the sulphenic acid preferentially 
reacts with GSH, yielding mixed disulphide, the reduction of which by GSH would generate the foreign 
thiols, as follows: 
RSOH + GSH RSSG RSH + GSSG
GSH
 
This oxidation/reduction cycle may be the main cause of GSH tissue depletion and/or alteration of the 
cellular oxidative status (Ziegler, 1980). 
Dermal administration of pyridine-2-thiol-N-oxide gave rise to the corresponding sulphonic acid as the major 
metabolite in rats, with the disulphide present in much smaller amounts (Min et al., 1970). 
Methylation 
Simple aliphatic and aromatic thiols undergo S-methylation in mammals to produce the corresponding 
methyl sulphides, which may be successively oxidised to the corresponding sulphoxides and sulphones. 
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Principally two enzymes, both of which require S-adenosyl-L-methionine as a methyl group donor, catalyse 
the methylation reaction.  
In microsomes, S-methylation is catalysed by thiol methyltransferase (TMT), which exhibits a substrate 
preference for ‘non-physiological’ aliphatic thiols. Compounds such as 2-mercaptoethanol, methylmercaptan 
and 2-mercaptopropionic acid are substrates for TMT (Bremer & Greenberg, 1961), but the endogenous 
aliphatic thiols, homocysteine and glutathione are not. TMT is an adenosine-L-methionine-dependent 
membrane-bound enzyme. In human red blood cells membranes TMT exhibits high and low affinity 
activities, which show distinct pH dependence.  
In the cytoplasm of all mammalian tissues, S-methylation is catalysed by thiopurine methyltransferase 
(TPMT). This enzyme has similar levels of activity in human liver, kidney and erythrocytes (Szumlanski et 
al., 1988). Preferential substrates for this enzyme are thiopurines and thiopyrimidines, but other aromatic and 
heterocyclic thiols are also metabolised, although apparent Km values of thiophenols are at least two orders 
of magnitude less than those for thiopurines (Woodson & Weinshilboum, 1983; Woodson et al., 1983; Ames 
et al., 1986). 
TPMT activity in human tissue is regulated by a common genetic polymorphism (Woodson et al., 1982). 
Results of family studies indicate that the polymorphism is due to a single genetic locus with two alleles, 
TPMTH for high activity and TPMTL for low activity, with 94 % and 6 % gene frequencies, respectively. 
This fact results in a trimodal frequency distribution of TPMT activities in the general population. Of 298 
subjects, 89 % showed high TPMT activity (homozygous for the high activity allele), 11.1 % being 
heterozygous showed intermediate activity and 0.3 % (TPMTL-TPMTL) showed no activity (Woodson et 
al., 1982). 
The impact of inherited differences in “methylator status” on the metabolism of thiols at extremely low 
levels of exposure via the diet is not currently known. However, microsomal TMT and cytoplasmic TPMT 
activities are regulated independently in human tissue (Keith et al., 1983). Therefore, S-methylation of thiols 
may occur even in individuals showing no TPMT activity, although with different rates. Furthermore, 
alternative metabolic pathways such as S-oxidation and conjugation reaction are active, suggesting that thiol-
containing flavouring substances would be metabolised even in the absence of TPMT activity.  
Examples of S-methylation cover a broad spectrum of aliphatic and aromatic substrates. Ethyl methyl 
sulphide was detected in the urine of guinea pigs and mice following an oral dose of diethyl disulphide. 
Presumably, diethyl disulphide was reductively cleaved to form ethanethiol, which was subsequently 
methylated to form ethyl methyl sulphide. Minor urinary metabolites of ethyl methyl sulphide were the 
sulphoxide and sulphone (Snow, 1957).  
The urine of rats orally dosed with 6 mg/kg [35S]-phenyl mercaptan contained metabolites derived from S-
methylation of the administered parent mercaptane. Phenyl methyl sulphide metabolites included phenyl 
methyl sulphone, and o- and p-hydroxylated phenyl methyl sulphone (McBain & Menn, 1969). The alkyl 
thiol, captopril, undergoes S-methylation in the presence of S-adenosyl-L-methionine when incubated with 
microsomal fractions prepared from human liver, renal cortex, renal medulla or intestinal mucosa (Pacifici et 
al., 1991a).  
The urine of rats given a 10 mg/kg oral dose of S-benzyl-N-malonyl-L-cysteine contained the sulphoxide 
and sulphone derivative of benzyl methyl sulphide. Presumably, benzyl methyl sulphide forms via 
methylation of the intermediary metabolite benzyl mercaptan (Richardson et al., 1991). 
Reaction with Glutathione 
Thiols react with glutathione to form mixed disulphides. Both membrane-bound and cytosolic 
thioltransferases have been reported to catalyse the formation of mixed disulphides. Mixed disulphides can 
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undergo reduction and oxidative desulphuration or oxidation to sulphonic acid via the intermediates, 
thiosulphinate and sulphinic acid (Figure III.1). 
The mixed disulphides formed from glutathione and thiols are not substrates for the potentially intoxicating 
enzyme, cysteine conjugate beta-lyase. The beta-lyase is vitamin B6-dependent and catalyses the reduction 
of cysteine conjugates of selected halogenated substrates, yielding unstable thiols that induce renal toxicity 
(Tateishi et al., 1978; Shaw & Blagbrough, 1989). 
Oxidation and Desulphuration 
Low molecular weight thiols undergo oxidative desulphuration in vivo to yield CO2 and SO4 2-. 
When 14C-labeled methanethiol (supporting substance [FL-no: 12.003]) was administered to rats by 
intraperitoneal injection, 40 % of the label was expired as CO2 and 6.4 % was expired as unchanged 
methanethiol within six hours. Only 2.3 % of methanethiol was excreted in the urine (Canellakis & Tarver, 
1953). In a separate experiment using 35S-labeled methanethiol, 31 % of the label was excreted in the urine 
as sulphate ion. The labelled carbon also was detected in the beta-carbon of serine and the methyl groups of 
methionine, choline and creatine (Canellakis & Tarver, 1953). Formaldehyde has been shown in vitro to be 
an intermediate in the oxidation of methanethiol (Mazel et al., 1964). Although the carbon atom from thiols 
may be utilised in the biosynthesis of amino acids, the sulphur atom is not utilised significantly in the 
synthesis of sulphur-containing amino acids (Mazel et al., 1964). Methanethiol has been reported to be a 
metabolite in normal humans (Williams, 1959a). 
Hydrolysis 
One of the candidate substances in subgroup III, 1-(methylthio)ethane-1-thiol [FL-no: 12.180] is a thioacetal, 
which can be hydrolysed to acetaldehyde [FL-no: 05.001], methyl mercaptan [FL-no: 12.003] and 
hydrogensulfide [not a Register substance] and another candidate substance from subgroup III, methyl 2-
mercaptopropionate [FL-no: 12.266] is a carboxylic acid ester, which is anticipated to be hydrolysed to 
methanol and 2-mercaptopropionic acid [FL-no: 12.039]. The hydrolysis products are shown in Table 2b.  
Studies for Candidate Substances 
Butane-1,4-dithiol [FL-no: 12.103] (Subgroup IV) 
Microsomal thiol S-methyltransferase activity in rat salivary glands was found to be specific to aliphatic 
thiols compared to S-containing amino acids and simple aliphatic diols. Relative activity of 4 mM butane-
1,4-dithiol [FL-no: 12.103] is 95.6 % (relative to dithiothreitol 100 %), whereas relative activity for 4 mM L-
cysteine or 2,3-butanediol are only 3.0 and 0.7 %, respectively. The authors suggest that microsomal thiol S-
methyltransferase activity in rat salivary glands detoxicates extracellular thiols and/or intracellular hydrogen 
sulphide to protect normal secretory functions (Yashiro & Takatsu, 2001). 
3-Mercapto-2-oxopropionic acid [FL-no: 12.136] (Subgroup III) 
The transamination pathway (3-mercaptopyruvate pathway) of L-cysteine metabolism in rats was studied, in 
part, to determine the metabolic fate of the intermediate product, the salt of 3-mercapto-2-oxopropionic acid 
[FL-no: 12.136]. It was determined that it is metabolised by reduction and trans-sulphuration to yield 3-
mercaptolactatecysteine mixed disulphide [S-(2-hydroxy-2-carboxyethylthio) cysteine, HCETC] and 
inorganic sulphate, respectively. The reduction of the salt of 3-mercapto-2-oxopropionic acid is catalysed by 
lactate dehydrogenase as indicated by the use of anti-lactate dehydrogenase antiserum. Formation of HCETC 
is favoured at low 3-mercaptopyruvate sulphurtransferase activity (Ubuka et al., 1992). 
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III.4. Disulphides, Trisulphides and Polysulphides 
The following discussion is pertinent to subgroups V and VI. 
Disulphides 
Disulphides may be reduced to two thiol molecules. Consequently, metabolic options available to thiols (see 
section III.3) may also be available to disulphides. The disulphide bond may in certain circumstances also be 
reduced to the corresponding dithiol in a reversible reaction in vivo.   
A proposed metabolic pathway for the candidate cyclic disulphide 3,5-dimethyl-1,2-dithiolane-4-one [FL-no: 
12.295] would be, ring opening and disulphide reduction to form a dithiol, and then further metabolism 
following the scheme suggested for thiols in section III.3. Analoguous to this; lipoic acid is a five-membered 
cyclic disulfide that undergoes rapid redox cycling between ring disulfide and open dithiol.  
Thiol-disulphide exchange (TDE) reactions occur in vivo and result from nucleophilic substitution by 
sulphur. These reactions require the presence of a thiolate ion, proximity and appropriate orientation of the 
disulphide, and enzymes capable of catalysing these reactions (Myers et al., 1977a). TDE reactions control 
cellular concentrations of endogenous thiols (i.e. GSH) and disulphides (i.e. GSSG). The GSH/GSSH ratio 
decreases when cells undergo oxidative stress. Cells combat this decrease by rapidly switching glucose 
equivalents away from glycolysis and into the production of NADPH-reducing equivalents via the pentose 
phosphate pathway (Brigelius, 1985; Sies et al., 1987). The NADPH-reducing equivalents are used to 
convert GSSG back to GSH. Therefore, disturbance of the redox balance of thiol components and/or over 
expression of TDE could initiate acute cytotoxicity (Cotgreave et al., 1989). 
Examples of in vivo reduction of naturally occurring disulphides include the metabolism of asparagusic acid 
(the disulphide of 1,3-dithio-2-propanecarboxylic acid) in asparagus. Five volunteers ingested 500 g of 
asparagus and the urinary metabolites detected after ingestion were methanethiol, dimethyl sulphide, 
dimethyl sulphoxide, dimethyl sulphone, dimethyl disulphide and bis(methylthio)methane. Presumably, 
asparagusic acid is reduced to the dithiol, which may then be methylated, followed by oxidation of adjacent 
carbons, liberating methanethiol. Subsequent oxidation, methylation and dimerisation of methanethiol would 
produce the other detected metabolites (Waring et al., 1987).  
Incubation of dimethyl or diethyl disulphides with mouse lung and liver tissues in vitro resulted in the rapid 
generation of thiols (Oginsky et al., 1956).  
Sulphate and ethyl methyl sulphide were detected in the urine of guinea pigs and mice following an oral dose 
of diethyl disulphide. The diethyl disulphide was reductively cleaved to form ethanethiol, which was 
subsequently methylated to form ethyl methyl sulphide (Snow, 1957). An unidentified metabolite was 
presumed to be the sulphoxide or sulphone of ethyl methyl sulphide or the glucuronic acid conjugate of 
ethanethiol. 
Disulphides are also oxidised to thiosulphinic acid derivatives (Figure III.1). Thiosulphinic acid derivatives 
may be hydrolysed to the corresponding sulphinic and sulphonic acids or oxidised to yield thiosulphonic acid 
derivatives (Ziegler, 1982; Ziegler, 1985). Thiosulphonates (thiosulphonic acid derivatives) are unstable and 
are readily hydrolysed to the corresponding sulphonic acid (see Figure III.1) (Ziegler, 1984). 
Tri-, tetra- and polysulphides 
Tri-, tetra- and polysulphides may react with endogenous thiols such as reduced glutathione (GSH) or 
cysteine forming a thiol and a hydropersulphide or perthiol (RSH + R’SSH or R’SSSH or R’SxH, 
respectively) (Münchberg et al., 2007). Compared to thiols, perthiols may be strong reducing agents, reacting 
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rapidly with oxidants to form reactive products. According to several authors the biological activity of 
sulphides increase in the order mono-< di- < tri-< tetra-sulphide.  
In a study by Munday et al (2003) the ability of di-, tri- and tetrasulphides to cause oxidative damage to 
erythrocytes in vitro was investigated. In this experiment sulphides (dipropyl sulphide, diallyl sulphide, 
dipropyl disulphide, diallyl disulphide, dipropyl trisulphide, diallyl trisulphide and diallyl tetrasulphide) were 
added to suspensions of rat erythrocytes. Percentage of methemoglobin was assayed after incubation of 
erythrocytes with 1 mM of respective sulphide for 2 hours. In control, erythrocytes and erythrocytes 
incubated with monosulphides small amounts of haemoglobin were oxidised to methemoglobin. (~0.5-0.6 
%), more with disulfides (~3-12 %), and the most with tri- and tetrasulphides (~38-46 %). Sulphhemoglobin 
was not detected in erythrocytes incubated with mono- and disulphides, nor in control erythrocytes, but was 
detected (~1-5 %) in erythrocytes incubated with tri- and tetrasulphides. Heinz bodies were observed in a 
proportion of the cells incubated with tri- and tetrasulphides. Formation of hydrogen peroxide was measured 
and erythrocytic levels of glutathione determined in erythrocytes incubated with 50 μM of respective 
sulphide for 1 hour. No hydrogen peroxide was detected in control cells or cells incubated with 
monosulphides or dipropyl disulphide. In erythrocytes incubated with diallyl disulphide, trisulphides or 
tetrasulphide hydrogen peroxide was detected in increasing amounts (~21-96 % inhibition of erythrocytic 
catalase). The diallyl sulphides being more active than the dipropyl sulphides in this regard. Decrease in 
erythrocytic GSH-levels was not noticed in control cells or cells incubated with monosulphides. The greatest 
decrease was found in cells incubated with tetrasulphides (~91-92 %) followed by trisulphides (~73-74 %) 
and disulphides (~17-32 %). 
The ability of di-, tri- and tetrasulphides to cause hemolytic anemia in vivo in rats was also studied (Munday 
et al, 2003). Groups of six female rats were dosed with the test sulphides (same as in the in vitro experiments 
described above) in soybean oil by gavage for 5 days. All compounds were given at 500 μmoles/kg bw/day 
(57 and 59 mg/kg for the monosulphides, 73 and 75 mg/kg for the disulphides, 89 and 91 mg/kg for the 
trisulphides and 105 and 107 mg/kg for the tetrasulphides). Rats were killed on the 6th day of the experiment. 
All rats were in good health during the experimental period. Rats dosed with diallyl disulphide and the tri- 
and tetrasulphides were anemic at the end of the 6 day experiment. The anemia was associated with 
pronounced formation of Heinz bodies. Splenic enlargement was seen in animals receiving tri- and 
tetrasulphides, and the histopathology was consistent with haemolytic anemia with compensatory 
erythropoiesis. The ability of the sulphides to increase the activity of the enzymes quinone reductase (QR) 
and glutathione-S-transferas (GST) was measured in liver, kidney, spleen, lungs, heart, digestive tract and 
urinary bladder from the experimental animals. While dially tri- and tetrasulphides increased QR-activities in 
all the tissues studied, the propyl derivatives did not have significant effects in these tissues. Allyl sulphides 
had smaller and less widespread effects on GST activities, and no effects were seen with the propyl 
derivatives.  
The authors drew the conclusion that the activity of the sulphides increased in the order di- < tri- < 
tetrasulphide. In the paper it is discussed that trisulphides are readily cleaved by GSH to form an equimolar 
mixture of thiol and perthiol, while tetrasulphides are symmetrically cleaved forming two molecules of 
perthiol. Redox cycling and production of “active oxygen” may be expected with tri-, tetra- and 
polysulphides. In this context the chain of reduction is proposed to start with GSH, which reduces the 
polysulphide and continues via the perthiol and haemoglobin to O2 which is reduced to H2O2. 
RSSSR + 2 GSH → RSSH + RSH + GSSG 
RSSSSR + 2 GSH → 2 RSSH + GSSG (Munday et al., 2003) 
Experiments with a synthetic persulphide, benzyl hydrodisulphide (benzyl-SSH) gave evidence that 
persulphides may produce reactive oxygen species (O2*-, H2O2 and HO*) under physiologically relevant 
conditions. This was proposed to be the mechanism behind the cytotoxicity of some naturally occurring 
products (Chatterji et al., 2005).  
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The ability of allyl sulphides (diallyl monosulphide, diallyl disulphide and diallyl trisulphide) to induce 
apoptosis and supress cell proliferation was investigated in human colon cancer cells. Whereas the growth of 
cells was significantly depressed by diallyl trisulphide, neither diallyl monosulphide nor diallyldisulphide 
showed such an effect. Apoptosis of cells was proposed to be associated with oxidative modification of β-
tubulin (Hosono et al., 2005). 
III.5. Sulphides with Thioacetal and Thioketal Structure 
The following discussion is pertinent to subgroup VII. 
The thioacetals could be subject to acid-hydrolysis in the stomach, similar to oxygen-containing acetals 
forming aldehydes and thiols. The potential hydrolysis products of the 12 candidate substances are shown in 
Table 2b. However, thioacetals are more resistant to hydrolysis than oxygen-acetals (Satchell & Satchell, 
1990; Smith & March, 2001). It is thus to be anticipated that these substances may reach the intestinal lumen 
intact and may also be absorbed as such. 
The following text concerns subgroup XI. 
Cyclic oxygen-acetals may be very resistant to hydrolysis, the same is expected for cyclic thioketals 
(Deslongchamps et al., 2000). It is thus anticipated that the candidate substance [FL-no: 15.007] may be 
absorbed as such. Acetals may be hydrolysed by enzymatic hydrolysis, however the process may be slow 
and incomplete (Edsbacker et al., 1987; Levine et al., 1940; Hitchcock & Nelson, 1943; Thurston et al., 
1968).  
There is no information on metabolism of the candidate substance. In general, methylsubstituted cyclic 
thioethers and acetals are expected to undergo S-oxidation to the corresponding sulphoxide. In a study of the 
metabolism of 7-(1,3-dithiolan-2-ylmethyl)-1,3-dimethylxanthine by rat liver microsomes enzymatic 
oxidation occurred at the sulphur atom, which was the major nucleophilic center of the molecule. The 
presence of sulphur atoms suppressed the metabolic activity at the acetal carbon, and sulphoxidation was the 
preferred metabolic pathway. The oxidation occurred at the sulphur which was most accessible, and no 
further oxidation to disulphide or sulphone was detected during incubation. This was explained by the 
polarity of the sulphoxides, which made them poor substrates for microsomal enzymes (Grosa et al., 1991). 
The fate of 2-aryl-1,3-dithiolanes was studied in rabbit lung enzyme preparations. The sulphuroxide was the 
only detectable product formed during the incubation time. Studies on the biochemical mechanism suggested 
that the reaction preferentially was catalysed by flavin-containing monooxygenase, even though cytochromes 
P-450 also may contribute to sulphur oxidation. The monooxygenase only catalysed formation of the trans-
isomer of the sulphoxide, at the pro-R-sulphur atom (Cashman & Williams, 1990). 
Takata et al (1983) studied the enzymatic oxygenation of sulphides with cytochrome P-450 from rabbit liver. 
Various dialkyl-, aryl-, alkyl-, and diaryl-sulphides were readily oxygenated to the corresponding 
sulphoxides, but no sulphones were detected. The yield of sulphoxide was markedly affected by the structure 
of the sulphide, i.e. by substituents on the sulphur. It was concluded that the enzymatic oxygenatin of the 
cyclic sulphide predominantly took place at the opposite side of the alkyl aubstituent at alpha-position, 
forming mainly the trans-sulphoxide (Takata et al., 1983). 
The candidate substance, a cyclic thioketal with fused oxolane rings, is expected to be resistant to hydrolysis, 
and to be mainly absorbed as such. The sulphur atoms of the molecule are expected to be the main target for 
metabolic activity. The proposed pathway of metabolism is sulphoxidation to yield the corresponding 
sulphoxide. 
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III.6. Thioesters and Thioc Acid 
The following discussion is pertinent to subgroup VIII.  
S-Thioesters are rapidly hydrolysed by lipases and esterases forming primarily the corresponding carboxylic 
acids and thiols (Kurooka et al., 1976). The rate of hydrolysis of thioesters increases as the C-chain length of 
the carboxylic acid fragment increases (Greenzaid & Jencks, 1971) and decreases as oxygenation of the 
carbon chain in the thiol moiety increases (Kurooka et al., 1976). 
The hydrolysis products of the candidate thioesters and ethanethioc acid [FL-no: 12.199] are shown in Table 
2b. 
Thioesters with a polar anionic group, such as carboxylic acid one or more carbon atoms away from the 
sulphur are inhibitors of rather than substrates for FMO (Taylor & Ziegler, 1987) and probably would be 
eliminated without S-oxidation. 
III.7. Sulphoxides/Sulphones and Sulphonates 
The only candidate substance of subgroup X is methyl methanethiosulfonate [FL-no: 12.159], which is 
anticipated to be hydrolysed to methanesulphonic acid and hydrogensulphide. See Table 2b. 
III.8. Conclusions 
The candidate substances and supporting substances are expected to participate in common routes of 
absorption, distribution and metabolism, and exhibit similar toxicological properties. Saturation of these 
metabolic pathways is unlikely, given the extremely low levels of exposure to sulphides and thiols from their 
use as flavouring substances.  
Organosulphur compounds and their oxygenated derivatives are readily metabolised to excretable 
metabolites. Monosulphides primarily undergo S-oxidation to sulphoxides and sulphones, whereas thiols and 
polysulphides may follow a combination of pathways including S-oxidation, reduction, oxidative 
desulphuration, alkylation, and conjugation with glutathione and/or glucuronic acid. The oxidation of thiols 
leads to reactive sulphenic (R-S-OH) acid, which is readily further oxidised to sulphinic (R-SO2H) acid. 
Once formed, sulphenic acid can react with excess thiol (preferentially GSH), yielding the corresponding 
disulphide, which can be either reduced back to thiols or be oxidised to thio-sulphinic, sulphinic and 
sulphonic (R-SO3H) acid. In the likely event that thiols and disulphides form mixed disulphides, reacting 
with endogenous thiols present in cellular macromolecules, an adverse effect could be produced.  
Tri-, tetra- and polysulphides may react with endogenous thiols such as reduced glutathione (GSH) or 
cysteine forming a thiol and a hydropersulphide or perthiol (RSH + R’SSH or R’SSSH or R’SxH, 
respectively). Compared to thiols, perthiols may be strong reducing agents, reacting rapidly with oxidants 
and to form reactive products. In vitro and in vivo studies indicate that the biological activity of sulphides 
increase in the order mono- <di- < tri- <tetrasulphides. 
The presence of additional oxygen-containing functional group in the molecule, seems not to significantly 
affect the rate of the above described pathways of organosulphur compound biotransformations, although 
very low amounts of metabolites can be produced via the well recognised metabolic pathways of alcohols, 
aldehydes, acids and ketones.  
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Due to the reactivity of the electrophilic metabolites, (e.g. by either ring scission or S-oxidation) towards 
cellular nucleophilic sites, the 70 candidate substances are not predicted to be metabolised to innocuous 
products.
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ANNEX IV: TOXICITY 
Oral acute toxicity data are available for four candidate substances of the present Flavouring Group Evaluation from chemical group 20 and 30, and for 35 
supporting substances evaluated by the JECFA at the 53rd meeting. The supporting substances are listed in brackets. 
Table IV.1: ACUTE TOXICITY 
Chemical Name  [FL-no] Species  Sex  Route  LD50 
(mg/kg bw)  
Reference  Comments 
Subgroup I – Acyclic Sulphides 
(Dimethyl sulfide [12.006]) Mouse NR  Gavage 3700 (Koptyaev, 1967b)  
Rat NR Gavage 3300  (Koptyaev, 1967b)  
(Dibutyl sulfide [12.007])  Rat  NR  Oral 2220  (Moreno, 1975g)  
(3-(Methylthio)propionaldehyde [12.001]) Rat  M, F  Oral M: 1000 F: 1680 (Ballantyne and Myers, 
2000) 
 
(Ethyl 3-(methylthio)propionate [12.053]) Rat M, F Gavage >5000 (Panasevich et al., 
1980) 
 
(2-(Methylthio)phenol [12.042]) Rat  M, F  Gavage  M: 1740  
F: 2400 
(Butterworth & Mason, 
1981) 
 
Mouse  M, F  Gavage  M: 1560  
F: 1750 
(Butterworth & Mason, 
1981) 
 
(Methyl 2-(methylthio)butyrate [12.086]) Rat  M, F  Gavage  2108 (Piccirillo & Lunchicki, 
1982) 
 
Subgroup II – Cyclic Sulphides 
Tetrahydrothiophene [15.102] Rat M, F 
5/sex/group 
Gavage M: 2000 
F. 1750 
(Auletta & Daly, 1985)  
Rat NR Oral 1200 (100% survival rate) 
3000 (100% fatality rate) 
(Dow Chemical 
Company, 1992a) 
 
Subgroup III – Monothiols 
(1-Propane-1-thiol [12.071]) Rat  NR  Gavage  134  (Elf Atochem, 1981b) Referred to as 3-
mercapto-1-propanol in 
reference 
Rat  NR  Gavage  1790  (Fairchild & Stokinger, 
1958)  
 
2-Methylpropane-2-thiol [12.174] Rat  NR  Gavage  4729  (Fairchild & Stokinger, 
1958) 
 
Rat  M, F Gavage  8400  (Phillips Petroleum 
Company, 1990a) 
 
(Butane-1-thiol [12.010]) Rat  NR  Gavage  1500  (Fairchild & Stokinger, 
1958) 
 
(2-Methylpropane-1-thiol [12.173])  Rat  NR  Gavage  7168  (Fairchild & Stokinger, 
1958) 
 
Butane-2-thiol [12.104] Rat  NR  Gavage  5176  (Elf Atochem, 1981a)  
2-Methylbutane-2-thiol [12.172] Rat  M  
6/group 
Gavage  >5000  (Elf Atochem, 1977)  
(Pentane-2-thiol [12.192]) Rat  M, F  Gavage  >5000  (Collinson, 1989a)  
(3-Methylbutane-2-thiol [12.049]) Rat  M, F  Gavage  540  (Harper & Ginn, 1964)  
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Table IV.1: ACUTE TOXICITY 
Chemical Name  [FL-no] Species  Sex  Route  LD50 
(mg/kg bw)  
Reference  Comments 
(Cyclopentanethiol [12.029]) Mouse  M, F  
5/group 
Oral  2680  (Oser, 1970c) Use of both sexes not 
clear from reference 
(p-Menth-1-ene-8-thiol [12.085]) Rat  M, F  Oral  >6000  (Mondino & Peano, 
1982) 
 
(Thiophenol [12.080]) Rat  NR Gavage  46  (Fairchild & Stokinger, 
1958) 
 
(3-Mercaptopentan-2-one [12.031]) Mouse  M, F  Gavage  M: 540 
F: 455 
(Shellenberger, 1971b)  
(2,6-(Dimethyl)thiophenol [12.082]) Rat  M, F  
5/sex/group 
Oral  3150 (Mondino & Peano, 
1979a) 
 
Subgroup IV – Dithiols 
(Ethane-1,2-dithiol [12.066]) Rat  M, F  Oral  144  (Phillips Petroleum 
Company, 1990b) 
 
Mouse  M, F  Oral  342  (Moran et al., 1980)  
Mouse  M, F  Gavage  342  (Fogleman & DeProspo, 
1974) 
 
Mouse  NR  Oral  120 (Pharmacology 
Research, Inc., 1963) 
 
Rat  M, F  Oral  218 (Phillips Petroleum 
Company, 1990b) 
 
(Propane-1,3-dithiol [12.076]) Rat  NR  Oral  100-200  (Eastman Kodak Co., 
1955b) 
 
Mouse  NR  Oral  10702  (Schafer and Bowles, 
1985) 
 
(Propane-1,2-dithiol [12.070]) Mouse  M, F  Oral  153  (Bailey, 1976a)  
Mouse  M, F  Gavage  170  (Fogleman & Suppers, 
1974c) 
 
(Octane-1,8-dithiol [12.034]) Mouse  M, F 
5/sex/group  
Oral  882 (940 M, 1300 F)  (Bailey, 1976b)  
Mouse M, F Oral 1262 (Moran et al., 1980)  
Subgroup V – Acyclic and cyclic disulphides 
(Dimethyl disulfide [12.026]) Rat  M, F  Oral 190 (Shapiro et al., 1985)  
(Dipropyl disulfide [12.014]) Rat  M, F  Oral  2000 (Elf Atochem, 1992) Reference is dipropyl 
disulfide. 
Rat  M  Gavage  60003 (Rohm & Haas Co., 
1980) 
 
(Diallyl disulfide [12.008]) Rat  M  Oral  260  (Moreno, 1980h) Paper reports compound 
as allyl sulphide. 
Rat  NR  Oral <50004   (Platte Chemical Co., 
1995) 
 
(Benzyl methyl disulfide [12.068]) Mouse  M, F  Oral  1080 (Bailey, 1976c)  
Subgroup VI –Acyclic polysulphides  
(Diallyl trisulfide [12.009]) Mouse  M, F  Oral  100-400 (Moran et al., 1980) Not definitive test. 
(Dipropyl trisulfide [12.023]) Mouse  M, F  Oral  800-1600 (Moran et al., 1980) Not definitive test. 
Subgroup VII – Mono-, di-, tri- and polysulphides with thioacetal structure
(3-Methyl-1,2,4-trithiane [15.036]) Rat  M, F  Oral  440  (Mondino & Peano,  
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Table IV.1: ACUTE TOXICITY 
Chemical Name  [FL-no] Species  Sex  Route  LD50 
(mg/kg bw)  
Reference  Comments 
1979b) 
(3,5-Dimethyl-1,2,4-trithiolane [15.025]) Rat Not specified Oral 115 (BIBRA, 1976)  
(2,5-Dihydroxy-2,5-dimethyl-1,4-dithiane [15.006]) Mouse  F  
5/group 
Gavage  360  (Fogleman & DeProspo, 
1973a) 
 
(2-Methyl-4-propyl-1,3-oxathiane [16.030]) Rat  NR Gavage  60001  (BIBRA, 1976)  
(2-Methyl-1,3-dithiolane [15.034]) Rat  M, F  Gavage  1610 (1.61 g/kg)  (Griffiths et al., 1979a)  
(Trithioacetone [15.009]) Mouse  M, F  Gavage  M: 2600 
 F: 2000 
(Fenwick & Hanley, 
1985) 
 
Subgroup VIII – Thioesters 
(Methylthio 2-(acetyloxy)propionate [12.203]) Rat  M, F Gavage 1050 (Watanabe & Kinosaki, 
1989a) 
 
(Methylthio-2-(propionyloxy) propionate [12.227]) Rat  M, F  Gavage  1330 (Watanabe & Kinosaki, 
1989b)  
 
Subgroup X – Sulphoxides/Sulphones and Sulphonates 
(Methylsulfinylmethane [12.175]) Rat  M, F  Gavage  20000  (Brown et al., 1963)  
Mouse  M, F  Gavage  20000  (Brown et al., 1963)  
Mouse  M, F  Oral  21400  (Willson et al., 1965)  
Rat  M, F  Oral  28300  (Willson et al., 1965)  
Mouse  M, F  Oral  16500  (Sommer & Tauberger, 
1964) 
 
Rat  M, F  Oral  19700  (Sommer & Tauberger, 
1964) 
 
Mouse NR  Oral  3100 (Fishman et al., 1969)  
Rat  NR  Oral  14500 (Fishman et al., 1969)  
NR = Not Reported. 
M = Male; F = Female. 
1 Estimated value. 
2 Reported as ALD (Approximate Lethal Dose). 
3 Value does not represent a true LD50 value. Test conducted with a mixture of seven components. Mixture contained 1.9% of diisopropyl disulfide. 
4 Value does not represent an LD50 value. Value reported is an LD100 value. 
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Subacute / Subchronic / Chronic / Carcinogenic toxicity data are available for two candidate substances of the present flavouring group evaluation from 
chemical group 20 and 30, and for 33 supporting substances evaluated by the JECFA at the 53rd meeting. The supporting substances are listed in brackets. 
Table IV.2: Subacute / Subchronic / Chronic / Carcinogenicity Studies 
Chemical Name [FL-no]  Species; Sex 
No/Group 
Route  Dose levels 
(mg/kg/day) 
Duration NOAEL 
(mg/kg/day) 
Reference Comments 
Subgroup I – Acyclic Sulphides 
(Methyl sulfide [12.006]) 
 
Rat; M, F 
15/sex/group 
Oral (gavage 
in corn oil) 
0 (control group), 2.5, 25, 
250 
14 Weeks  No adverse effect 
measured at the highest 
tested dose  (250)1 
(Butterworth et al., 1975b) Study published on a peer reviewed journal. 
Acceptable quality. 
Rat (sex unspecified) 
5/group 
Oral (gavage) 0 (control group), 0.0015, 
0.015, 0.6, 15 
225 days 0.6 (Koptyaev, 1967b) Insufficiently reported study. Validity cannot 
be evaluated – no histopathology data.  
Rabbit (sex 
unspecified) 
18 (reported as total 
number) 
Oral (gavage) 0 (control group), 0.0015, 
0.015, 0.6, 15 
225 days 0.6 (Koptyaev, 1967b) Insufficiently reported study. Validity cannot 
be evaluated – no histopathology data.  
Rabbit; M, F  
10/group 
Oral (in 
drinking 
water) 
0(control group), 2000 13 Weeks  No adverse effect 
measured at the highest 
tested dose  (2000)1 
(Wood et al., 1971) Limited relevance (The only end-point 
followed was lenticular changes). 
(2,8-Dithianon-4-ene-4-carboxaldehyde 
[12.065]) 
Rat; M, F  
5/sex/group 
Oral (gavage 
in corn oil)  
0 (control group), 0.33, 3.3 2 Weeks  No adverse effect 
measured at the highest 
tested dose  (3.3)1 
(deGroot et al., 1974) Unpublished report; limited quality due to 
scant data reporting. 
3-(Methylthio)propionic acid [12.183]  Rat; M  
5/group 
Diet  0 (control group), 2.57% 
(corresponding to 2570 mg) 
2 Weeks  Not determined: effects 
observed at the only 
tested dose  
(Steele et al., 1979) Study published on a peer reviewed journal 
Acceptable quality. 
Subgroup II – Cyclic Sulphides 
(4,5-Dihydro-3(2H)-thiophenone 
[15.012]) 
Rat; M, F  
15/sex/group 
Diet 0 (control group), 9.16 
(nominal dose; actual dose 
= 10 ) 
90 Days  No adverse effect 
measured at the only 
tested dose  (10)1 
(Morgareidge & Oser, 
1970a) 
Unpublished /uncompleted report: 
histopathology results not available.  
2,8-Epithio-p-menthane [12.120] Rat; M, F 
10/sex/group 
Oral (gavage) 0 (control group), 10 28 Days No adverse effect 
measured at the only 
tested dose  (10)1 
(Finlay, 2004) Unpublished report: acceptable quality. 
Subgroup III –Monothiols 
(2-Mercapto-3-butanol [12.024]) Rat; M, F  
15/sex/group 
Diet  0 (control group), 0.752 
(nominal dose; actual dose 
= 0.705) 
90 Days  No adverse effect 
measured at the only 
tested dose  (0.705)1 
(Cox et al., 1974a) Unpublished report: acceptable quality.  
(o-Toluenethiol [12.027]) Rat; M, F  
20-32 
Diet  0 (control group), 0.52 90 Days  No adverse effect 
measured at the only 
tested dose  (0.52)1 
(Posternak et al., 1969) Poorly reported study (only a summary 
available). 
(Cyclopentanethiol [12.029]) Rat; M, F  
15/sex/group 
Diet  0 (control group), 0.49 
(nominal dose; actual dose 
=0.56) 
90 Days  No adverse effect 
measured at the only 
tested dose  (0.56)1  
(Morgareidge & Oser, 
1970b) 
Unpublished report: acceptable quality. 
(3-Mercapto-2-pentanone [12.031]) Mouse; M, F  
15/sex/group 
Diet 0 (control group), 1.7 
(nominal dose; actual dose 
= 1.89) 
90 Days  No adverse effect 
measured at the only 
tested dose  (1.89)1  
(Morgareidge, 1971b) Unpublished /uncomplete report:  
histopathology results not available.   
(2,3- and 10-mercaptopinane [12.035]) Rat; M, F  
17/sex/group 
Diet  0 (control group), 0.06 90 Days  No adverse effect 
measured at the only 
tested dose  (0.06)1  
(Oser, 1966)  Unpublished report: acceptable quality. 
(2,6-Dimethylthiophenol [12.082]) Rat; M, F  Oral (gavage 0 (control group), 0.43 13 Weeks No adverse effect (Peano et al., 1981) Good quality unpublished report. 
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Table IV.2: Subacute / Subchronic / Chronic / Carcinogenicity Studies 
Chemical Name [FL-no]  Species; Sex 
No/Group 
Route  Dose levels 
(mg/kg/day) 
Duration NOAEL 
(mg/kg/day) 
Reference Comments 
16/sex/group in corn oil) measured at the only 
tested dose  (0.43)1  
(3-Mercapto-3-methylbutyl formate 
[12.138]) 
Rat; M, F  
5/sex/group 
Diet  0 (control group), 10 2 Weeks  No adverse effect 
measured at the only 
tested dose  (10)1 
(Wnorowski, 1996e) Good quality GLP study. 
(Prenylthiol [12.170]) Rat; M, F  
5/sex/group 
Diet  0 (control group), 12.8 (M 
& F)  
2 Weeks  No adverse effect 
measured at the only 
tested dose  (12.8)1  
(Wnorowski, 1997a) Good quality GLP study. 
(3-Mercaptohexanol [12.217]) Rat; M, F  
5/sex/group 
Diet  0 (control group), 11.80(M) 
and 10.73 (F) 
2 Weeks  No adverse effect 
measured at the only 
tested dose  (11.8)1  
(Wnorowski, 1996d) Good quality GLP study. 
(3-Mercaptohexyl acetate [12.234]) Rat; M, F  
5/sex/group 
Diet  0 (control group), 11.66  2 Weeks  No adverse effect 
measured at the only 
tested dose  (11.66)1 
(Wnorowski, 1996a) Good quality GLP study. 
(3-Mercaptohexyl butyrate [12.235]) Rat; M, F  
5/sex/group 
Diet  0 (control group), 11.87 
(M) and 11.99 (F) 
2 Weeks  No adverse effect 
measured at the only 
tested dose  (11.9)1 
(Wnorowski, 1996b) Good quality GLP study. 
Subgroup IV –Dithiols  
(2,3-Butanedithiol [12.022]) Rat; M, F  
15/sex/group 
Oral 0 (control group), 0.752 
(nominal dose; actual dose 
= 0.703) 
90 Days  No adverse effect 
measured at the only 
tested dose  (0.703)1 
(Cox et al., 1974c) Unpublished report: acceptable quality. 
(1,8-Octanedithiol [12.034]) Rat; M, F  
15/sex/group 
Oral  0 (control group), 0.752 
(nominal dose; actual dose 
= 0.705) 
90 Days  No adverse effect 
measured at the only 
tested dose  (0.705)1. 
(Cox et al., 1974d) Unpublished report: acceptable quality. 
Subgroup V – Acyclic and cyclic disulphides 
(Diallyl disulfide [12.008]) Rat; F  
12 (control group)  
6 (treatment group) 
Oral (gavage 
in peanuts oil)  
0 (control group), 36.5, 
146, 732 
6 Days  146 
(hemolytic anemia at the 
higher dose)  
(Munday & Manns, 1994) Study published on a peer reviewed journal. 
Acceptable quality. 
(Dipropyl disulfide [12.014]) Rat; F  
12 (control group)  
6 (treatment group) 
Oral (gavage 
in peanuts oil)  
0 (control group), 37.6, 
150.4, 752 
6 Days  150.4  
(hemolytic anemia at the 
higher dose)  
(Munday & Manns, 1994) Study published on a peer reviewed journal. 
Acceptable quality. 
Rat; M  
10-16 
Diet  7.29 90 Days  No adverse effect 
measured at the only 
tested dose  (7.29)1 
(Posternak et al., 1969) Poorly reported study (only a summary is 
available). 
(Dicyclohexyl disulfide [12.028]) Rat; M, F  
15/sex/group 
Diet 0 (control group), 0.752 
(nominal dose; actual dose 
= 0.232 ) 
90 Days  No adverse effect 
measured at the only 
tested dose  (0.23)1 
(Cox et al., 1974e) Unpublished report: acceptable quality. 
(Phenyl disulfide [12.043]) Rat; F  
6 
Oral (gavage 
in peanuts oil) 
0 (control group), 218 6 Days  < 218 (Munday et al., 1990) Limited validity: the study was only looking at 
some haematological parameters. 
(Benzyl methyl disulfide [12.068]) Rat; M, F  
15/sex/group 
Diet   0 (control group), 1.13 
(nominal dose; actual dose 
= 1.15 )  
90 Days  No adverse effect 
measured at the only 
tested dose  (1.15)1  
(Gallo et al., 1976a) Unpublished report: acceptable quality. 
Subgroup VI – Acyclic polysulphides 
(Diallyl trisulfide [12.009]) Rat; M, F  
15/sex/group 
Diet 0 (control group), 4.16 
(nominal dose; actual dose 
= 4.6) 
90 Days No adverse effect 
measured at the only 
tested dose  (4.6)1  
(Morgareidge & Oser, 
1970d) 
Unpublished /uncomplete report: 
histopathology results not available. 
(Dipropyl trisulfide [12.023])  Rat; M, F  Diet  0 (control group), 4.16 90 Days  No adverse effect (Morgareidge & Oser, Unpublished /uncomplete report: results of 
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Table IV.2: Subacute / Subchronic / Chronic / Carcinogenicity Studies 
Chemical Name [FL-no]  Species; Sex 
No/Group 
Route  Dose levels 
(mg/kg/day) 
Duration NOAEL 
(mg/kg/day) 
Reference Comments 
15/sex/group (nominal dose; actual dose 
= 4.8) 
measured at the only 
tested dose  (4.8)1 
1970c) histopathology not available.  
Subgroup VII – Mono-, di-, tri- and polysulphides with thioacetal structure 
(Trithioacetone [15.009])  Rat; M, F  
15/sex/group 
Diet 0 (control group), 0.2338 
(nominal dose; actual dose 
= 0.2 ) 
90 Days  No adverse effect 
measured at the only 
tested dose  (0.2)1 
(Cox et al., 1973b) Unpublished report; acceptable quality. 
(3,5-Dimethyl-1,2,4-trithiolane [15.025]) Rat; M, F  
15/sex/group 
Oral (gavage 
in corn oil)  
0 (control group), 1.88  90 Days  No adverse effect 
measured at the only 
tested dose  (1.88)1  
(BIBRA, 1976) Unpublished report; acceptable quality. 
(2-Methyl-1,3-dithiolane [15.034]) Rat; M, F  
16/sex/group 
Oral (gavage 
in water/ 
propylglcol) 
0 (control group), 7 91 Days  No adverse effect 
measured at the only 
tested dose  (7.0)1  
(Griffiths et al., 1979a) Unpublished report; acceptable quality. 
(3-Methyl-1,2,4-trithiane [15.036]) Rat; M, F  
16/sex/group 
Oral (gavage 
in corn oil) 
0 (control group), 0.3  13 Weeks  No adverse effect 
measured at the only 
tested dose  (0.3)1  
(Mondino, 1981a) Good quality unpublished report. 
(2-Methyl-4-propyl-1,3-oxathiane 
[16.030]) 
Rat; M, F  
15/sex/group 
Oral (gavage 
in corn oil) 
0 (control group), 0.44 13 Weeks  No adverse effect 
measured at the only 
tested dose  (0.44)1 
(BIBRA, 1976) Unpublished report; acceptable quality. 
Subgroup VIII – Thioesters 
(Ethyl thioacetate [12.018]) Rat; M, F  
12/sex/group 
Diet 0 (control group), 6.48 
(nominal dose; actual dose 
=6.63 (M) and 6.7 (F) 
90 Days  No adverse effect 
measured at the only 
tested dose  (6.7)1 
(Shellenberger, 1970b) Unpublished report: acceptable quality. 
(Prenyl thioacetate [12.195])  Rat; M, F  
7/sex/group 
Oral (gavage 
in corn oil) 
0 (control group), 10  2 Weeks  No adverse effect 
measured at the only 
tested dose  (10)1  
(Wnorowski, 1997b) Good quality GLP study. 
(Methylthio 2-(acetyloxy)propionate 
[12.203]) 
Rat; M, F  
5/sex/group 
Diet  0 (control group), 500  2 Weeks  Not determined: some 
effects on food 
consumption and 
relative kidney weight at 
500  
(Hermansky & Weaver, 
1990) 
Unpublished /uncomplete report: results are 
reported as a summary - validity of 
conclusions could not be evaluated. 
(Methylthio 2-(propionyloxy) propionate 
[12.227]) 
Rat; M, F  
5/sex/group 
Diet  0 (control group), 500  2 Weeks  Not determined: some 
effects on food 
consumption and 
relative kidney weight at 
500  
(Hermansky & Weaver, 
1990) 
Unpublished /uncomplete report: results are 
reported as a summary - validity of 
conclusions could not be evaluated. 
Subgroup X – Sulphoxides/sulphones and sulphonates 
(Methylsulfinylmethane [12.175]) Rat; M, F  
50/sex/group 
Oral (gavage 
in 50% 
aqueous 
solution)  
control group (receiving 9 
ml distilled water), 1, 3, 9 
ml2,3 
18 Months  1 ml/kg (corresponding 
to 1100 mg/kg) 
(Noel et al., 1975) Study published on a peer reviewed journal. 
No histopathology reported.  
Dog; M, F  
5/sex/group 
Oral (gavage 
in 50% 
aqueous 
solution)   
control group (receiving 1 
ml distilled water), 1, 3, 9 
ml2,4 
2 Years  Not determined: effects 
observed at the lowest 
tested dose  
(Noel et al., 1975) Study published on a peer reviewed journal. 
No histopathology was reported (with 
exception of the eye). 
Monkey; M, F  
3-4 
Oral (gavage 
in DMSO)   
control group, 1, 3, 9 
ml/kg2 
74 - 87 Weeks   2970 (Vogin et al., 1970) Study published on a peer-reviewed journal. 
DMSO-induced effects confounded the 
obtained results, limiting their quality. 
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Table IV.2: Subacute / Subchronic / Chronic / Carcinogenicity Studies 
Chemical Name [FL-no]  Species; Sex 
No/Group 
Route  Dose levels 
(mg/kg/day) 
Duration NOAEL 
(mg/kg/day) 
Reference Comments 
Subgroup XI – Cyclic thioketal with oxolane rings      
spiro(2,4-dithia-1-methyl-8-oxa-
bicyclo[3.3.0]octane-3,3’-(1’-oxa-2’-
methyl)-cyclopentane and spiro(dithia-6-
methyl-7-oxa-bicyclo[3.3.0]octane-3,3’-
spiro(2,4-(1’-oxa-2-methyl)cyclopentane) 
[15.007] 
Rats, M 
10 
Diet 0, 25, 250 mg/kg bw per 
day,  
The 3rd dosed group was 
initially exposed to 250 
mg/kg bw per day, 
increased to 500 mg/kg bw 
per day after week 1 and to 
1000 mg/kg bw per day at 
week 6. 
90 days No NOAEL could be 
derived 
(Wheldon et al., 1970) Unpublished /uncomplete report:  not 
approtpriate for derivation of NOAEL due to 
limitations of the study.  
M = Male; F = Female.  
1 This study was performed with either a single dose level or multiple dose levels that produced no adverse effect.  
2 Reported as total volume dosed.  
3 10/sex/group sacrificed at 52 weeks.  
4 After 18 weeks only half of each original group continued to be treated; the rest was observed for signs of recovery.
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Developmental and reproductive toxicity data are not available for any candidate substances of the present flavouring group evaluation from chemical group 
20 and 30, but for two supporting substance evaluated by the JECFA at the 53rd meeting. Supporting substance listed in brackets. 
 
Table IV.3: Developmental and Reproductive Toxicity Studies 
Chemical Name [FL-no]  Study type 
Duration  
 
Species/Sex  
No/group 
Route  Dose  levels NOAEL (mg/kg/day) 
including information on 
possible maternal toxicity 
Reference  Comments 
Subgroup III – Monothiols 
(Butane-1-thiol [12.010]) Gestation days 6-16  Mice; F  
25 
Inhalation  0, 10, 68, 152 ppm  
total body, 6hr/day 
Maternal: 10 ppm 
Foetal: 10 ppm 
(Thomas et al., 1987) Limited relevance due to the route 
of exposure. 
Gestation days 6-19  Rat; F  
25 
Inhalation  0, 10, 68, 152 ppm 
total body, 6hr/day 
Maternal: 152 ppm 
Foetal: 152 ppm 
(Thomas et al., 1987) Limited relevance due to the route 
of exposure. 
(Thiophenol [12.080]) Gestation days 6 – 19  Rabbit; F 
15-26  
Oral  
 
10, 30 , 40 mg/kg/d Maternal: 10  
Foetal: 40  
(George et al., 1995) Limited relevance: abstract only, 
the quality could not be checked. 
Gestation days 6 – 15  Rat; F 
25  
Oral  
 
20, 35 , 50 mg/kg/d Maternal: < 20  
Foetal: 20  
(George et al., 1995) Limited relevance: abstract only 
the quality could not be checked. 
> 48 weeks Rat; F, M 
40  
Gavage  
 
0, 9, 19, 35 mg/kg Maternal: Not determined 1 
Reproduction: 9  
(NTP, 1996b) Good quality study. 
1 Liver and kidney weights accompanied by histological changes at the lowest dose tested. 
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In vitro mutagenicity/genotoxicity data are available for five candidate substances of the present flavouring group evaluation from chemical group 20 and 30, 
and for 14 supporting substances evaluated by the JECFA at the 53rd meeting. Supporting substances are listed in brackets. 
Table IV.4: GENOTOXICITY (in vitro) 
Chemical Name  [FL-no] Test system Test Object  Concentration Result  Reference  Comments 
Subgroup I – Acyclic Sulphides 
(Allyl sulfide [12.088]) Ames test  S. typhimurium TA100  0.004 – 0.44 µg/ml Negative  
(±S9) 
(Eder et al., 1982a) Review. No details on method and 
results reported. Only TA100 used. 
Sister chromatid exchange  Chinese hamster ovary cells  200 - 600 µg/ml Positive1 (Musk et al., 1997) Limited quality of study. 
Insufficiently reported. 
Chromosomal aberrations  Chinese hamster ovary cells  200 - 600 µg/ml Positive 1 (Musk et al., 1997) Limited quality of study. 
Insufficiently reported. 
Di-(1-propenyl)-sulfid (mixture) 
[12.298] 
Ames test S. typhimurium TA98, TA100, TA102, 
TA1535, TA1537 
1 – 100 µg/plate Negative1 (Stien, 2005c) Un-published GLP study. Study 
considered valid. 
Subgroup II – Cyclic Sulphides 
Tetrahydrothiophene [15.102] Ames test  S. typhimurium TA98, TA100, TA1535, 
TA1537  
50 – 5000 µg/plate  Negative (±S9)  (Pennwalt Corporation, 1987a-d) Validity of this study cannot be fully 
evaluated (only abstract provided). 
Cytogenetic assay  Human lymphocytes  12.5 – 125 µg/ml  Negative (±S9) (Pennwalt Corporation, 1987a-d) Validity of this study cannot be fully 
evaluated (only abstract provided). 
HPRT assay  Chinese hamster ovary cells  100 – 200 µg/ml Negative (±S9) (Pennwalt Corporation, 1987a-d) Validity of this study cannot be fully 
evaluated (only abstract provided). 
Sister chromatid exchange  Chinese hamster ovary cells  15.63 – 125 µg/ml  Negative (±S9)  (Pennwalt Corporation, 1987e) Validity of this study cannot be fully 
evaluated (only abstract provided). 
Unscheduled DNA synthesis  Human epithelial cells  2.5 – 5120 µg/ml  Negative (±S9) (Pennwalt Corporation, 1987a-d) Validity of this study cannot be fully 
evaluated (only abstract provided). 
(1,4-Dithiane [15.066]) Ames test  S. typhimurium TA98, TA100  0.8 – 100 µ mol/plate (96.2 - 12024 
µg/plate)  
Positive  (-S9) 
Negative  
(+S9)  
(Lee et al., 1994a) Only two strains were tested, 
otherwise acceptable study.  
 Sister chromatid exchange  Chinese hamster ovary cells  2000 µM (240 µg/ml)  Negative (±S9)  (Lee et al., 1994a) Insufficient quality. 
Subgroup III – Monothiols 
2-Methylpropane-2-thiol [12.174] Ames test  
 
S. typhimurium TA98, TA100, TA1535, 
TA1537, TA1538  
10000 µg/plate  Negative (±S9)  (Phillips Petroleum Company, 
1990a) 
Validity of this study cannot be fully 
evaluated (only abstract provided). 
Forward mutational MLTK 
assay  
L5178Y/tk+/- mouse lymphoma cells  1000 µg/ml  Positive (-S9) 
Negative (+S9)  
(Phillips Petroleum Company, 
1990a) 
Validity of this study cannot be fully 
evaluated (only abstract provided). 
Sister chromatid exchange  Chinese hamster ovary cells  1350 µg/ml  Negative 
(+S9)2 
(Phillips Petroleum Company, 
1990a) 
Validity of this study cannot be fully 
evaluated (only abstract provided). 
(Allyl mercaptan [12.004]) Modified Ames test S. typhimurium TA98, TA100, TA1535, 
TA1537, TA1538 
0.005 – 1.5 µl/ml (4.6 – 1400 µg/ml)  Negative  
(±S9)   
(Eder et al., 1980) Acceptable quality. 
(Benzyl mercaptan [12.005]) Ames test S. typhimurium TA98, TA100, TA1535, 
TA1537, TA1538 
3.6 mg/plate (3600 µg/plate) Negative  
(±S9) 
(Wild et al., 1983) Review. Methods and results 
insufficiently documented. 
(2-Mercaptopropionic acid [12.039]) Ames test  S. typhimurium TA98, TA100, TA1535, 
TA1537, TA1538  
3.6 mg/plate (3600 µg/plate)  Negative (±S9)  (Wild et al., 1983) Review. Methods and results 
insufficiently documented. 
(Benzenethiol [12.080]) Ames test S. typhimurium TA98, TA100 25 – 500 µg/plate  Negative  
(±S9) 
(LaVoie et al., 1979) Insufficient quality (only two strains 
were used, and all doses -except the 
lowest dose - were toxic). 
Subgroup IV – Dithiols 
(1,2-Ethanedithiol [12.066]) Ames test  S. typhimurium TA98, TA100, TA1535, 
TA1537, TA1538  
5 doses up to 5000 µg/plate  Negative (±S9)  (Phillips Petroleum Company, 
1990b) 
Validity cannot be fully evaluated 
(only abstract provided). 
Flavouring Group Evaluation 08, Revision 3
 
 
111 EFSA Journal 2011; 9(5):1988 
Table IV.4: GENOTOXICITY (in vitro) 
Chemical Name  [FL-no] Test system Test Object  Concentration Result  Reference  Comments 
Sister chromatid exchange  Chinese hamster ovary cells  0.5 - 50 µg/ml  Positive (±S9)   (Pence et al., 1982) Acceptable quality. 
Forward mutational assay   L5178Y/tk+/- mouse lymphoma cells  150 µg/ml  Positive  (-S9)   (Pence et al., 1982) Positive only at cytotoxic  
concentrations. 
Forward mutational assay  L5178Y/tk+/- mouse lymphoma cells  1 µg/ml  Negative (+S9) (Pence et al., 1982) Insufficiently documented. 
Subgroup V – Acyclic and cyclic disulphides 
(Diallyl disulfide [12.008]) Modified Ames test  S. typhimurium TA98, TA100, TA1535, 
TA1537, TA1538 
0.0015 – 0.15 µg/ml  Weakly 
positive (±S9)   
(Eder et al., 1980) Acceptable quality. 
Sister chromatid exchange  Chinese hamster ovary cells  2 - 25 µg/ml  Positive (±S9)   (Musk et al., 1997) Limited quality. Insufficiently 
reported. 
Chromosomal aberrations  Chinese hamster ovary cells  2 - 25 µg/ml  Positive (-S9) (Musk et al., 1997) Limited quality. Insufficiently 
reported. 
(Dimethyl disulfide [12.026]) Ames test  S. typhimurium TA98, TA100, TA102  0.000011 – 1.1 mmol/plate  
(1.04 - 104000 µg/plate) 
Negative  
(±S9)   
(Aeschbacher et al., 1989) Limited quality (only 3 strains used). 
(Phenyl disulfide [12.043]) Ames test  S. typhimurium TA98, TA100, TA1535, 
TA1537, TA1538  
3.6 mg/plate (3600 µg/plate)  Negative  
(±S9)   
(Wild et al., 1983) Review. Methods and results 
insufficiently documented. 
(Benzyl disulfide [12.081]) 
 
Ames test  S. typhimurium TA98, TA100, TA1535, 
TA1537, TA1538  
3.6 mg/plate (3600 µg/plate)  Negative  
(±S9) 
(Wild et al., 1983) Review. Methods and results 
insufficiently documented. 
Dibutyl disulfide [12.111] Forward mutational assay  Mouse lymphoma cells  NR  Negative  (-S9)  (Dooley et al., 1987) Validity cannot be fully evaluated 
(only abstract provided). 
Subgroup VIII – Thioesters 
(Methylthio 2-(acetyloxy)propionate 
[12.203]) 
Ames test S. typhimurium TA98, TA100, TA1535, 
TA1537, E. Coli WP2uvrA 
0.156-5.0 mg/plate (156-5000 
μg/plate 
Negative  
(±S9) 
(Watanabe & Morimoto, 1989a) Acceptable quality. 
(Methylthio 2-(propionyloxy) 
propionate [12.227]) 
Ames test  
 
S. typhimurium TA98, TA100, TA1535, 
TA1537, E. Coli WP2uvrA 
0.156 – 5.0 mg/plate (156 - 5000 
µg/plate)  
Negative (±S9)  (Watanabe & Morimoto, 1989b) Acceptable quality. 
Subgroup X – Sulfoxides/sulphones and sulphonates 
Methyl methane-thiosulfonate 
[12.159] 
Ames test  S. typhimurium TA98, TA100, TA1535, 
TA1537, TA1538, TA2637  
0.6 – 60 µg/plate  Negative (-S9)   (Dorange et al., 1983) Test is not appropriate for 
antimicrobial agents6. 
Ames test  S. typhimurium TA98, TA100, TA1535, 
TA1537, TA1538, TA2637  
2 – 600 µg/plate  Negative  
(+S9)  
(Dorange et al., 1983) Test is not appropriate for 
antimicrobial agents6. 
Ames test  S. typhimurium TA98, TA100, TA2637  0.6 – 60 µg/plate  Negative (-S9) (Dorange et al., 1983) Test is not appropriate for 
antimicrobial agents6. 
Ames test  S. typhimurium TA98, TA100, TA2637  0.6 – 200 µg/plate  Negative  
(+S9) 
(Dorange et al., 1983) Test is not appropriate for 
antimicrobial agents6. 
Ames test  S. typhimurium TA98, TA100, TA2637  NR Negative3 (Dorange et al., 1983) Test is not appropriate for 
antimicrobial agents6. 
Ames test  S. typhimurium TA98, TA100, TA2637  0.6 – 200 µg/plate  Negative4 (Dorange et al., 1983) Test is not appropriate for 
antimicrobial agents6. 
Yeast assay  S. cerevisiae Strain D7 1– 300 µg/ml  Negative  
(±S9) 
(Dorange et al., 1983) Test is not appropriate for 
antimicrobial agents6. 
Yeast assay 
 
S. cerevisiae Haploid strain N123 1– 100 µg/ml  Negative  
(±S9) 
(Dorange et al., 1983) Test is not appropriate for 
antimicrobial agents6. 
(Methylsulfinyl methane [12.175]) 
(synonym: dimethylsulfoxid, DMSO) 
Ames test  S. typhimurium TA97, TA98, TA100  100000 – 300000 µg/plate  Negative (±S9) (Brams et al., 1987) Insufficient method (3 strains and 3 
concentrations only). 
Ames test  S. typhimurium TA97, TA98, TA100, 
TA1535, TA1537  
100 – 10000 µg/plate  Negative (±S9)  (Zeiger et al., 1992) Acceptable quality. 
Ames test  S. typhimurium TA97, TA98, TA100, 
TA102, TA104, TA1535, TA1538, E. 
Coli WP2  
0.1 – 0.4 ml/plate (100000 - 400000 
µg/plate)  
Negative  (-S9) (Hakura et al., 1993) Good quality study. 
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Table IV.4: GENOTOXICITY (in vitro) 
Chemical Name  [FL-no] Test system Test Object  Concentration Result  Reference  Comments 
Ames test  S. typhimurium TA1537, TA2637, E. 
Coli WP2uvrA  
0.1 – 0.4 ml/plate (100000 - 400000 
µg/plate)  
Positive (-S9) 5  (Hakura et al., 1993) Good quality study. Positive at high 
doses with reduced bacterial 
survival. Doses routinely used in 
Ames test were negative. 
NR: Not reported 
1 With and without metabolic activation at clearly cytotoxic concentrations. 
2 A statistically significant increase in the number of SCEs per chromosome was seen at 1350 µg/ml and the 450 µg/ml dose level in the presence of metabolic activation; but no significant increase was seen in the remaining dose levels, and no dose 
level showed a two fold increase in SCEs; therefore, t-butyl mercaptan is not considered to be mutagenic. 
3 With 100 µl/plate fecalase  
4 With 100 µl/plate S9 metabolic activation and 100 µl/plate fecalase. Negative results reported after 2 days of incubation. Results for TA98 test strain were positive after 5 days of incubation. 
5 Positive results obtained at doses where lethal toxicity was observed. Negative results obtained at doses routinely used in Ames test. 
6 Thiosulfonates in general, and methyl methane thiosulfonate in particular, are non-specific antimicrobial agents that are active at low concentrations on prokaryotic bacteria, as well as on yeast and other eukaryotic fungi. This was even pointed out 
by Dorange et al. (1983). Therefore bacterial test systems and yeast assays are not appropriate to evaluate genotoxicity of thiosulphonates. 
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In vivo mutagenicity/genotoxicity data are available for one candidate substance of the present flavouring group evaluation from chemical group 20 and 30, 
and for four supporting substances evaluated by the JECFA at the 53rd meeting. Supporting substances are listed in brackets. 
Table IV.5: GENOTOXICITY (in vivo) 
Chemical Name [FL-no]  Test System Test 
Object  
Route Dose Result  Reference  Comments 
Subgroup I – Acyclic Sulphides 
(Allyl sulfide [12.088]) In vivo mouse 
micronucleus test  
Mouse  gavage 0.33 – 0.67 
mM/kg (38 – 77 
mg/kg)1 
Negative (Marks et al., 1992) Insufficient quality. Mixture of three substances was tested. 
Subgroup III – Monothiols  
(2-Mercaptopropionic acid [12.039]) In vivo Basc test  Drosophila  dietary route 10 mM  
(1061 µg/ml) 
Negative (Wild et al., 1983) Limited quality (insufficiently documented). The article compiles results 
obtained with 76 substances in 3 test systems. 
Subgroup V – Acyclic and cyclic disulphides 
(Allyl disulfide [12.008]) In vivo mouse 
micronucleus test  
Mouse gavage 0.33 – 0.67 
mM/kg (48 – 98 
mg/kg) 1  
Negative  (Marks et al., 1992) Insufficient quality. Mixture of three substances was tested. 
Subgroup VI – Acyclic polysulphides 
(Diallyl trisulfide [12.009]) In vivo mouse 
micronucleus test  
Mouse  gavage 0.33 – 0.67 
mM/kg (59 - 120 
mg/kg)1 
Negative  (Marks et al., 1992) Insufficient quality. Mixture of three substances was tested. 
Subgroup X – Sulphoxides/sulphones and sulphonates 
Methyl methane-thiosulfonate 
[12.159] 
In vivo genetic 
mutation 
Nicotiana 
tabacum 
seeds  
- 2 - 4 mg/ml  
(2000 - 4000 
µg/ml)  
Negative  (Dorange et al., 1983) Obscure test system2. This assay cannot be regarded as standard test. 
In vivo genetic 
mutation 
Nicotiana 
tabacum 
seeds  
- 50 – 400 µg/ml  Negative  (Dorange et al., 1983) Obscure test system2. This assay cannot be regarded as standard test. 
1 Study used a mixture of allyl sulfide, allyl disulfide and ally trisulfide in the respective ratio, 68:20:12. 
2 Heterozygotic seeds were used. After exposure, the seeds were blotted on filter paper and planted in earthenware pots in medium normally used for planting tobacco. The leaves were analysed for alterations indicating genotoxicity. 
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ABBREVIATIONS 
ADI  Acceptable Daily Intake 
CAS  Chemical Abstract Service 
CEF Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
Chemical Abstract Service 
CHO  Chinese hamster ovary (cells) 
CoE  Council of Europe 
DMSO  Dimethyl Sulphoxide 
DNA  Deoxyribonucleic acid 
EC European Commission 
EFFA  European Flavour and Fragrance Association 
EFSA  The European Food Safety Authority 
EU  European Union 
FAO  Food and Agriculture Organization of the United Nations  
FEMA  Flavor and Extract Manufacturers Association 
FGE  Flavouring Group Evaluation  
FLAVIS (FL) Flavour Information System (database) 
FMO  Flavin-containing monooxygenases 
GC  Gas Chromatography 
GI   Gastro Intestinal 
GSH  Glutathione 
GST  Glutathione-S-Transferas  
HPRT  Hypoxanthine-guanine phosphoribosyltransferase 
ID   Identity 
IOFI  International Organization of the Flavour Industry 
IR   Infrared spectroscopy 
JECFA  The Joint FAO/WHO Expert Committee on Food Additives 
LD50  Lethal Dose, 50 %; Median lethal dose 
MS  Mass spectrometry 
MSDI  Maximised Survey-derived Daily Intake 
mTAMDI Modified Theoretical Added Maximum Daily Intake 
MMS  Methyl methanesulphonate 
MMTS  Methyl methanethiosulphonate 
NAD  Nicotinamide Adenine Dinucleotide  
NADP  Nicotinamide Adenine Dinucleotide Phosphate 
NADPH Nicotinamide Adenine Dinucleotide Phosphate – reduced form 
No  Number 
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NOAEL No Observed Adverse Effect Level 
NOEL  No Observed Effect Level 
NTP  National Toxicology Program 
QR  Quinone Reductase  
SCE  Sister Chromatid Exchange 
SCF  Scientific Committee on Food 
SMART  Somatic Mutation and Recombination Test  
TAMDI Theoretical Added Maximum Daily Intake 
TDE  Thiol-Disulphide Exchange 
TMT  Thiol Methyl Transferase 
TPMT  Thio Purine Methyl Transferase 
UDS  Unscheduled DNA Synthesis  
WHO  World Health Organisation 
